Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
ethylene dichloride | [no description available] | medium | 5 | 0 | chloroethanes | hepatotoxic agent; mutagen; non-polar solvent |
1,2,4-trichlorobenzene | [no description available] | medium | 2 | 0 | trichlorobenzene | |
acetone | [no description available] | high | 130 | 0 | ketone body; methyl ketone; propanones; volatile organic compound | EC 3.5.1.4 (amidase) inhibitor; human metabolite; polar aprotic solvent |
benzene | [no description available] | medium | 34 | 0 | aromatic annulene; benzenes; volatile organic compound | carcinogenic agent; environmental contaminant; non-polar solvent |
benzyl alcohol | [no description available] | medium | 5 | 0 | benzyl alcohols | antioxidant; fragrance; metabolite; solvent |
1-butanol | [no description available] | medium | 19 | 0 | alkyl alcohol; primary alcohol; short-chain primary fatty alcohol | human metabolite; mouse metabolite; protic solvent |
2-cresol | [no description available] | medium | 1 | 0 | cresol | human xenobiotic metabolite |
3-cresol | [no description available] | medium | 3 | 0 | cresol | human xenobiotic metabolite |
methanol | [no description available] | medium | 619 | 0 | alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound | amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite |
methanol | [no description available] | medium | 619 | 3 | alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound | amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite |
naphthalene | [no description available] | medium | 11 | 0 | naphthalenes; ortho-fused bicyclic arene | apoptosis inhibitor; carcinogenic agent; environmental contaminant; mouse metabolite; plant metabolite; volatile oil component |
1-octanol | [no description available] | medium | 12 | 0 | octanol; primary alcohol | antifungal agent; bacterial metabolite; fuel additive; kairomone; plant metabolite |
4-nitrophenol | [no description available] | medium | 4 | 0 | 4-nitrophenols | human xenobiotic metabolite; mouse metabolite |
phenanthrene | [no description available] | medium | 4 | 0 | ortho-fused polycyclic arene; ortho-fused tricyclic hydrocarbon; phenanthrenes | environmental contaminant; mouse metabolite |
phenol | [no description available] | medium | 13 | 0 | phenols | antiseptic drug; disinfectant; human xenobiotic metabolite; mouse metabolite |
1-propanol | [no description available] | medium | 32 | 0 | propan-1-ols; short-chain primary fatty alcohol | metabolite; protic solvent |
pyridine | [no description available] | medium | 18 | 0 | azaarene; mancude organic heteromonocyclic parent; monocyclic heteroarene; pyridines | environmental contaminant; NMR chemical shift reference compound |
toluene | [no description available] | medium | 42 | 0 | methylbenzene; toluenes; volatile organic compound | cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent |
ether | [no description available] | medium | 14 | 0 | ether; volatile organic compound | inhalation anaesthetic; non-polar solvent; refrigerant |
2-propanol | [no description available] | medium | 65 | 0 | secondary alcohol; secondary fatty alcohol | protic solvent |
carbon tetrachloride | [no description available] | medium | 16 | 0 | chlorocarbon; chloromethanes | hepatotoxic agent; refrigerant |
aniline | [no description available] | medium | 11 | 0 | anilines; primary arylamine | |
chloroform | [no description available] | medium | 71 | 0 | chloromethanes; one-carbon compound | carcinogenic agent; central nervous system drug; inhalation anaesthetic; non-polar solvent; refrigerant |
dimethylformamide | [no description available] | high | 42 | 0 | formamides; volatile organic compound | geroprotector; hepatotoxic agent; polar aprotic solvent |
n-pentanol | [no description available] | medium | 4 | 0 | pentanol; short-chain primary fatty alcohol | human metabolite; plant metabolite |
1,1,1-trichloroethane | [no description available] | medium | 3 | 0 | chloroethanes | polar solvent |
methyl bromide | [no description available] | medium | 3 | 0 | bromohydrocarbon; bromomethanes; methyl halides | algal metabolite; fumigant insecticide; marine metabolite |
ethyl chloride | [no description available] | medium | 3 | 0 | chloroethanes | antipruritic drug; inhalation anaesthetic; local anaesthetic |
methylene chloride | [no description available] | high | 55 | 0 | chloromethanes; volatile organic compound | carcinogenic agent; polar aprotic solvent; refrigerant |
1,1-dichloroethane | [no description available] | medium | 2 | 0 | organochlorine compound | |
nitromethane | [no description available] | high | 9 | 0 | primary nitroalkane; volatile organic compound | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; explosive; NMR chemical shift reference compound; polar aprotic solvent |
tert-butyl alcohol | [no description available] | medium | 9 | 0 | tertiary alcohol | human xenobiotic metabolite |
tert-amyl alcohol | [no description available] | medium | 3 | 0 | aliphatic alcohol; tertiary alcohol | protic solvent |
isobutyl alcohol | [no description available] | medium | 3 | 0 | alkyl alcohol; primary alcohol | Saccharomyces cerevisiae metabolite |
propylene dichloride | [no description available] | medium | 1 | 0 | chloroalkane; volatile organic compound | |
2-butanol | [no description available] | medium | 2 | 0 | secondary alcohol | |
methylethyl ketone | [no description available] | high | 5 | 0 | butanone; dialkyl ketone; methyl ketone; volatile organic compound | bacterial metabolite; polar aprotic solvent |
1,1,2-trichloroethane | [no description available] | medium | 2 | 0 | chloroethanes | |
trichloroethylene | [no description available] | medium | 4 | 0 | chloroethenes | inhalation anaesthetic; mouse metabolite |
1,1,2,2-tetrachloroethane | [no description available] | medium | 2 | 0 | chloroethanes | |
1,2,3-trichlorobenzene | [no description available] | medium | 2 | 0 | trichlorobenzene | |
2-nitrotoluene | [no description available] | medium | 1 | 0 | mononitrotoluene | carcinogenic agent; environmental contaminant |
thymol | [no description available] | medium | 1 | 0 | monoterpenoid; phenols | volatile oil component |
quinoline | [no description available] | medium | 7 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinolines | |
2-xylene | [no description available] | medium | 1 | 0 | xylene | |
2-dichlorobenzene | [no description available] | medium | 1 | 0 | dichlorobenzene | hepatotoxic agent; metabolite |
1,2,4,5-tetrachlorobenzene | [no description available] | medium | 1 | 0 | tetrachlorobenzene | |
diethyl ketone | [no description available] | medium | 1 | 0 | pentanone | animal metabolite |
cyclopentanol | [no description available] | medium | 2 | 0 | cyclopentanols | |
ethyl 2-methylpropanoate | [no description available] | medium | 1 | 0 | fatty acid ethyl ester | plant metabolite |
butylphen | [no description available] | medium | 3 | 0 | phenols | allergen |
acetophenone | [no description available] | medium | 6 | 0 | acetophenones | animal metabolite; photosensitizing agent; xenobiotic |
nitrobenzene | [no description available] | medium | 5 | 0 | nitroarene; nitrobenzenes | |
anisole | [no description available] | medium | 7 | 0 | monomethoxybenzene | plant metabolite |
ethyl propionate | [no description available] | medium | 1 | 0 | propanoate ester | metabolite |
ethyl butyrate | [no description available] | medium | 1 | 0 | butyrate ester | plant metabolite |
2,4-dimethylphenol | [no description available] | medium | 1 | 0 | aromatic fungicide; phenols | disinfectant; volatile oil component |
methyl formate | [no description available] | high | 2 | 0 | formate ester; methyl ester; volatile organic compound | fumigant; insecticide; polar aprotic solvent; refrigerant |
2-pentanone | [no description available] | medium | 2 | 0 | methyl ketone; pentanone | plant metabolite |
methyl isobutyl ketone | [no description available] | medium | 1 | 0 | ketone | |
3-xylene | [no description available] | medium | 1 | 0 | xylene | |
1,3,5-trichlorobenzene | [no description available] | medium | 1 | 0 | trichlorobenzene | |
chlorobenzene | [no description available] | medium | 6 | 0 | monochlorobenzenes | solvent |
cyclohexanol | [no description available] | medium | 8 | 0 | cyclohexanols; secondary alcohol | solvent |
cyclohexanone | [no description available] | medium | 4 | 0 | cyclohexanones | human xenobiotic metabolite |
propyl acetate | [no description available] | medium | 1 | 0 | acetate ester | fragrance; plant metabolite |
pentane | [no description available] | medium | 4 | 0 | alkane; volatile organic compound | non-polar solvent; refrigerant |
1-pentene | [no description available] | medium | 1 | 0 | | |
butyl chloride | [no description available] | medium | 3 | 0 | | |
ethyl formate | [no description available] | medium | 1 | 0 | ethyl ester; formate ester | fumigant; plant metabolite |
tetrahydrofuran | [no description available] | high | 66 | 0 | cyclic ether; oxolanes; saturated organic heteromonocyclic parent; volatile organic compound | polar aprotic solvent |
isobutyl acetate | [no description available] | medium | 1 | 0 | acetate ester | Saccharomyces cerevisiae metabolite |
2-octanone | [no description available] | medium | 1 | 0 | methyl ketone | metabolite |
1-hexanol | [no description available] | medium | 2 | 0 | hexanol; primary alcohol | alarm pheromone; antibacterial agent; fragrance; plant metabolite |
heptanol | [no description available] | medium | 2 | 0 | heptanol; primary alcohol | flavouring agent; fragrance; gap junctional intercellular communication inhibitor; plant metabolite |
cyclopentanone | [no description available] | medium | 1 | 0 | cyclopentanones | Maillard reaction product |
2-naphthol | [no description available] | medium | 8 | 0 | naphthol | antinematodal drug; genotoxin; human urinary metabolite; human xenobiotic metabolite; mouse metabolite; radical scavenger |
ethyl acetate | [no description available] | high | 52 | 0 | acetate ester; ethyl ester; volatile organic compound | EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor; metabolite; polar aprotic solvent; Saccharomyces cerevisiae metabolite |
dibutyl ether | [no description available] | medium | 1 | 0 | | |
Ethyl pentanoate | [no description available] | medium | 1 | 0 | fatty acid ester | |
1,3-dichlorobenzene | [no description available] | medium | 1 | 0 | dichlorobenzene | |
pentachlorobenzene | [no description available] | medium | 1 | 0 | pentachlorobenzenes | persistent organic pollutant |
2-hexanol | [no description available] | medium | 2 | 0 | hexanol; secondary alcohol | human metabolite; plant metabolite; semiochemical |
amyl acetate | [no description available] | medium | 1 | 0 | acetate ester | metabolite |
1,2,3,4-tetrachlorobenzene | [no description available] | medium | 1 | 0 | tetrachlorobenzene | |
1,2,3,5-tetrachlorobenzene | [no description available] | medium | 1 | 0 | tetrachlorobenzene | |
butyl acetate | [no description available] | medium | 1 | 0 | acetate ester | metabolite |
monoisopropanolamine | [no description available] | medium | 1 | 0 | amino alcohol; secondary alcohol | Escherichia coli metabolite |
acetic acid | [no description available] | medium | 73 | 0 | monocarboxylic acid | antimicrobial food preservative; Daphnia magna metabolite; food acidity regulator; protic solvent |
formic acid | [no description available] | medium | 120 | 0 | monocarboxylic acid | antibacterial agent; astringent; metabolite; protic solvent; solvent |
formic acid | [no description available] | medium | 120 | 1 | monocarboxylic acid | antibacterial agent; astringent; metabolite; protic solvent; solvent |
methane | [no description available] | medium | 35 | 0 | alkane; gas molecular entity; mononuclear parent hydride; one-carbon compound | bacterial metabolite; fossil fuel; greenhouse gas |
2-mercaptoacetate | [no description available] | medium | 1 | 0 | sulfur-containing carboxylic acid | |
urea | [no description available] | medium | 34 | 0 | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
halothane | [no description available] | medium | 1 | 0 | haloalkane; organobromine compound; organochlorine compound; organofluorine compound | inhalation anaesthetic |
trimethoprim | [no description available] | medium | 4 | 0 | aminopyrimidine; methoxybenzenes | antibacterial drug; diuretic; drug allergen; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; environmental contaminant; xenobiotic |
dimethylnitrosamine | [no description available] | medium | 1 | 0 | nitrosamine | geroprotector; mutagen |
bromoacetate | [no description available] | medium | 1 | 0 | | |
ethylene | [no description available] | medium | 5 | 0 | alkene; gas molecular entity | plant hormone; refrigerant |
acetylene | [no description available] | medium | 8 | 0 | alkyne; gas molecular entity; terminal acetylenic compound | |
methyl chloride | [no description available] | medium | 3 | 0 | chloromethanes; methyl halides | marine metabolite; mutagen; refrigerant |
methyl iodide | [no description available] | medium | 4 | 0 | iodomethanes; methyl halides | fumigant insecticide |
methylamine | [no description available] | medium | 3 | 0 | methylamines; one-carbon compound; primary aliphatic amine | mouse metabolite |
methylacetylene | [no description available] | medium | 1 | 0 | alkyne; gas molecular entity; terminal acetylenic compound | |
ethylamine | [no description available] | medium | 2 | 0 | primary aliphatic amine | human metabolite |
difluoromethane | [no description available] | medium | 1 | 0 | fluoromethanes | refrigerant |
2-propylamine | [no description available] | medium | 3 | 0 | alkylamines; primary aliphatic amine | |
1,1-difluoroethane | [no description available] | medium | 1 | 0 | | |
1,1-difluoroethylene | [no description available] | medium | 1 | 0 | olefinic compound; organofluorine compound | |
dichlorofluoromethane | [no description available] | medium | 1 | 0 | | |
fluorocarbon 22 | [no description available] | medium | 1 | 0 | hydrochlorofluorocarbon | |
trifluoroethanol | [no description available] | medium | 20 | 0 | fluoroalcohol | |
freon 114 | [no description available] | medium | 1 | 0 | | |
perfluoroethane | [no description available] | medium | 1 | 0 | fluoroalkane; fluorocarbon | refrigerant |
n-methylacetamide | [no description available] | medium | 2 | 0 | acetamides; monocarboxylic acid amide | metabolite |
methyl acetate | [no description available] | high | 1 | 0 | acetate ester; methyl ester; volatile organic compound | EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor; fragrance; polar aprotic solvent |
nitroethane | [no description available] | medium | 3 | 0 | primary nitroalkane | |
benzenesulfonamide | [no description available] | medium | 1 | 0 | sulfonamide | |
3-nitrotoluene | [no description available] | medium | 1 | 0 | mononitrotoluene | |
3-dinitrobenzene | [no description available] | medium | 1 | 0 | dinitrobenzene | neurotoxin |
methylphenylsulfide | [no description available] | medium | 1 | 0 | aryl sulfide; benzenes | |
1-butene | [no description available] | medium | 1 | 0 | butene | |
propylamine | [no description available] | medium | 1 | 0 | alkylamines | |
acrylonitrile | [no description available] | high | 19 | 0 | aliphatic nitrile; volatile organic compound | antifungal agent; carcinogenic agent; fungal metabolite; mutagen; polar aprotic solvent |
3-chloroaniline | [no description available] | medium | 1 | 0 | | |
bromobenzene | [no description available] | medium | 3 | 0 | bromoarene; bromobenzenes; volatile organic compound | hepatotoxic agent; mouse metabolite; non-polar solvent |
thiophenol | [no description available] | medium | 2 | 0 | aryl thiol | |
ethyl vinyl ether | [no description available] | medium | 1 | 0 | | |
pyrroles | [no description available] | medium | 8 | 0 | pyrrole; secondary amine | |
2-ethoxyethanol | [no description available] | medium | 1 | 0 | glycol ether; primary alcohol | protic solvent; teratogenic agent |
propylene | [no description available] | medium | 2 | 0 | alkene; gas molecular entity | refrigerant; xenobiotic |
dimethyl ether | [no description available] | medium | 1 | 0 | ether | |
2,2,2-trichloroethanol | [no description available] | medium | 1 | 0 | chloroethanol | mouse metabolite |
cycloguanil | [no description available] | medium | 1 | 0 | triazines | antifolate; antiinfective agent; antimalarial; antiparasitic agent; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor |
diethyl sulfide | [no description available] | medium | 1 | 0 | ethyl sulfide | |
2-fluoroethanol | [no description available] | medium | 1 | 0 | | |
fluorobenzenes | [no description available] | medium | 6 | 0 | monofluorobenzenes | NMR chemical shift reference compound |
propadiene | [no description available] | medium | 1 | 0 | allenes | |
dimethylacetylene | [no description available] | medium | 1 | 0 | | |
nitrosobenzene | [no description available] | medium | 1 | 0 | benzenes; nitroso compound | xenobiotic metabolite |
iodobenzene | [no description available] | medium | 2 | 0 | | |
fluoromethane | [no description available] | medium | 3 | 0 | fluorohydrocarbon; fluoromethanes; methyl halides | refrigerant |
diisopropylnitrosamine | [no description available] | medium | 1 | 0 | | |
methylnitrosourea | [no description available] | medium | 3 | 0 | N-nitrosoureas | alkylating agent; carcinogenic agent; mutagen; teratogenic agent |
methyl phenyl sulfoxide | [no description available] | medium | 2 | 0 | benzenes; sulfoxide | |
2,5-dihydrofuran | [no description available] | medium | 1 | 0 | | |
4,6-diamino-2,2-dimethyl-1,2-dihydro-1-phenyl-s-triazine | [no description available] | medium | 1 | 0 | | |
diaveridine | [no description available] | medium | 1 | 0 | aminopyrimidine | antiparasitic agent; drug allergen |
tetrachloroethylene | [no description available] | medium | 3 | 0 | chlorocarbon; chloroethenes | nephrotoxic agent |
trichloroacetamide | [no description available] | medium | 1 | 0 | | |
trifluoroacetamide | [no description available] | medium | 1 | 0 | | |
5-iodouracil | [no description available] | medium | 1 | 0 | organoiodine compound | antimetabolite |
2,4-diamino-5-benzylpyrimidine | [no description available] | medium | 1 | 0 | | |
carbodiimides | [no description available] | medium | 2 | 0 | carbodiimide | |
thiourea | [no description available] | medium | 8 | 0 | one-carbon compound; thioureas; ureas | antioxidant; chromophore |
n-ethylthiourea | [no description available] | medium | 1 | 0 | thioureas | |
5-nitroso-salicylate | [no description available] | medium | 1 | 0 | hydroxybenzoic acid | |
coumarin | [no description available] | medium | 4 | 0 | coumarins | fluorescent dye; human metabolite; plant metabolite |
indole | [no description available] | medium | 3 | 0 | indole; polycyclic heteroarene | Escherichia coli metabolite |
amitriptyline | [no description available] | medium | 8 | 0 | carbotricyclic compound; tertiary amine | adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic |
desipramine | [no description available] | medium | 2 | 0 | dibenzoazepine; secondary amino compound | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; cholinergic antagonist; drug allergen; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; serotonin uptake inhibitor |
imipramine | [no description available] | medium | 5 | 0 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
mirtazapine | [no description available] | medium | 4 | 0 | benzazepine; tetracyclic antidepressant | alpha-adrenergic antagonist; anxiolytic drug; H1-receptor antagonist; histamine antagonist; oneirogen; serotonergic antagonist |
pyrilamine | [no description available] | medium | 1 | 0 | aromatic ether; ethylenediamine derivative | H1-receptor antagonist |
risperidone | [no description available] | medium | 2 | 0 | 1,2-benzoxazoles; heteroarylpiperidine; organofluorine compound; pyridopyrimidine | alpha-adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; psychotropic drug; second generation antipsychotic; serotonergic antagonist |
quinoxalines | [no description available] | medium | 4 | 0 | mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene | |
benzothiazole | [no description available] | medium | 2 | 0 | benzothiazoles | environmental contaminant; plant metabolite; xenobiotic |
benzonitrile | [no description available] | medium | 11 | 0 | benzenes; nitrile | |
4-cyanopyridine | [no description available] | medium | 1 | 0 | | |
2-chloropyridine | [no description available] | medium | 1 | 0 | monochloropyridine | |
isoquinoline | [no description available] | medium | 1 | 0 | azaarene; isoquinolines; mancude organic heterobicyclic parent; ortho-fused heteroarene | |
cinnoline | [no description available] | medium | 1 | 0 | azaarene; cinnolines; mancude organic heterobicyclic parent; ortho-fused heteroarene | |
benzoxazoles | [no description available] | medium | 3 | 0 | 1,3-benzoxazoles; mancude organic heterobicyclic parent | |
flavone | [no description available] | medium | 3 | 0 | flavones | metabolite; nematicide |
ferrocin c | [no description available] | medium | 1 | 0 | | |
n,n-dimethylbenzamide | [no description available] | medium | 1 | 0 | | |
triphenylphosphine oxide | [no description available] | medium | 1 | 0 | phosphine oxide | NMR chemical shift reference compound |
diphenyl sulfoxide | [no description available] | medium | 1 | 0 | sulfoxide | |
4-acetylpyridine | [no description available] | medium | 1 | 0 | | |
1,4-dioxane | [no description available] | high | 37 | 0 | dioxane; volatile organic compound | carcinogenic agent; metabolite; NMR chemical shift reference compound; non-polar solvent |
anthranil | [no description available] | medium | 1 | 0 | 2,1-benzoxazoles; mancude organic heterobicyclic parent | |
4-methoxybenzonitrile | [no description available] | medium | 1 | 0 | | |
2,6-difluoropyridine | [no description available] | medium | 1 | 0 | | |
1-benzylimidazole | [no description available] | medium | 2 | 0 | | |
6-chloroindole | [no description available] | medium | 1 | 0 | indoles | |
paliperidone | [no description available] | medium | 1 | 0 | 1,2-benzoxazoles; heteroarylpiperidine; organofluorine compound; pyridopyrimidine; secondary alcohol | |
l 663581 | [no description available] | medium | 1 | 0 | | |
asenapine | [no description available] | medium | 1 | 0 | 5-chloro-2-methyl-2,3,3a,12b-tetrahydrodibenzo[2,3:6,7]oxepino[4,5-c]pyrrole | |
org 4428 | [no description available] | medium | 1 | 0 | | |
4-hydroxybenzyl alcohol | [no description available] | medium | 2 | 0 | benzyl alcohols; phenols | plant metabolite |
4-hydroxybenzaldehyde | [no description available] | medium | 1 | 0 | hydroxybenzaldehyde | EC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor; mouse metabolite; plant metabolite |
4-hydroxybenzoic acid | [no description available] | medium | 3 | 0 | monohydroxybenzoic acid | algal metabolite; plant metabolite |
ethylene glycol | [no description available] | medium | 13 | 0 | ethanediol; glycol | metabolite; mouse metabolite; solvent; toxin |
acetaldehyde | [no description available] | medium | 10 | 0 | aldehyde | carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent |
benzaldehyde | [no description available] | medium | 6 | 0 | benzaldehydes | EC 3.1.1.3 (triacylglycerol lipase) inhibitor; EC 3.5.5.1 (nitrilase) inhibitor; flavouring agent; fragrance; odorant receptor agonist; plant metabolite |
benzoic acid | [no description available] | medium | 7 | 0 | benzoic acids | algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite |
dibenzofuran | [no description available] | medium | 1 | 0 | dibenzofurans; mancude organic heterotricyclic parent; polycyclic heteroarene | xenobiotic |
hydroquinone | [no description available] | medium | 2 | 0 | benzenediol; hydroquinones | antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent |
acetanilide | [no description available] | medium | 1 | 0 | acetamides; anilide | analgesic |
n,n-dimethylaniline | [no description available] | medium | 4 | 0 | dimethylaniline; tertiary amine | |
phenylacetic acid | [no description available] | medium | 4 | 0 | benzenes; monocarboxylic acid; phenylacetic acids | allergen; Aspergillus metabolite; auxin; EC 6.4.1.1 (pyruvate carboxylase) inhibitor; Escherichia coli metabolite; human metabolite; plant growth retardant; plant metabolite; Saccharomyces cerevisiae metabolite; toxin |
acetohexamide | [no description available] | medium | 1 | 0 | acetophenones; N-sulfonylurea | hypoglycemic agent; insulin secretagogue |
amobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
barbital | [no description available] | medium | 1 | 0 | barbiturates | drug allergen |
bendroflumethiazide | [no description available] | medium | 2 | 0 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
benzocaine | [no description available] | medium | 3 | 0 | benzoate ester; substituted aniline | allergen; antipruritic drug; sensitiser; topical anaesthetic |
butamben | [no description available] | medium | 1 | 0 | amino acid ester; benzoate ester; primary amino compound; substituted aniline | local anaesthetic |
4-cresol | [no description available] | medium | 3 | 0 | cresol | Escherichia coli metabolite; human metabolite; uremic toxin |
diazepam | [no description available] | medium | 5 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
dibenzothiophene | [no description available] | medium | 2 | 0 | dibenzothiophenes; mancude organic heterotricyclic parent | keratolytic drug |
fenbufen | [no description available] | medium | 1 | 0 | 4-oxo monocarboxylic acid; biphenyls | non-steroidal anti-inflammatory drug |
fludiazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound; organofluorine compound | anxiolytic drug |
flufenamic acid | [no description available] | medium | 1 | 0 | aromatic amino acid; organofluorine compound | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
flurbiprofen | [no description available] | medium | 5 | 0 | fluorobiphenyl; monocarboxylic acid | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
furosemide | [no description available] | medium | 3 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
hexobarbital | [no description available] | medium | 2 | 0 | barbiturates | |
hydrochlorothiazide | [no description available] | medium | 4 | 0 | benzothiadiazine; organochlorine compound; sulfonamide | antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
ketoprofen | [no description available] | medium | 9 | 0 | benzophenones; oxo monocarboxylic acid | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic |
meclofenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; organochlorine compound; secondary amino compound | analgesic; anticonvulsant; antineoplastic agent; antipyretic; antirheumatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
medazepam | [no description available] | medium | 1 | 0 | organic molecular entity | |
mefenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; secondary amino compound | analgesic; antipyretic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic |
vitamin k 3 | [no description available] | medium | 2 | 0 | 1,4-naphthoquinones; vitamin K | angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical |
fenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; secondary amino compound | membrane transport modulator |
nimetazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; GABA modulator; sedative |
nitrazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; C-nitro compound | anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative |
4-chlorophenol | [no description available] | medium | 3 | 0 | monochlorophenol | |
pentobarbital | [no description available] | medium | 2 | 0 | barbiturates | GABAA receptor agonist |
phenazine | [no description available] | medium | 2 | 0 | azaarene; heteranthrene; mancude organic heterotricyclic parent; phenazines; polycyclic heteroarene | |
phenobarbital | [no description available] | medium | 3 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
sulfadiazine | [no description available] | medium | 1 | 0 | pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
sulfadimethoxine | [no description available] | medium | 1 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
sulfamerazine | [no description available] | medium | 2 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen |
sulfamonomethoxine | [no description available] | medium | 1 | 0 | benzenes; sulfonamide | |
sulfanilamide | [no description available] | medium | 1 | 0 | substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
sulfaphenazole | [no description available] | medium | 1 | 0 | primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor |
sulfapyridine | [no description available] | medium | 2 | 0 | pyridines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic |
sulfisomidine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent |
sulfisoxazole | [no description available] | medium | 1 | 0 | isoxazoles; sulfonamide antibiotic; sulfonamide | antibacterial drug; drug allergen |
tolnaftate | [no description available] | medium | 1 | 0 | monothiocarbamic ester | antifungal drug |
hydrocortisone acetate | [no description available] | medium | 1 | 0 | cortisol ester; tertiary alpha-hydroxy ketone | |
cortisone acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
corticosterone | [no description available] | medium | 5 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
prednisolone | [no description available] | medium | 3 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | adrenergic agent; anti-inflammatory drug; antineoplastic agent; drug metabolite; environmental contaminant; immunosuppressive agent; xenobiotic |
spironolactone | [no description available] | medium | 2 | 0 | 3-oxo-Delta(4) steroid; oxaspiro compound; steroid lactone; thioester | aldosterone antagonist; antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
prednisolone acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
cyclobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
allobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
paramethasone | [no description available] | medium | 1 | 0 | fluorinated steroid | |
phenylethyl alcohol | [no description available] | medium | 4 | 0 | benzenes; primary alcohol | Aspergillus metabolite; fragrance; plant growth retardant; plant metabolite; Saccharomyces cerevisiae metabolite |
4-nitrobenzoic acid | [no description available] | medium | 2 | 0 | nitrobenzoic acid | |
fluocinolone acetonide | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic ketal; fluorinated steroid; glucocorticoid; organic heteropentacyclic compound; primary alpha-hydroxy ketone | anti-inflammatory drug; antipruritic drug |
4-hydroxypropiophenone | [no description available] | medium | 1 | 0 | acetophenones | |
triamcinolone acetonide | [no description available] | medium | 2 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; cyclic ketal; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone | anti-allergic agent; anti-inflammatory drug |
p-tert-amylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
dehydrocholic acid | [no description available] | medium | 1 | 0 | 12-oxo steroid; 3-oxo-5beta-steroid; 7-oxo steroid; oxo-5beta-cholanic acid | gastrointestinal drug |
carbazole | [no description available] | medium | 3 | 0 | carbazole | |
xanthenes | [no description available] | medium | 4 | 0 | xanthene | |
phenothiazine | [no description available] | medium | 2 | 0 | phenothiazine | ferroptosis inhibitor; plant metabolite; radical scavenger |
thianthrene | [no description available] | medium | 1 | 0 | mancude organic heterotricyclic parent; organosulfur heterocyclic compound; thianthrenes | |
benzidine | [no description available] | medium | 1 | 0 | biphenyls; substituted aniline | carcinogenic agent |
methyl benzoate | [no description available] | medium | 2 | 0 | benzoate ester; methyl ester | insect attractant; metabolite |
ethyl benzoate | [no description available] | medium | 1 | 0 | benzoate ester; ethyl ester | flavouring agent; fragrance; volatile oil component |
butylparaben | [no description available] | medium | 1 | 0 | organic molecular entity | |
benzothiophene | [no description available] | medium | 2 | 0 | 1-benzothiophenes; benzothiophene | |
4-isopropylphenol | [no description available] | medium | 1 | 0 | phenols | flavouring agent |
4-hydroxyacetophenone | [no description available] | medium | 2 | 0 | monohydroxyacetophenone | fungal metabolite; mouse metabolite; plant metabolite |
4-chloronitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound | |
4-nitroaniline | [no description available] | medium | 2 | 0 | nitroaniline | bacterial xenobiotic metabolite |
ethylbenzene | [no description available] | medium | 4 | 0 | alkylbenzene | |
benzyl chloride | [no description available] | medium | 1 | 0 | benzyl chlorides | |
methylaniline | [no description available] | medium | 1 | 0 | methylaniline; phenylalkylamine; secondary amine | |
phenetole | [no description available] | medium | 1 | 0 | aromatic ether | |
1,4-dibromobenzene | [no description available] | medium | 1 | 0 | dibromobenzene | |
4-bromophenol | [no description available] | medium | 2 | 0 | bromophenol | human urinary metabolite; human xenobiotic metabolite; marine metabolite; mouse metabolite; persistent organic pollutant; rat metabolite |
4-xylene | [no description available] | medium | 1 | 0 | xylene | |
isobutylmethylcarbinol | [no description available] | medium | 1 | 0 | | |
3-chlorophenol | [no description available] | medium | 1 | 0 | monochlorophenol | |
methyl cellosolve | [no description available] | medium | 1 | 0 | glycol ether | protic solvent; solvent |
diethylamine | [no description available] | medium | 10 | 0 | secondary aliphatic amine | |
1,4-butanediol | [no description available] | medium | 1 | 0 | butanediol; glycol | neurotoxin; prodrug; protic solvent |
1,5-pentanediol | [no description available] | medium | 1 | 0 | primary alcohol | |
mephobarbital | [no description available] | medium | 1 | 0 | barbiturates | anticonvulsant |
ethyl-p-hydroxybenzoate | [no description available] | medium | 1 | 0 | ethyl ester; paraben | antifungal agent; antimicrobial food preservative; phytoestrogen; plant metabolite |
2-methylbutanol | [no description available] | medium | 1 | 0 | alkyl alcohol; primary alcohol | Saccharomyces cerevisiae metabolite |
p-cresyl acetate | [no description available] | medium | 1 | 0 | benzoate ester; phenols | |
3-hydroxyanisole | [no description available] | medium | 1 | 0 | monomethoxybenzene; phenols | |
mequinol | [no description available] | medium | 1 | 0 | methoxybenzenes; phenols | metabolite |
phenanthridine | [no description available] | medium | 1 | 0 | azaarene; mancude organic heterotricyclic parent; phenanthridines; polycyclic heteroarene | |
acridines | [no description available] | medium | 9 | 0 | acridines; mancude organic heterotricyclic parent; polycyclic heteroarene | genotoxin |
carbutamide | [no description available] | medium | 1 | 0 | benzenes; sulfonamide | |
4-fluorophenol | [no description available] | medium | 1 | 0 | fluorophenol; monofluorobenzenes | |
3-fluorophenol | [no description available] | medium | 1 | 0 | | |
betamethasone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | anti-asthmatic agent; anti-inflammatory drug; immunosuppressive agent |
3,3-dimethyl-2-butanol | [no description available] | medium | 1 | 0 | | |
chenodeoxycholic acid | [no description available] | medium | 2 | 0 | bile acid; C24-steroid; dihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite |
phloroglucinol dimethyl ether | [no description available] | medium | 1 | 0 | methoxybenzenes; phenols | |
1,3-propanediol | [no description available] | medium | 2 | 0 | propane-1,3-diols | metabolite; protic solvent |
phenylacetylene | [no description available] | medium | 2 | 0 | benzenes | |
4-iodophenol | [no description available] | medium | 2 | 0 | iodophenol | |
3-bromophenol | [no description available] | medium | 1 | 0 | | |
3,5-dichlorophenol | [no description available] | medium | 1 | 0 | dichlorophenol | |
3-isopropylphenol | [no description available] | medium | 1 | 0 | | |
3-ethylphenol | [no description available] | medium | 1 | 0 | phenols | |
4-Ethoxyphenol | [no description available] | medium | 1 | 0 | aromatic ether; phenols | |
hexamethylene glycol | [no description available] | medium | 1 | 0 | diol; primary alcohol | |
4-propylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
4-nitrophenyl acetate | [no description available] | medium | 2 | 0 | C-nitro compound; phenyl acetates | |
4-n-Butylphenol | [no description available] | medium | 1 | 0 | phenols | |
sulfamethomidine | [no description available] | medium | 1 | 0 | organic molecular entity | |
2-octanol | [no description available] | medium | 1 | 0 | octanol; secondary alcohol | plant metabolite; volatile oil component |
hydrocortisone-17-butyrate | [no description available] | medium | 1 | 0 | butyrate ester; cortisol ester; primary alpha-hydroxy ketone | dermatologic drug; drug allergen |
4-n-Pentylphenol | [no description available] | medium | 1 | 0 | phenols | |
4-ethylphenol | [no description available] | medium | 2 | 0 | phenols | fungal xenobiotic metabolite |
isopentyl alcohol | [no description available] | medium | 1 | 0 | alkyl alcohol; primary alcohol; volatile organic compound | antifungal agent; Saccharomyces cerevisiae metabolite; xenobiotic metabolite |
triamcinolone | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 16alpha-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | anti-allergic agent; anti-inflammatory drug |
ursodeoxycholic acid | [no description available] | medium | 2 | 0 | bile acid; C24-steroid; dihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite |
progabide | [no description available] | medium | 1 | 0 | diarylmethane | |
1-n-butylimidazole | [no description available] | medium | 2 | 0 | | |
phenoxazine | [no description available] | medium | 1 | 0 | phenoxazine | ferroptosis inhibitor; radical scavenger |
cresatin | [no description available] | medium | 1 | 0 | benzoate ester; phenols | |
3-propylphenol | [no description available] | medium | 1 | 0 | | |
cyclobutanol | [no description available] | medium | 1 | 0 | | |
triflumizol | [no description available] | medium | 1 | 0 | | |
1-adamantaneacetic acid | [no description available] | medium | 1 | 0 | | |
cholic acid | [no description available] | medium | 11 | 0 | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite |
cortisone | [no description available] | medium | 4 | 0 | 11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite |
griseofulvin | [no description available] | medium | 3 | 0 | 1-benzofurans; antibiotic antifungal drug; benzofuran antifungal drug; organochlorine compound; oxaspiro compound | antibacterial agent; Penicillium metabolite |
3-coumaric acid | [no description available] | medium | 1 | 0 | 3-coumaric acid | |
trans-4-coumaric acid | [no description available] | medium | 2 | 0 | 4-coumaric acid | food component; mouse metabolite; plant metabolite |
cinnarizine | [no description available] | medium | 2 | 0 | diarylmethane; N-alkylpiperazine; olefinic compound | anti-allergic agent; antiemetic; calcium channel blocker; geroprotector; H1-receptor antagonist; histamine antagonist; muscarinic antagonist |
thiopental | [no description available] | medium | 2 | 0 | barbiturates | anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic |
dinoprostone | [no description available] | medium | 1 | 0 | prostaglandins E | human metabolite; mouse metabolite; oxytocic |
epoprostenol | [no description available] | medium | 1 | 0 | prostaglandins I | mouse metabolite |
dodecylphosphocholine | [no description available] | medium | 3 | 0 | phosphocholines | detergent |
phosphorylcholine | [no description available] | medium | 6 | 0 | phosphocholines | allergen; epitope; hapten; human metabolite; mouse metabolite |
carbendazim | [no description available] | medium | 6 | 0 | benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | antifungal agrochemical; antinematodal drug; metabolite; microtubule-destabilising agent |
dimethomorph | [no description available] | medium | 1 | 0 | aromatic ether; enamide; monochlorobenzenes; morpholine fungicide; tertiary carboxamide | |
carbamates | [no description available] | medium | 32 | 0 | amino-acid anion | |
anthracene | [no description available] | medium | 9 | 0 | acene; anthracenes; ortho-fused tricyclic hydrocarbon | |
1-aminoanthracene | [no description available] | medium | 1 | 0 | anthracenamine | |
potassium sulfate | [no description available] | medium | 3 | 0 | inorganic potassium salt; potassium salt | |
quinine | [no description available] | medium | 8 | 0 | cinchona alkaloid | antimalarial; muscle relaxant; non-narcotic analgesic |
3,4-diaminocyclobut-3-ene-1,2-dione | [no description available] | medium | 2 | 0 | | |
phenyl acetate | [no description available] | medium | 177 | 1 | benzenes; phenyl acetates | |
favipiravir | [no description available] | medium | 1 | 0 | hydroxypyrazine; organofluorine compound; primary carboxamide | anticoronaviral agent; antiviral drug; EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor |
glycosides | [no description available] | medium | 19 | 0 | | |
galactose | [no description available] | medium | 4 | 0 | | |
tetracycline | [no description available] | medium | 4 | 0 | | |
phthalocyanine | [no description available] | medium | 2 | 0 | phthalocyanines; tetrapyrrole fundamental parent | |
ruthenium | [no description available] | medium | 18 | 0 | iron group element atom; platinum group metal atom | |
disiloxane | [no description available] | medium | 1 | 0 | siloxane | |
silanediol | [no description available] | medium | 1 | 0 | silicon hydroxide | |
baicalin | [no description available] | medium | 3 | 0 | dihydroxyflavone; glucosiduronic acid; glycosyloxyflavone; monosaccharide derivative | antiatherosclerotic agent; antibacterial agent; anticoronaviral agent; antineoplastic agent; antioxidant; cardioprotective agent; EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; ferroptosis inhibitor; neuroprotective agent; non-steroidal anti-inflammatory drug; plant metabolite; prodrug |
phosphoric acid | [no description available] | medium | 45 | 0 | phosphoric acids | algal metabolite; fertilizer; human metabolite; NMR chemical shift reference compound; solvent |
methotrexate | [no description available] | medium | 6 | 0 | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent |
chloramine-t | [no description available] | medium | 1 | 0 | organic sodium salt | allergen; antifouling biocide; disinfectant |
peoniflorin | [no description available] | medium | 3 | 0 | | |
triethylamine | [no description available] | medium | 41 | 1 | tertiary amine | |
moxifloxacin | [no description available] | medium | 2 | 0 | aromatic ether; cyclopropanes; fluoroquinolone antibiotic; pyrrolidinopiperidine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antibacterial drug |
cereulide | [no description available] | medium | 1 | 0 | | |
nitroxyl | [no description available] | medium | 1 | 0 | nitrogen oxoacid | |
sodium hydroxide | [no description available] | medium | 19 | 1 | alkali metal hydroxide | |
norpseudoephedrine | [no description available] | medium | 1 | 0 | amphetamines; phenethylamine alkaloid | central nervous system stimulant; plant metabolite; psychotropic drug |
monomethylpropion | [no description available] | medium | 1 | 0 | aromatic ketone; secondary amino compound | |
triazoles | [no description available] | medium | 27 | 0 | 1,2,3-triazole | |
azides | [no description available] | medium | 8 | 0 | pseudohalide anion | mitochondrial respiratory-chain inhibitor |
aflatoxin b1 | [no description available] | medium | 13 | 0 | aflatoxin; aromatic ether; aromatic ketone | carcinogenic agent; human metabolite |
melamine | [no description available] | medium | 6 | 0 | triamino-1,3,5-triazine | xenobiotic metabolite |
palladium | [no description available] | medium | 16 | 0 | metal allergen; nickel group element atom; platinum group metal atom | |
n-benzyl-n,n-dimethylamine | [no description available] | medium | 1 | 0 | | |
dimethyl sulfoxide | [no description available] | high | 117 | 0 | sulfoxide; volatile organic compound | alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger |
curcumin | [no description available] | medium | 6 | 0 | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger |
itaconic acid | [no description available] | medium | 2 | 0 | dicarboxylic acid; dicarboxylic fatty acid; olefinic compound | fungal metabolite; human metabolite |
imatinib mesylate | [no description available] | medium | 1 | 0 | methanesulfonate salt | anticoronaviral agent; antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor |
cellulose | [no description available] | medium | 23 | 0 | glycoside | |
silicon | [no description available] | medium | 4 | 0 | carbon group element atom; metalloid atom; nonmetal atom | |
stearylamine | [no description available] | medium | 3 | 0 | primary aliphatic amine | film-forming compound |
chlorthalidone | [no description available] | medium | 2 | 0 | isoindoles; monochlorobenzenes; sulfonamide | |
oxadiazoles | [no description available] | medium | 6 | 0 | | |
tak 491 | [no description available] | medium | 1 | 0 | 1,2,4-oxadiazole; aromatic ether; benzimidazoles; carboxylic ester; cyclic carbonate ester; dioxolane | angiotensin receptor antagonist; antihypertensive agent; prodrug |
ammonium acetate | [no description available] | medium | 84 | 1 | acetate salt; ammonium salt | buffer; food acidity regulator |
strychnine | [no description available] | medium | 3 | 0 | monoterpenoid indole alkaloid; organic heteroheptacyclic compound | avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide |
kainic acid | [no description available] | medium | 1 | 0 | dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid | antinematodal drug; excitatory amino acid agonist |
nodularin | [no description available] | medium | 1 | 0 | ether | |
domoic acid | [no description available] | medium | 1 | 0 | L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid; tricarboxylic acid | algal metabolite; hapten; marine metabolite; neuromuscular agent; neurotoxin |
okadaic acid | [no description available] | medium | 2 | 0 | ketal | |
microcystin rr | [no description available] | medium | 1 | 0 | microcystin; organic molecular entity | bacterial metabolite; environmental contaminant; xenobiotic |
cyanoginosin lr | [no description available] | medium | 1 | 0 | microcystin | bacterial metabolite; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; environmental contaminant; xenobiotic |
1-hexyl-3-methylimidazolium | [no description available] | medium | 2 | 0 | 1-alkyl-3-methylimidazolium | |
gallic acid | [no description available] | medium | 5 | 0 | trihydroxybenzoic acid | antineoplastic agent; antioxidant; apoptosis inducer; astringent; cyclooxygenase 2 inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; geroprotector; human xenobiotic metabolite; plant metabolite |
glucosamine | [no description available] | medium | 7 | 0 | D-glucosamine | Escherichia coli metabolite; geroprotector; mouse metabolite |
linezolid | [no description available] | medium | 4 | 0 | acetamides; morpholines; organofluorine compound; oxazolidinone | antibacterial drug; protein synthesis inhibitor |
cytochrome c-t | [no description available] | medium | 10 | 0 | | |
iridium | [no description available] | medium | 4 | 0 | cobalt group element atom; platinum group metal atom | |
histidine | [no description available] | medium | 6 | 0 | amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
1-phenyl-2-(1-pyrrolidinyl)-1-pentanone | [no description available] | medium | 1 | 0 | | |
fipronil sulfone | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; pyrazoles; sulfone | marine xenobiotic metabolite |
fipronil | [no description available] | medium | 3 | 0 | (trifluoromethyl)benzenes; dichlorobenzene; nitrile; primary amino compound; pyrazoles; sulfoxide | |
ozone | [no description available] | medium | 7 | 0 | elemental molecule; gas molecular entity; reactive oxygen species; triatomic oxygen | antiseptic drug; disinfectant; electrophilic reagent; greenhouse gas; mutagen; oxidising agent; tracer |
deoxynivalenol | [no description available] | medium | 5 | 0 | cyclic ketone; enone; primary alcohol; secondary alpha-hydroxy ketone; trichothecene; triol | mycotoxin |
1,2,3,4-tetrahydroisoquinoline | [no description available] | medium | 2 | 0 | isoquinolines | |
glycerol | [no description available] | medium | 11 | 0 | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent |
2,2-di(4-methacryloxyphenyl)propane | [no description available] | medium | 2 | 0 | bisphenol; enoate ester | metabolite |
sulfur | [no description available] | medium | 17 | 0 | chalcogen; nonmetal atom | macronutrient |
trifluoroacetic acid | [no description available] | medium | 68 | 0 | fluoroalkanoic acid | human xenobiotic metabolite; NMR chemical shift reference compound; reagent |
tamsulosin | [no description available] | medium | 2 | 0 | 5-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamide | alpha-adrenergic antagonist; antineoplastic agent |
cysteine | [no description available] | medium | 11 | 0 | cysteinium | fundamental metabolite |
pemetrexed | [no description available] | medium | 1 | 0 | N-acyl-L-glutamic acid; pyrrolopyrimidine | antimetabolite; antineoplastic agent; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; EC 2.1.1.45 (thymidylate synthase) inhibitor; EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor |
1-(9-fluorenyl)methyl chloroformate | [no description available] | medium | 2 | 0 | | |
glycine | [no description available] | medium | 10 | 0 | alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical |
phosphinothricin | [no description available] | medium | 1 | 0 | organic anion | |
betadex | [no description available] | medium | 38 | 0 | cyclodextrin | |
oxytocin | [no description available] | medium | 2 | 0 | heterodetic cyclic peptide; peptide hormone | oxytocic; vasodilator agent |
platinum | [no description available] | medium | 11 | 0 | elemental platinum; nickel group element atom; platinum group metal atom | |
methylmethacrylate | [no description available] | medium | 1 | 0 | enoate ester; methyl ester | allergen; polymerisation monomer |
alkenes | [no description available] | medium | 20 | 0 | | |
choline | [no description available] | medium | 7 | 0 | cholines | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite |
palmitic acid | [no description available] | medium | 4 | 0 | long-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor; plant metabolite |
tryptophan | [no description available] | medium | 21 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
simendan | [no description available] | medium | 1 | 0 | | |
lysine | [no description available] | medium | 12 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
ammonium bicarbonate | [no description available] | medium | 3 | 0 | organooxygen compound | |
hydrogen carbonate | [no description available] | medium | 6 | 0 | carbon oxoanion | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
2,4-dichlorophenoxyacetic acid | [no description available] | medium | 2 | 0 | chlorophenoxyacetic acid; dichlorobenzene | agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin |
2-methylfuran | [no description available] | medium | 1 | 0 | furans; volatile organic compound | flavouring agent; fuel; hepatotoxic agent; human urinary metabolite; plant metabolite |
2,5-dimethylfuran | [no description available] | medium | 2 | 0 | furans | antifungal agent; bacterial metabolite; fuel; fumigant; human urinary metabolite; Maillard reaction product; plant metabolite |
nicotine | [no description available] | medium | 3 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic |
formaldehyde | [no description available] | medium | 10 | 0 | aldehyde; one-carbon compound | allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
ciguatoxins | [no description available] | medium | 1 | 0 | ciguatoxin | metabolite |
ramosetron | [no description available] | medium | 1 | 0 | indoles | |
carbene | [no description available] | medium | 4 | 0 | carbene; methanediyl | |
cocaine | [no description available] | medium | 7 | 0 | benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid | adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
18-crown-6 | [no description available] | medium | 7 | 0 | crown ether; saturated organic heteromonocyclic parent | phase-transfer catalyst |
lenvatinib | [no description available] | medium | 1 | 0 | aromatic amide; aromatic ether; cyclopropanes; monocarboxylic acid amide; monochlorobenzenes; phenylureas; quinolines | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist; orphan drug; vascular endothelial growth factor receptor antagonist |
fg-4592 | [no description available] | medium | 1 | 0 | aromatic ether; isoquinolines; N-acylglycine | EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor |
gsk1278863 | [no description available] | medium | 1 | 0 | | |
indoxacarb | [no description available] | medium | 2 | 0 | methyl ester; organochlorine insecticide | voltage-gated sodium channel blocker |
n-acetylneuraminic acid | [no description available] | medium | 1 | 0 | N-acetylneuraminic acids | antioxidant; bacterial metabolite; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; human metabolite; mouse metabolite |
titanium | [no description available] | medium | 24 | 0 | titanium group element atom | |
titanium dioxide | [no description available] | medium | 21 | 0 | titanium oxides | food colouring |
sodium bicarbonate | [no description available] | medium | 5 | 0 | one-carbon compound; organic sodium salt | antacid; food anticaking agent |
paclitaxel | [no description available] | medium | 11 | 0 | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
penconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; triazoles | |
fisetin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavonoid; 7-hydroxyflavonol; tetrahydroxyflavone | anti-inflammatory agent; antioxidant; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; metabolite; plant metabolite |
3-hydroxyflavone | [no description available] | medium | 9 | 0 | flavonols; monohydroxyflavone | |
trimethoprim, sulfamethoxazole drug combination | [no description available] | medium | 2 | 1 | | |
sulfamethoxazole | [no description available] | medium | 3 | 0 | isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic |
alpha-chymotrypsin | [no description available] | medium | 20 | 0 | | |
2-methylpentane | [no description available] | medium | 68 | 0 | alkane | |
imidazole | [no description available] | medium | 5 | 0 | imidazole | |
isoxazoles | [no description available] | medium | 4 | 0 | isoxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
potassium phosphate | [no description available] | medium | 23 | 2 | inorganic phosphate salt; inorganic potassium salt | |
citrulline | [no description available] | medium | 1 | 0 | amino acid zwitterion; citrulline | Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite |
acrylamide | [no description available] | medium | 8 | 0 | acrylamides; N-acylammonia; primary carboxamide | alkylating agent; carcinogenic agent; Maillard reaction product; mutagen; neurotoxin |
propranolol | [no description available] | medium | 10 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
n-propylbenzene | [no description available] | medium | 3 | 0 | alkylbenzene | |
octane | [no description available] | medium | 8 | 0 | alkane | xenobiotic |
chlorpyrifos | [no description available] | medium | 2 | 0 | chloropyridine; organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic |
thiophenes | [no description available] | medium | 14 | 0 | mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound | non-polar solvent |
bisphenol a | [no description available] | medium | 7 | 0 | bisphenol | endocrine disruptor; environmental contaminant; xenobiotic; xenoestrogen |
bisphenol f diglycidyl ether | [no description available] | medium | 1 | 0 | aromatic ether; diarylmethane; epoxide | |
chondroitin sulfates | [no description available] | medium | 1 | 0 | | |
amikacin | [no description available] | medium | 1 | 0 | alpha-D-glucoside; amino cyclitol glycoside; aminoglycoside; carboxamide | antibacterial drug; antimicrobial agent; nephrotoxin |
ammonium hydroxide | [no description available] | medium | 10 | 0 | inorganic hydroxy compound | food acidity regulator |
zearalenone | [no description available] | medium | 8 | 0 | macrolide; resorcinols | fungal metabolite; mycoestrogen |
ochratoxin a | [no description available] | medium | 11 | 0 | isochromanes; monocarboxylic acid amide; N-acyl-L-phenylalanine; organochlorine compound; phenylalanine derivative | Aspergillus metabolite; calcium channel blocker; carcinogenic agent; mycotoxin; nephrotoxin; Penicillium metabolite; teratogenic agent |
chlormequat | [no description available] | medium | 1 | 0 | quaternary ammonium ion | plant growth retardant |
tebuconazole | [no description available] | medium | 2 | 0 | monochlorobenzenes; tertiary alcohol; triazoles | |
uracil | [no description available] | medium | 19 | 0 | pyrimidine nucleobase; pyrimidone | allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite |
artemether | [no description available] | medium | 3 | 0 | artemisinin derivative; cyclic acetal; organic peroxide; semisynthetic derivative; sesquiterpenoid | antimalarial |
lumefantrine | [no description available] | medium | 1 | 0 | fluorenes; monochlorobenzenes; secondary alcohol; tertiary amine | antimalarial |
n-hexane | [no description available] | medium | 36 | 0 | alkane; volatile organic compound | neurotoxin; non-polar solvent |
warfarin | [no description available] | medium | 31 | 0 | benzenes; hydroxycoumarin; methyl ketone | |
biphenylacetylene | [no description available] | medium | 1 | 0 | arylacetylene; benzenes | fluorochrome |
n,n-dimethylarginine | [no description available] | medium | 1 | 0 | dimethylarginine; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor |
arginine | [no description available] | medium | 7 | 0 | arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical |
symmetric dimethylarginine | [no description available] | medium | 1 | 0 | amino acid zwitterion; dimethylarginine; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor |
n(g),n(g')-dimethyl-l-arginine | [no description available] | medium | 1 | 0 | alpha-amino acid | |
coronene | [no description available] | medium | 1 | 0 | ortho- and peri-fused polycyclic arene | |
nickel | [no description available] | medium | 14 | 0 | metal allergen; nickel group element atom | epitope; micronutrient |
dimethylacetamide | [no description available] | medium | 7 | 0 | acetamides; monocarboxylic acid amide | human metabolite |
2-nitrobenzaldehyde | [no description available] | medium | 1 | 0 | benzaldehydes; C-nitro compound | |
rebaudioside a | [no description available] | medium | 1 | 0 | beta-D-glucoside; rebaudioside; tetracyclic diterpenoid | sweetening agent |
glucose, (beta-d)-isomer | [no description available] | medium | 22 | 0 | D-glucopyranose | epitope; mouse metabolite |
stevioside | [no description available] | medium | 1 | 0 | beta-D-glucoside; bridged compound; diterpene glycoside; ent-kaurane diterpenoid; tetracyclic diterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; hypoglycemic agent; plant metabolite; sweetening agent |
carbostyril | [no description available] | medium | 12 | 0 | monohydroxyquinoline; quinolone | bacterial xenobiotic metabolite |
anthranilamide | [no description available] | medium | 1 | 0 | substituted aniline | |
anthranilic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid | human metabolite; mouse metabolite |
ammonium hydroxide | [no description available] | medium | 26 | 0 | azane; gas molecular entity; mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant |
4-aminobenzoic acid | [no description available] | medium | 1 | 0 | aminobenzoate; aromatic amino-acid anion | Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
9-carboxymethoxymethylguanine | [no description available] | medium | 1 | 0 | oxopurine | |
guanine | [no description available] | medium | 6 | 0 | 2-aminopurines; oxopurine; purine nucleobase | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
acyclovir | [no description available] | medium | 1 | 0 | 2-aminopurines; oxopurine | antimetabolite; antiviral drug |
acetamide | [no description available] | medium | 6 | 0 | acetamides; carboximidic acid; monocarboxylic acid amide; N-acylammonia | |
adenosine monophosphate | [no description available] | medium | 2 | 0 | adenosine 5'-phosphate; purine ribonucleoside 5'-monophosphate | adenosine A1 receptor agonist; cofactor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.11 (fructose-bisphosphatase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
alanine | [no description available] | medium | 6 | 0 | alanine zwitterion; alanine; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid | EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; fundamental metabolite |
s 8932 | [no description available] | medium | 1 | 0 | aromatic amine; C-nucleoside; carboxylic ester; nitrile; phosphoramidate ester; pyrrolotriazine | anticoronaviral agent; antiviral drug; prodrug |
niacinamide | [no description available] | medium | 6 | 0 | pyridine alkaloid; pyridinecarboxamide; vitamin B3 | anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor |
uric acid | [no description available] | medium | 6 | 0 | uric acid | Escherichia coli metabolite; human metabolite; mouse metabolite |
metformin | [no description available] | medium | 6 | 0 | guanidines | environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic |
haloperidol | [no description available] | medium | 7 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
malondialdehyde | [no description available] | medium | 4 | 0 | dialdehyde | biomarker |
alternariol | [no description available] | medium | 2 | 0 | benzochromenone; phenols | EC 3.1.1.8 (cholinesterase) inhibitor; metabolite; mycotoxin |
sodium dodecyl sulfate | [no description available] | medium | 54 | 0 | organic sodium salt | detergent; protein denaturant |
mobic | [no description available] | medium | 2 | 0 | 1,3-thiazoles; benzothiazine; monocarboxylic acid amide | analgesic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
thiazoles | [no description available] | medium | 20 | 0 | 1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
procainamide | [no description available] | medium | 2 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
deuterium | [no description available] | medium | 17 | 0 | dihydrogen | |
virginiamycin | [no description available] | medium | 2 | 0 | | |
erythromycin | [no description available] | medium | 6 | 0 | cyclic ketone; erythromycin | |
streptogramin a | [no description available] | medium | 1 | 0 | 1,3-oxazoles; cyclic ketone; enamide; lactam; macrolide antibiotic; macrolide; pyrroline; secondary alcohol; secondary carboxamide; tertiary carboxamide | antibacterial drug; Mycoplasma genitalium metabolite |
penicillin g | [no description available] | medium | 4 | 0 | penicillin allergen; penicillin | antibacterial drug; drug allergen; epitope |
virginiamycin factor s1 | [no description available] | medium | 1 | 0 | cyclodepsipeptide; macrolide antibiotic | antibacterial drug; bacterial metabolite |
2-thiocytosine | [no description available] | medium | 1 | 0 | | |
cytosine | [no description available] | medium | 7 | 0 | aminopyrimidine; pyrimidine nucleobase; pyrimidone | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
sodium thiosulfate | [no description available] | medium | 6 | 0 | inorganic sodium salt | antidote to cyanide poisoning; antifungal drug; nephroprotective agent |
thiosulfates | [no description available] | medium | 8 | 0 | divalent inorganic anion; sulfur oxide; sulfur oxoanion | human metabolite |
leucylleucine | [no description available] | medium | 1 | 0 | peptide | |
muramidase | [no description available] | medium | 17 | 0 | | |
selenium | [no description available] | medium | 2 | 0 | chalcogen; nonmetal atom | micronutrient |
chlorite | [no description available] | medium | 1 | 0 | chlorine oxoanion; monovalent inorganic anion | |
sarcosine | [no description available] | medium | 1 | 0 | N-alkylglycine zwitterion; N-alkylglycine; N-methyl-amino acid; N-methylglycines | Escherichia coli metabolite; glycine receptor agonist; glycine transporter 1 inhibitor; human metabolite; mouse metabolite |
chlorine | [no description available] | medium | 17 | 0 | halide anion; monoatomic chlorine | cofactor; Escherichia coli metabolite; human metabolite |
gamma-valerolactone | [no description available] | medium | 1 | 0 | butan-4-olide | flavouring agent; human xenobiotic metabolite |
homocysteine | [no description available] | medium | 2 | 0 | amino acid zwitterion; homocysteine; serine family amino acid | fundamental metabolite; mouse metabolite |
methyl tert-butyl ether | [no description available] | medium | 13 | 0 | ether | fuel additive; metabolite; non-polar solvent |
dansyl chloride | [no description available] | medium | 2 | 0 | aminonaphthalene; sulfonic acid derivative | |
tyramine | [no description available] | medium | 3 | 0 | monoamine molecular messenger; primary amino compound; tyramines | EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter |
histamine | [no description available] | medium | 4 | 0 | aralkylamino compound; imidazoles | human metabolite; mouse metabolite; neurotransmitter |
trichloroacetic acid | [no description available] | medium | 12 | 1 | monocarboxylic acid; organochlorine compound | carcinogenic agent; metabolite; mouse metabolite |
spermidine | [no description available] | medium | 2 | 0 | polyazaalkane; triamine | autophagy inducer; fundamental metabolite; geroprotector |
putrescine | [no description available] | medium | 3 | 0 | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite |
cadaverine | [no description available] | medium | 2 | 0 | alkane-alpha,omega-diamine | Daphnia magna metabolite; Escherichia coli metabolite; mouse metabolite; plant metabolite |
florfenicol | [no description available] | medium | 2 | 0 | organochlorine compound; organofluorine compound; secondary alcohol; secondary carboxamide; sulfone | antimicrobial agent |
thiamphenicol | [no description available] | medium | 5 | 0 | monocarboxylic acid amide; sulfone | antimicrobial agent; immunosuppressive agent |
chloramphenicol | [no description available] | medium | 9 | 0 | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
1-butyl-3-methylimidazolium tetrafluoroborate | [no description available] | medium | 6 | 0 | | |
salicylaldehyde | [no description available] | medium | 4 | 0 | hydroxybenzaldehyde | nematicide; plant metabolite |
alpha-cyano-4-hydroxycinnamate | [no description available] | medium | 3 | 0 | | |
myelin basic protein | [no description available] | medium | 1 | 0 | | |
mbp-8298 | [no description available] | medium | 1 | 0 | | |
isavuconazole | [no description available] | medium | 1 | 0 | 1,3-thiazoles; conazole antifungal drug; difluorobenzene; nitrile; tertiary alcohol; triazole antifungal drug | EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; ergosterol biosynthesis inhibitor; orphan drug |
itraconazole | [no description available] | medium | 4 | 0 | aromatic ether; conazole antifungal drug; cyclic ketal; dichlorobenzene; dioxolane; N-arylpiperazine; triazole antifungal drug; triazoles | EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; Hedgehog signaling pathway inhibitor; P450 inhibitor |
fluconazole | [no description available] | medium | 4 | 0 | conazole antifungal drug; difluorobenzene; tertiary alcohol; triazole antifungal drug | environmental contaminant; P450 inhibitor; xenobiotic |
voriconazole | [no description available] | medium | 3 | 0 | conazole antifungal drug; difluorobenzene; pyrimidines; tertiary alcohol; triazole antifungal drug | P450 inhibitor |
posaconazole | [no description available] | medium | 1 | 0 | aromatic ether; conazole antifungal drug; N-arylpiperazine; organofluorine compound; oxolanes; triazole antifungal drug; triazoles | trypanocidal drug |
1-anilino-8-naphthalenesulfonate | [no description available] | medium | 18 | 0 | aminonaphthalene; naphthalenesulfonic acid | fluorescent probe |
4-nitrophenyl laurate | [no description available] | medium | 1 | 0 | | |
2-isobutyl-3-methoxypyrazine | [no description available] | medium | 1 | 0 | | |
pyrazines | [no description available] | medium | 6 | 0 | diazine; pyrazines | Daphnia magna metabolite |
chloranilic acid | [no description available] | medium | 4 | 0 | | |
2-aminopyrimidine | [no description available] | medium | 1 | 0 | aminopyrimidine | |
coumachlor | [no description available] | medium | 3 | 0 | hydroxycoumarin | |
moexipril | [no description available] | medium | 1 | 0 | peptide | |
benazepril | [no description available] | medium | 2 | 0 | benzazepine; dicarboxylic acid monoester; ethyl ester; lactam | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; prodrug |
benazeprilat | [no description available] | medium | 2 | 0 | benzazepine; dicarboxylic acid; lactam | EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
azoxystrobin | [no description available] | medium | 6 | 0 | aryloxypyrimidine; enoate ester; enol ether; methoxyacrylate strobilurin antifungal agent; methyl ester; nitrile | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; quinone outside inhibitor; xenobiotic |
octadecylsilane | [no description available] | medium | 8 | 0 | | |
hydrogen | [no description available] | medium | 38 | 0 | elemental hydrogen; elemental molecule; gas molecular entity | antioxidant; electron donor; food packaging gas; fuel; human metabolite |
oligonucleotides | [no description available] | medium | 14 | 0 | | |
furaneol | [no description available] | medium | 1 | 0 | cyclic ketone; enol; furans | flavouring agent; fragrance; plant metabolite |
zoxamide | [no description available] | medium | 1 | 0 | alpha-chloroketone; benzamides; dichlorobenzene | |
pyrethrins | [no description available] | medium | 10 | 0 | | |
fenvalerate | [no description available] | medium | 4 | 0 | aromatic ether; carboxylic ester; monochlorobenzenes | pyrethroid ester acaricide; pyrethroid ester insecticide |
cypermethrin | [no description available] | medium | 3 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound | agrochemical; molluscicide; pyrethroid ester acaricide; pyrethroid ester insecticide |
cyfluthrin | [no description available] | medium | 1 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester insecticide |
formetanate | [no description available] | medium | 1 | 0 | carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
perampanel | [no description available] | medium | 2 | 0 | bipyridines; nitrile; pyridone | AMPA receptor antagonist; anticonvulsant |
piperidines | [no description available] | medium | 12 | 0 | | |
alogliptin | [no description available] | medium | 1 | 0 | nitrile; piperidines; primary amino compound; pyrimidines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent |
magnesium sulfate | [no description available] | medium | 14 | 0 | magnesium salt; metal sulfate; organic magnesium salt | anaesthetic; analgesic; anti-arrhythmia drug; anticonvulsant; calcium channel blocker; cardiovascular drug; fertilizer; tocolytic agent |
1,7-phenanthroline | [no description available] | medium | 10 | 0 | phenanthroline | |
dodecyl sulfate | [no description available] | medium | 1 | 0 | alkyl sulfate | |
bradykinin | [no description available] | medium | 3 | 0 | oligopeptide | human blood serum metabolite; vasodilator agent |
concanavalin a | [no description available] | medium | 1 | 0 | | |
rotenone | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin |
fluorescein-5-isothiocyanate | [no description available] | medium | 3 | 0 | fluorescein isothiocyanate | |
lactic acid | [no description available] | medium | 6 | 0 | 2-hydroxy monocarboxylic acid | algal metabolite; Daphnia magna metabolite |
fentanyl | [no description available] | medium | 2 | 0 | anilide; monocarboxylic acid amide; piperidines | adjuvant; anaesthesia adjuvant; anaesthetic; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic |
biguanides | [no description available] | medium | 2 | 0 | guanidines | |
fenspiride | [no description available] | medium | 1 | 0 | azaspiro compound | |
patulin | [no description available] | medium | 3 | 0 | furopyran; gamma-lactone; lactol | antimicrobial agent; Aspergillus metabolite; carcinogenic agent; mutagen; mycotoxin; Penicillium metabolite |
dextrothyroxine | [no description available] | medium | 7 | 0 | | |
doramectin | [no description available] | medium | 3 | 0 | macrolide | |
bms-650032 | [no description available] | medium | 1 | 0 | oligopeptide | |
lipoamide | [no description available] | medium | 1 | 0 | dithiolanes; monocarboxylic acid amide | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
gamma-aminobutyric acid | [no description available] | medium | 7 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid | human metabolite; neurotransmitter; Saccharomyces cerevisiae metabolite; signalling molecule |
glutamine | [no description available] | medium | 4 | 0 | amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
glutamic acid | [no description available] | medium | 3 | 0 | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
venlafaxine hydrochloride | [no description available] | medium | 2 | 0 | hydrochloride | |
lesinurad | [no description available] | medium | 1 | 0 | aryl sulfide; cyclopropanes; monocarboxylic acid; naphthalenes; organobromine compound; triazoles | uricosuric drug |
cyanoacetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
silver | [no description available] | medium | 12 | 0 | copper group element atom; elemental silver | Escherichia coli metabolite |
piperidine | [no description available] | medium | 3 | 0 | azacycloalkane; piperidines; saturated organic heteromonocyclic parent; secondary amine | base; catalyst; human metabolite; non-polar solvent; plant metabolite; protic solvent; reagent |
dufulin | [no description available] | medium | 1 | 0 | | |
l 743,872 | [no description available] | medium | 1 | 0 | | |
catechin | [no description available] | medium | 12 | 0 | catechin | antioxidant; plant metabolite |
taxifolin | [no description available] | medium | 2 | 0 | taxifolin | metabolite |
quercetin | [no description available] | medium | 10 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger |
chlorantranilipole | [no description available] | medium | 3 | 0 | monochlorobenzenes; organobromine compound; pyrazole insecticide; pyrazoles; pyridines; secondary carboxamide | ryanodine receptor agonist |
finasteride | [no description available] | medium | 2 | 0 | 3-oxo steroid; aza-steroid; delta-lactam | androgen antagonist; antihyperplasia drug; EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor |
rhodium | [no description available] | medium | 2 | 0 | cobalt group element atom | |
nad | [no description available] | medium | 9 | 0 | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite |
arsenic | [no description available] | medium | 5 | 0 | metalloid atom; pnictogen | micronutrient |
pentaerythrityl triacrylate | [no description available] | medium | 7 | 0 | | |
1,1-diphenyl-2-picrylhydrazyl | [no description available] | medium | 5 | 1 | | |
benzofuran | [no description available] | medium | 1 | 0 | 1-benzofurans; benzofuran | |
benzofurans | [no description available] | medium | 11 | 0 | | |
tyrosine | [no description available] | medium | 7 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine | EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical |
adenine | [no description available] | medium | 7 | 0 | 6-aminopurines; purine nucleobase | Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
phenylalanine | [no description available] | medium | 10 | 0 | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
xanthine | [no description available] | medium | 1 | 0 | xanthine | Saccharomyces cerevisiae metabolite |
uridine | [no description available] | medium | 2 | 0 | uridines | drug metabolite; fundamental metabolite; human metabolite |
metronidazole | [no description available] | medium | 4 | 0 | C-nitro compound; imidazoles; primary alcohol | antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic |
beta-lactams | [no description available] | medium | 3 | 0 | beta-lactam antibiotic allergen; beta-lactam | |
lauryl gallate | [no description available] | medium | 1 | 0 | gallate ester | |
morin | [no description available] | medium | 2 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent |
rutin | [no description available] | medium | 5 | 0 | disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone | antioxidant; metabolite |
chrysin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; dihydroxyflavone | anti-inflammatory agent; antineoplastic agent; antioxidant; EC 2.7.11.18 (myosin-light-chain kinase) inhibitor; hepatoprotective agent; plant metabolite |
potassium hydroxide | [no description available] | medium | 11 | 0 | alkali metal hydroxide | |
s 1743 | [no description available] | medium | 1 | 0 | magnesium salt | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
aripiprazole | [no description available] | medium | 1 | 0 | aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone | drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist |
opc-14857 | [no description available] | medium | 1 | 0 | | |
epoxiconazole | [no description available] | medium | 1 | 0 | epoxide; monochlorobenzenes; monofluorobenzenes; triazoles | |
hexaconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; tertiary alcohol; triazoles | chelator |
systhane | [no description available] | medium | 1 | 0 | monochlorobenzenes; nitrile; triazoles | |
paclobutrazol | [no description available] | medium | 1 | 0 | | |
diniconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; olefinic compound; secondary alcohol; triazoles | |
cumene | [no description available] | medium | 1 | 0 | alkylbenzene | |
ajoene | [no description available] | medium | 1 | 0 | sulfoxide | |
allicin | [no description available] | medium | 2 | 0 | botanical anti-fungal agent; sulfoxide | antibacterial agent |
linoleic acid | [no description available] | medium | 6 | 0 | octadecadienoic acid; omega-6 fatty acid | algal metabolite; Daphnia galeata metabolite; plant metabolite |
ar c155858 | [no description available] | medium | 1 | 0 | | |
pyrimidine | [no description available] | medium | 6 | 0 | diazine; pyrimidines | Daphnia magna metabolite |
pyrimidinones | [no description available] | medium | 6 | 0 | | |
azd3965 | [no description available] | medium | 1 | 0 | | |
oleanolic acid | [no description available] | medium | 2 | 0 | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite |
3,3'-iminodipropionitrile | [no description available] | medium | 1 | 0 | | |
o-phthalaldehyde | [no description available] | medium | 11 | 0 | benzaldehydes; dialdehyde | epitope |
acetylcysteine | [no description available] | medium | 2 | 0 | acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid | antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary |
captopril | [no description available] | medium | 2 | 0 | alkanethiol; L-proline derivative; N-acylpyrrolidine; pyrrolidinemonocarboxylic acid | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
allyl alcohol | [no description available] | medium | 1 | 0 | primary allylic alcohol; propenol | antibacterial agent; fungicide; herbicide; insecticide; plant metabolite |
e-z cinnamic acid | [no description available] | medium | 3 | 0 | cinnamic acid | plant metabolite |
hydroxyethyl methacrylate | [no description available] | medium | 4 | 0 | enoate ester | allergen; polymerisation monomer |
ethylene dimethacrylate | [no description available] | medium | 23 | 0 | enoate ester | allergen; cross-linking reagent; polymerisation monomer |
metalaxyl | [no description available] | medium | 3 | 0 | alanine derivative; aromatic amide; carboxamide; ether; methyl ester | |
amoxicillin | [no description available] | medium | 7 | 0 | penicillin allergen; penicillin | antibacterial drug |
p-aminoazobenzene | [no description available] | medium | 1 | 0 | | |
sudan iii | [no description available] | medium | 1 | 0 | azobenzenes; bis(azo) compound; naphthols | carcinogenic agent; fluorochrome; histological dye |
methacrylic acid | [no description available] | medium | 13 | 0 | alpha,beta-unsaturated monocarboxylic acid | |
carbonyl sulfide | [no description available] | medium | 1 | 0 | one-carbon compound; organosulfur compound | |
amlodipine | [no description available] | medium | 5 | 0 | dihydropyridine; ethyl ester; methyl ester; monochlorobenzenes; primary amino compound | antihypertensive agent; calcium channel blocker; vasodilator agent |
cytisine | [no description available] | medium | 1 | 0 | alkaloid; bridged compound; lactam; organic heterotricyclic compound; secondary amino compound | nicotinic acetylcholine receptor agonist; phytotoxin; plant metabolite |
fluoroacetamide | [no description available] | medium | 1 | 0 | 2-fluoroacetamides | |
fluoroacetic acid | [no description available] | medium | 1 | 0 | haloacetic acid; organofluorine compound | EC 4.2.1.3 (aconitate hydratase) inhibitor |
gentian violet | [no description available] | medium | 5 | 0 | organic chloride salt | anthelminthic drug; antibacterial agent; antifungal agent; antiseptic drug; histological dye |
5-methylcytidine | [no description available] | medium | 2 | 0 | methylcytidine | |
cytidine | [no description available] | medium | 3 | 0 | cytidines | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
deoxycytidine | [no description available] | medium | 3 | 0 | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
cetyltrimethylammonium ion | [no description available] | medium | 6 | 0 | quaternary ammonium ion | |
tropisetron | [no description available] | medium | 1 | 0 | indolyl carboxylic acid | |
granisetron | [no description available] | medium | 2 | 0 | aromatic amide; indazoles | |
ondansetron | [no description available] | medium | 3 | 1 | carbazoles | |
chloroacetonitrile | [no description available] | medium | 2 | 0 | nitrile | |
dibromoacetonitrile | [no description available] | medium | 1 | 0 | aliphatic nitrile | |
dichloroacetonitrile | [no description available] | medium | 1 | 0 | aliphatic nitrile | |
trichloroacetonitrile | [no description available] | medium | 1 | 0 | aliphatic nitrile; organochlorine compound | |
luteolin-7-glucoside | [no description available] | medium | 1 | 0 | beta-D-glucoside; glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone | antioxidant; plant metabolite |
hyperoside | [no description available] | medium | 1 | 0 | beta-D-galactoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | hepatoprotective agent; plant metabolite |
luteolin | [no description available] | medium | 3 | 0 | 3'-hydroxyflavonoid; tetrahydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; c-Jun N-terminal kinase inhibitor; EC 2.3.1.85 (fatty acid synthase) inhibitor; immunomodulator; nephroprotective agent; plant metabolite; radical scavenger; vascular endothelial growth factor receptor antagonist |
kaempferol | [no description available] | medium | 3 | 0 | 7-hydroxyflavonol; flavonols; tetrahydroxyflavone | antibacterial agent; geroprotector; human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; plant metabolite |
acacetin | [no description available] | medium | 1 | 0 | dihydroxyflavone; monomethoxyflavone | anticonvulsant; plant metabolite |
chlorogenic acid | [no description available] | medium | 8 | 0 | cinnamate ester; tannin | food component; plant metabolite |
guanosine tetraphosphate | [no description available] | medium | 1 | 0 | guanosine bisphosphate | Escherichia coli metabolite; mouse metabolite |
5-phenylhydantoin, (+-)-isomer | [no description available] | medium | 1 | 0 | | |
phenytoin | [no description available] | medium | 5 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
fosphenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | |
hydantoins | [no description available] | medium | 4 | 0 | imidazolidine-2,4-dione | |
ginsenosides | [no description available] | medium | 7 | 0 | | |
vicenin ii | [no description available] | medium | 1 | 0 | C-glycosyl compound; trihydroxyflavone | metabolite |
isoschaftoside | [no description available] | medium | 1 | 0 | C-glycosyl compound; trihydroxyflavone | metabolite |
apigenin | [no description available] | medium | 5 | 0 | trihydroxyflavone | antineoplastic agent; metabolite |
methocarbamol | [no description available] | medium | 1 | 0 | aromatic ether; carbamate ester; secondary alcohol | |
guaifenesin | [no description available] | medium | 3 | 0 | methoxybenzenes | |
salicylic acid | [no description available] | medium | 8 | 0 | monohydroxybenzoic acid | algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite |
aspirin | [no description available] | medium | 8 | 0 | benzoic acids; phenyl acetates; salicylates | anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent |
styrene | [no description available] | medium | 4 | 0 | styrenes; vinylarene; volatile organic compound | mouse metabolite; mutagen; plant metabolite |
kaurenoic acid | [no description available] | medium | 1 | 0 | | |
4-nitrophenyl butyrate | [no description available] | medium | 3 | 0 | butyrate ester; C-nitro compound | |
quinic acid | [no description available] | medium | 1 | 0 | | |
isochlorogenic acid | [no description available] | medium | 1 | 0 | quinic acid | |
mercaptoethanol | [no description available] | medium | 4 | 0 | alkanethiol; primary alcohol | geroprotector |
2-aminoisobutyric acid | [no description available] | medium | 2 | 0 | 2,2-dialkylglycine zwitterion; 2,2-dialkylglycine | |
mdv 3100 | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; benzamides; imidazolidinone; monofluorobenzenes; nitrile; thiocarbonyl compound | androgen antagonist; antineoplastic agent |
stigmasterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; phytosterols; stigmastane sterol | plant metabolite |
metaproterenol | [no description available] | medium | 1 | 0 | aralkylamino compound; phenylethanolamines; resorcinols; secondary alcohol; secondary amino compound | |
tetracyanoethylene | [no description available] | medium | 4 | 0 | | |
atenolol | [no description available] | medium | 4 | 0 | ethanolamines; monocarboxylic acid amide; propanolamine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic |
reserpine | [no description available] | medium | 2 | 0 | alkaloid ester; methyl ester; yohimban alkaloid | adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic |
quinidine | [no description available] | medium | 3 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
cimetidine | [no description available] | medium | 1 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
levofloxacin | [no description available] | medium | 2 | 0 | 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid; fluoroquinolone antibiotic; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
atorvastatin | [no description available] | medium | 3 | 0 | aromatic amide; dihydroxy monocarboxylic acid; monofluorobenzenes; pyrroles; statin (synthetic) | environmental contaminant; xenobiotic |
ammonium sulfate | [no description available] | medium | 8 | 0 | ammonium salt; inorganic sulfate salt | fertilizer |
carbaspirin calcium | [no description available] | medium | 1 | 0 | | |
valerophenone | [no description available] | medium | 1 | 0 | aromatic ketone | plant metabolite; volatile oil component |
4-methylimidazole | [no description available] | medium | 1 | 0 | imidazoles | carcinogenic agent; reaction intermediate |
linagliptin | [no description available] | medium | 1 | 0 | aminopiperidine; quinazolines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent |
9,10-dimethylanthracene | [no description available] | medium | 1 | 0 | | |
aspartic acid | [no description available] | medium | 3 | 0 | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
hydrogen cyanide | [no description available] | medium | 11 | 0 | hydracid; one-carbon compound | Escherichia coli metabolite; human metabolite; poison |
mirabegron | [no description available] | medium | 1 | 0 | 1,3-thiazoles; aromatic amide; ethanolamines; monocarboxylic acid amide | beta-adrenergic agonist |
gw9508 | [no description available] | medium | 1 | 0 | aromatic amine | |
imiquimod | [no description available] | medium | 1 | 0 | imidazoquinoline | antineoplastic agent; interferon inducer |
gefitinib | [no description available] | medium | 2 | 0 | aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist |
chlorfluazuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide; dichlorobenzene; organochlorine insecticide; organofluorine insecticide | |
phencyclidine | [no description available] | medium | 3 | 0 | benzenes; piperidines | anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug |
limonin | [no description available] | medium | 1 | 0 | epoxide; furans; hexacyclic triterpenoid; lactone; limonoid; organic heterohexacyclic compound | inhibitor; metabolite; volatile oil component |
rutecarpine | [no description available] | medium | 1 | 0 | beta-carbolines | |
evodiamine | [no description available] | medium | 1 | 0 | beta-carbolines | |
quinazolines | [no description available] | medium | 5 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinazolines | |
tiletamine hydrochloride | [no description available] | medium | 8 | 0 | | |
viscosinamide | [no description available] | medium | 1 | 0 | | |
iodosobenzene | [no description available] | medium | 1 | 0 | | |
atrazine | [no description available] | medium | 2 | 0 | chloro-1,3,5-triazine; diamino-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
manganese | [no description available] | medium | 8 | 0 | elemental manganese; manganese group element atom | Escherichia coli metabolite; micronutrient |
dithiothreitol | [no description available] | medium | 8 | 0 | 1,4-dimercaptobutane-2,3-diol; butanediols; dithiol; glycol; thiol | chelator; human metabolite; reducing agent |
tris(2-carboxyethyl)phosphine | [no description available] | medium | 1 | 0 | phosphine derivative; tricarboxylic acid | reducing agent |
peptide a | [no description available] | medium | 1 | 0 | | |
efavirenz | [no description available] | medium | 3 | 0 | acetylenic compound; benzoxazine; cyclopropanes; organochlorine compound; organofluorine compound | antiviral drug; HIV-1 reverse transcriptase inhibitor |
urethane | [no description available] | medium | 1 | 0 | carbamate ester | fungal metabolite; mutagen |
lidocaine | [no description available] | medium | 6 | 0 | benzenes; monocarboxylic acid amide; tertiary amino compound | anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic |
zirconium | [no description available] | medium | 13 | 0 | titanium group element atom | |
pregabalin | [no description available] | medium | 1 | 0 | gamma-amino acid | anticonvulsant; calcium channel blocker |
humulin s | [no description available] | medium | 2 | 0 | | |
n,n'-methylenebisacrylamide | [no description available] | medium | 2 | 0 | | |
phosphoric acid, trisodium salt | [no description available] | medium | 13 | 0 | sodium phosphate | |
hydrochloric acid | [no description available] | medium | 14 | 0 | chlorine molecular entity; gas molecular entity; hydrogen halide; mononuclear parent hydride | mouse metabolite |
sucrose | [no description available] | medium | 3 | 0 | glycosyl glycoside | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent |
nortriptyline | [no description available] | medium | 5 | 0 | organic tricyclic compound; secondary amine | adrenergic uptake inhibitor; analgesic; antidepressant; antineoplastic agent; apoptosis inducer; drug metabolite |
n-heptane | [no description available] | medium | 8 | 0 | alkane; volatile organic compound | non-polar solvent; plant metabolite |
sodium acetate, anhydrous | [no description available] | medium | 12 | 0 | organic sodium salt | NMR chemical shift reference compound |
tadalafil | [no description available] | medium | 6 | 0 | benzodioxoles; pyrazinopyridoindole | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
ethylenediamine | [no description available] | medium | 2 | 0 | alkane-alpha,omega-diamine | GABA agonist |
creosol | [no description available] | medium | 1 | 0 | methoxybenzenes; phenols | |
quinone methide | [no description available] | medium | 3 | 0 | quinomethane | |
2-hydroxy-1-naphthaldehyde | [no description available] | medium | 2 | 0 | naphthaldehydes; naphthols | |
fluorine | [no description available] | medium | 8 | 0 | diatomic fluorine; gas molecular entity | NMR chemical shift reference compound |
2-aminophenol | [no description available] | medium | 1 | 0 | aminophenol | bacterial metabolite |
9,10-anthraquinone | [no description available] | medium | 4 | 0 | anthraquinone | |
1,4-diaminoanthraquinone | [no description available] | medium | 1 | 0 | | |
1-aminoanthraquinone | [no description available] | medium | 1 | 0 | | |
cyanides | [no description available] | medium | 44 | 0 | pseudohalide anion | EC 1.9.3.1 (cytochrome c oxidase) inhibitor |
testosterone propionate | [no description available] | medium | 1 | 0 | steroid ester | |
azobis(isobutyronitrile) | [no description available] | medium | 4 | 0 | | |
europium | [no description available] | medium | 5 | 0 | f-block element atom; lanthanoid atom | |
cloxyquin | [no description available] | medium | 1 | 0 | organochlorine compound; quinolines | |
terbium | [no description available] | medium | 5 | 0 | f-block element atom; lanthanoid atom | |
calixarenes | [no description available] | medium | 16 | 0 | | |
mustard gas | [no description available] | medium | 2 | 0 | ethyl sulfide; organochlorine compound | alkylating agent; carcinogenic agent; vesicant |
2-aminopurine | [no description available] | medium | 1 | 0 | 2-aminopurines; nucleobase analogue | antimetabolite |
aluminum | [no description available] | medium | 10 | 0 | boron group element atom; elemental aluminium; metal atom | |
resorufin | [no description available] | medium | 2 | 0 | phenoxazine | |
fluorides | [no description available] | medium | 14 | 0 | halide anion; monoatomic fluorine | |
chlorine | [no description available] | medium | 16 | 0 | diatomic chlorine; gas molecular entity | bleaching agent |
edetic acid | [no description available] | medium | 13 | 0 | ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid | anticoagulant; antidote; chelator; copper chelator; geroprotector |
sorbic acid | [no description available] | medium | 2 | 0 | alpha,beta-unsaturated monocarboxylic acid; sorbic acid | |
diclofenac | [no description available] | medium | 5 | 0 | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
tetrabutylammonium | [no description available] | medium | 19 | 0 | quaternary ammonium ion | |
tocopherols | [no description available] | medium | 2 | 0 | | |
tocotrienols | [no description available] | medium | 1 | 0 | diterpenoid | |
n-methacryloyl-l-histidine methyl ester | [no description available] | medium | 1 | 0 | | |
thiophanate | [no description available] | medium | 1 | 0 | benzimidazole precursor fungicide; carbamate ester; carbamate fungicide; thioureas | antifungal drug |
fuberidazole | [no description available] | medium | 1 | 0 | benzimidazole fungicide; benzimidazoles; furans | antifungal agrochemical |
beauvericin | [no description available] | medium | 1 | 0 | | |
enniatin b | [no description available] | medium | 1 | 0 | enniatin | antimicrobial agent |
ethyl chloroformate | [no description available] | medium | 1 | 0 | | |
ginkgolic acid | [no description available] | medium | 1 | 0 | hydroxybenzoic acid | |
salicylates | [no description available] | medium | 4 | 0 | monohydroxybenzoate | plant metabolite |
chlorquinaldol | [no description available] | medium | 1 | 0 | monohydroxyquinoline; organochlorine compound | antibacterial drug; antiprotozoal drug; antiseptic drug |
2'-hydroxychalcone | [no description available] | medium | 1 | 0 | chalcones; phenols | anti-inflammatory agent |
3-nitrophenol | [no description available] | medium | 1 | 0 | 3-nitrophenols | |
nitrophenols | [no description available] | medium | 7 | 0 | | |
9-methyladenine | [no description available] | medium | 2 | 0 | methyladenine | metabolite |
2'-deoxyadenosine | [no description available] | medium | 1 | 0 | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
furaldehyde | [no description available] | medium | 3 | 0 | aldehyde; furans | Maillard reaction product; metabolite |
5-hydroxymethylfurfural | [no description available] | medium | 2 | 0 | arenecarbaldehyde; furans; primary alcohol | indicator; Maillard reaction product |
metergoline | [no description available] | medium | 1 | 0 | carbamate ester; ergoline alkaloid | dopamine agonist; geroprotector; serotonergic antagonist |
papaverine | [no description available] | medium | 2 | 0 | benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines | antispasmodic drug; vasodilator agent |
diosgenin | [no description available] | medium | 2 | 0 | 3beta-sterol; hexacyclic triterpenoid; sapogenin; spiroketal | antineoplastic agent; antiviral agent; apoptosis inducer; metabolite |
solanidine | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; solanid-5-en-3-ol; steroid alkaloid fundamental parent | plant metabolite; toxin |
zolpidem | [no description available] | medium | 2 | 0 | imidazopyridine | central nervous system depressant; GABA agonist; sedative |
singlet oxygen | [no description available] | medium | 14 | 0 | chalcogen; monoatomic oxygen; nonmetal atom | macronutrient |
oxalic acid | [no description available] | medium | 4 | 0 | alpha,omega-dicarboxylic acid | algal metabolite; human metabolite; plant metabolite |
beta-nitrostyrene | [no description available] | medium | 1 | 0 | | |
antipyrine | [no description available] | medium | 4 | 0 | pyrazolone | antipyretic; cyclooxygenase 3 inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
propyphenazone | [no description available] | medium | 2 | 0 | pyrazolone | non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug |
acetaminophen | [no description available] | medium | 10 | 0 | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
4-aminophenol | [no description available] | medium | 2 | 0 | aminophenol | allergen; metabolite |
caffeine | [no description available] | medium | 12 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
10-methyl-9,10-dihydroacridine | [no description available] | medium | 2 | 0 | | |
carbocyanines | [no description available] | medium | 2 | 0 | cyanine dye; organic iodide salt | fluorochrome |
bromfenacoum | [no description available] | medium | 2 | 0 | benzenes; naphthalenes; ring assembly | |
coumatetralyl | [no description available] | medium | 1 | 0 | hydroxycoumarin | |
difenacoum | [no description available] | medium | 2 | 0 | benzenes; naphthalenes; ring assembly | |
bromadiolone | [no description available] | medium | 2 | 0 | diarylheptanoid | |
cellulase | [no description available] | medium | 4 | 0 | cellotriose | |
hexylamine | [no description available] | medium | 1 | 0 | primary aliphatic amine | metabolite |
iodine | [no description available] | medium | 7 | 0 | diatomic iodine | nutrient |
iodine | [no description available] | medium | 15 | 0 | halide anion; monoatomic iodine | human metabolite |
3-aminopropionaldehyde | [no description available] | medium | 1 | 0 | omega-aminoaldehyde; propanals | |
fructose-6-phosphate | [no description available] | medium | 1 | 0 | D-fructose 6-phosphate | |
dihydroxyacetone | [no description available] | medium | 2 | 0 | ketotriose; primary alpha-hydroxy ketone | antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
5-methyl-2-pyrimidinone | [no description available] | medium | 1 | 0 | | |
nitrites | [no description available] | medium | 8 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | human metabolite |
phosphine | [no description available] | medium | 3 | 0 | mononuclear parent hydride; phosphanes; phosphine | carcinogenic agent; fumigant insecticide |
bromine | [no description available] | medium | 8 | 0 | diatomic bromine | |
cyflumetofen | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; 2-methoxyethyl ester; beta-ketoester; nitrile | |
2,2',4,4'-tetrabromodiphenyl ether | [no description available] | medium | 1 | 0 | aromatic ether; organobromine compound | |
lopinavir | [no description available] | medium | 2 | 0 | amphetamines; dicarboxylic acid diamide | anticoronaviral agent; antiviral drug; HIV protease inhibitor |
allantoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione; ureas | Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite; vulnerary |
betaine | [no description available] | medium | 7 | 0 | amino-acid betaine; glycine derivative | fundamental metabolite |
formal glycol | [no description available] | medium | 2 | 0 | cyclic acetal; dioxolane | |
propane | [no description available] | medium | 8 | 0 | alkane; gas molecular entity | food propellant |
tes | [no description available] | medium | 1 | 0 | amino sulfonic acid; ethanolamines; TES | |
eperisone | [no description available] | medium | 1 | 0 | aromatic ketone; piperidines | |
tolperisone | [no description available] | medium | 1 | 0 | aromatic ketone | |
tenofovir | [no description available] | medium | 1 | 0 | nucleoside analogue; phosphonic acids | antiviral drug; drug metabolite; HIV-1 reverse transcriptase inhibitor |
cyclohexane | [no description available] | medium | 20 | 0 | cycloalkane; volatile organic compound | non-polar solvent |
organophosphonates | [no description available] | medium | 8 | 0 | divalent inorganic anion; phosphite ion | |
perfluorobutyric acid | [no description available] | medium | 3 | 0 | fluoroalkanoic acid | chromatographic reagent; environmental contaminant; xenobiotic |
retinaldehyde | [no description available] | medium | 3 | 0 | retinal; vitamin A | gap junctional intercellular communication inhibitor; human metabolite; mouse metabolite |
glycidol | [no description available] | medium | 1 | 0 | epoxide; primary alcohol | |
gs 4071 | [no description available] | medium | 1 | 0 | acetate ester; amino acid; cyclohexenecarboxylic acid; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; marine xenobiotic metabolite |
oseltamivir | [no description available] | medium | 2 | 0 | acetamides; amino acid ester; cyclohexenecarboxylate ester; primary amino compound | antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; environmental contaminant; prodrug; xenobiotic |
imipenem, anhydrous | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; carbapenems; zwitterion | antibacterial drug |
cilastatin | [no description available] | medium | 1 | 0 | carboxamide; L-cysteine derivative; non-proteinogenic L-alpha-amino acid; organic sulfide | EC 3.4.13.19 (membrane dipeptidase) inhibitor; environmental contaminant; protease inhibitor; xenobiotic |
n-acetyl-s-(2-hydroxyethyl)cysteine | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
n-acetyl-s-(2-cyanoethyl)cysteine | [no description available] | medium | 1 | 0 | N-acyl-L-amino acid | |
praseodymium | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom | |
zearalenol | [no description available] | medium | 1 | 0 | | |
zeranol | [no description available] | medium | 1 | 0 | macrolide | |
oxazolidin-2-one | [no description available] | medium | 5 | 0 | carbamate ester; oxazolidinone | metabolite |
phosphonic acid | [no description available] | medium | 1 | 0 | | |
dicofol | [no description available] | medium | 1 | 0 | monochlorobenzenes; organochlorine acaricide; tertiary alcohol | |
1-butyl-3-methylimidazolium hexafluorophosphate | [no description available] | medium | 2 | 0 | | |
tributyrin | [no description available] | medium | 1 | 0 | butyrate ester; triglyceride | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor; prodrug; protective agent |
lapatinib | [no description available] | medium | 2 | 0 | furans; organochlorine compound; organofluorine compound; quinazolines | antineoplastic agent; tyrosine kinase inhibitor |
sorafenib | [no description available] | medium | 2 | 0 | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; phenylureas; pyridinecarboxamide | angiogenesis inhibitor; anticoronaviral agent; antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; ferroptosis inducer; tyrosine kinase inhibitor |
carbonates | [no description available] | medium | 9 | 0 | carbon oxoanion | |
hydrazine | [no description available] | medium | 10 | 0 | azane; hydrazines | EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor |
dansyl hydrazine | [no description available] | medium | 2 | 0 | | |
1,3-dimethyluracil | [no description available] | medium | 1 | 0 | pyrimidone | metabolite |
thymine | [no description available] | medium | 6 | 0 | pyrimidine nucleobase; pyrimidone | Escherichia coli metabolite; human metabolite; mouse metabolite |
5-bromo-1,3-dimethyluracil | [no description available] | medium | 1 | 0 | | |
propylsulfonic acid | [no description available] | medium | 3 | 0 | | |
hypoiodous acid | [no description available] | medium | 1 | 0 | iodine oxoacid | |
fructans | [no description available] | medium | 3 | 0 | | |
tretinoin | [no description available] | medium | 7 | 0 | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule |
azobenzene | [no description available] | medium | 1 | 0 | azobenzenes | |
cobalt | [no description available] | medium | 6 | 0 | cobalt group element atom; metal allergen | micronutrient |
cadmium | [no description available] | medium | 4 | 0 | cadmium molecular entity; zinc group element atom | |
donepezil | [no description available] | medium | 1 | 0 | aromatic ether; indanones; piperidines; racemate | EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nootropic agent |
daptomycin | [no description available] | medium | 2 | 0 | | |
baclofen | [no description available] | medium | 1 | 0 | amino acid zwitterion; gamma-amino acid; monocarboxylic acid; monochlorobenzenes; primary amino compound | central nervous system depressant; GABA agonist; muscle relaxant |
gabapentin | [no description available] | medium | 4 | 0 | gamma-amino acid | anticonvulsant; calcium channel blocker; environmental contaminant; xenobiotic |
glycerylphosphorylcholine | [no description available] | medium | 2 | 0 | glycerophosphocholine | |
n-(1-naphthyl)ethylenediamine | [no description available] | medium | 1 | 0 | N-substituted diamine | |
vitamin k 1 | [no description available] | medium | 2 | 0 | phylloquinones; vitamin K | cofactor; human metabolite; plant metabolite |
cholecalciferol | [no description available] | medium | 3 | 0 | D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol; steroid hormone | geroprotector; human metabolite |
menaquinone 6 | [no description available] | medium | 1 | 0 | | |
vitamin d 2 | [no description available] | medium | 2 | 0 | hydroxy seco-steroid; seco-ergostane; vitamin D | bone density conservation agent; nutraceutical; plant metabolite; rodenticide |
2,4-dinitrophenol | [no description available] | medium | 2 | 0 | dinitrophenol | allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor |
cycloxydim | [no description available] | medium | 1 | 0 | | |
hydroxyindoleacetic acid | [no description available] | medium | 4 | 0 | indole-3-acetic acids | drug metabolite; human metabolite; mouse metabolite |
3-nitrotyrosine | [no description available] | medium | 1 | 0 | 2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid | |
kynurenic acid | [no description available] | medium | 2 | 0 | monohydroxyquinoline; quinolinemonocarboxylic acid | G-protein-coupled receptor agonist; human metabolite; neuroprotective agent; nicotinic antagonist; NMDA receptor antagonist; Saccharomyces cerevisiae metabolite |
kynurenine | [no description available] | medium | 1 | 0 | aromatic ketone; non-proteinogenic alpha-amino acid; substituted aniline | human metabolite |
trimethyl phosphine | [no description available] | medium | 1 | 0 | tertiary phosphine | |
resorcinarene | [no description available] | medium | 2 | 0 | | |
sodium azide | [no description available] | medium | 3 | 0 | inorganic sodium salt | antibacterial agent; explosive; mitochondrial respiratory-chain inhibitor; mutagen |
picolinic acid | [no description available] | medium | 2 | 0 | pyridinemonocarboxylic acid | human metabolite; MALDI matrix material |
quinolinic acid | [no description available] | medium | 1 | 0 | pyridinedicarboxylic acid | Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist |
anabasine | [no description available] | medium | 1 | 0 | anabasine | |
acrylic acid | [no description available] | medium | 4 | 0 | alpha,beta-unsaturated monocarboxylic acid | metabolite |
entecavir | [no description available] | medium | 2 | 0 | 2-aminopurines; oxopurine; primary alcohol; secondary alcohol | antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
1,6-diaminohexane | [no description available] | medium | 1 | 0 | alkane-alpha,omega-diamine | human xenobiotic metabolite |
glycine amide | [no description available] | medium | 1 | 0 | amino acid amide; glycine derivative | |
imidacloprid | [no description available] | medium | 4 | 0 | imidacloprid; imidazolidines; monochloropyridine | environmental contaminant; genotoxin; neonicotinoid insectide; nicotinic acetylcholine receptor agonist; xenobiotic |
thidiazuron | [no description available] | medium | 1 | 0 | ureas | |
n-(2-chloro-4-pyridyl)-n'-phenylurea | [no description available] | medium | 1 | 0 | monochloropyridine; phenylureas | plant growth regulator |
vancomycin | [no description available] | medium | 4 | 0 | glycopeptide | antibacterial drug; antimicrobial agent; bacterial metabolite |
colistin | [no description available] | medium | 3 | 0 | | |
ezetimibe | [no description available] | medium | 3 | 0 | azetidines; beta-lactam; organofluorine compound | anticholesteremic drug; antilipemic drug; antimetabolite |
benzylamine | [no description available] | medium | 2 | 0 | aralkylamine; primary amine | allergen; EC 3.5.5.1 (nitrilase) inhibitor; plant metabolite |
hydroxytryptophol | [no description available] | medium | 1 | 0 | indoles | |
n-acetylserotonin | [no description available] | medium | 1 | 0 | acetamides; N-acylserotonin; phenols | antioxidant; human metabolite; mouse metabolite; tropomyosin-related kinase B receptor agonist |
perfluorooctanoic acid | [no description available] | medium | 3 | 0 | fluoroalkanoic acid | carcinogenic agent; endocrine disruptor; environmental contaminant; surfactant; xenobiotic |
tetrabromobisphenol a | [no description available] | medium | 2 | 0 | brominated flame retardant; bromobisphenol | |
perfluorooctane sulfonic acid | [no description available] | medium | 3 | 0 | perfluoroalkanesulfonic acid | antilipemic drug; persistent organic pollutant |
caprylates | [no description available] | medium | 5 | 0 | fatty acid anion 8:0; straight-chain saturated fatty acid anion | human metabolite; Saccharomyces cerevisiae metabolite |
rucaparib | [no description available] | medium | 1 | 0 | azepinoindole; caprolactams; organofluorine compound; secondary amino compound | antineoplastic agent; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
nitazoxanide | [no description available] | medium | 1 | 0 | benzamides; carboxylic ester | |
epigallocatechin gallate | [no description available] | medium | 5 | 0 | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
n-vinyl-2-pyrrolidinone | [no description available] | medium | 3 | 0 | pyrrolidin-2-ones | |
citrinin | [no description available] | medium | 2 | 0 | | |
gold tetrachloride, acid | [no description available] | medium | 2 | 0 | | |
gold | [no description available] | medium | 15 | 0 | copper group element atom; elemental gold | |
sinapinic acid | [no description available] | medium | 4 | 0 | sinapic acid | MALDI matrix material; plant metabolite |
ferulic acid | [no description available] | medium | 5 | 0 | ferulic acids | anti-inflammatory agent; antioxidant; apoptosis inhibitor; cardioprotective agent; MALDI matrix material; plant metabolite |
adenosine | [no description available] | medium | 3 | 0 | adenosines; purines D-ribonucleoside | analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent |
scandium | [no description available] | medium | 1 | 0 | d-block element atom; rare earth metal atom; scandium group element atom | |
magnesium perchlorate | [no description available] | medium | 3 | 0 | alkaline earth salt | |
scandium triflate | [no description available] | medium | 1 | 0 | | |
benzanthrone | [no description available] | medium | 1 | 0 | phenanthrenes | |
o-demethyltramadol | [no description available] | medium | 1 | 0 | | |
tramadol | [no description available] | medium | 3 | 0 | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol | adrenergic uptake inhibitor; antitussive; capsaicin receptor antagonist; delta-opioid receptor agonist; kappa-opioid receptor agonist; metabolite; mu-opioid receptor agonist; muscarinic antagonist; nicotinic antagonist; NMDA receptor antagonist; opioid analgesic; serotonergic antagonist; serotonin uptake inhibitor |
mefloquine | [no description available] | medium | 2 | 0 | | |
lithium | [no description available] | medium | 13 | 0 | alkali metal atom | |
pyridine n-oxide | [no description available] | medium | 1 | 0 | pyridine N-oxides | drug metabolite |
guanidine | [no description available] | medium | 11 | 0 | carboxamidine; guanidines; one-carbon compound | |
ferrocenium | [no description available] | medium | 1 | 0 | | |
albendazole sulfoxide | [no description available] | medium | 2 | 0 | sulfoxide | |
fenbendazole | [no description available] | medium | 1 | 0 | aryl sulfide; benzimidazoles; carbamate ester | antinematodal drug |
oxfendazole | [no description available] | medium | 1 | 0 | benzimidazoles; carbamate ester; sulfoxide | antinematodal drug |
albendazole | [no description available] | medium | 2 | 0 | aryl sulfide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | anthelminthic drug; microtubule-destabilising agent; tubulin modulator |
fenitrothion | [no description available] | medium | 1 | 0 | C-nitro compound; organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide |
diazinon | [no description available] | medium | 3 | 0 | organic thiophosphate; pyrimidines | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; nematicide; xenobiotic |
hypochlorous acid | [no description available] | medium | 2 | 0 | chlorine oxoacid; reactive oxygen species | EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; human metabolite |
diethylurea | [no description available] | medium | 1 | 0 | | |
dronabinol | [no description available] | medium | 5 | 0 | benzochromene; diterpenoid; phytocannabinoid; polyketide | cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic |
11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid | [no description available] | medium | 2 | 0 | 1-benzopyran | |
stilbenes | [no description available] | medium | 9 | 0 | stilbene | |
pramipexole | [no description available] | medium | 1 | 0 | benzothiazoles; diamine | antidyskinesia agent; antiparkinson drug; dopamine agonist; radical scavenger |
ethane | [no description available] | medium | 5 | 0 | alkane; gas molecular entity | plant metabolite; refrigerant |
benzo(b)fluorene | [no description available] | medium | 1 | 0 | carbotetracyclic compound | |
tinuvin 770 | [no description available] | medium | 1 | 0 | | |
niobium | [no description available] | medium | 1 | 0 | vanadium group element atom | |
phenylphosphonic acid | [no description available] | medium | 1 | 0 | benzenes | |
valproic acid | [no description available] | medium | 2 | 0 | branched-chain fatty acid; branched-chain saturated fatty acid | anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent |
kresoxim-methyl | [no description available] | medium | 2 | 0 | aromatic ether; methoxyiminoacetate strobilurin antifungal agent; methyl ester; oxime O-ether | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic |
trifloxystrobin | [no description available] | medium | 2 | 0 | | |
picoxystrobin | [no description available] | medium | 1 | 0 | aromatic ether; enoate ester; enol ether; methoxyacrylate strobilurin antifungal agent; organofluorine compound; pyridines | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor |
2-thiothymine | [no description available] | medium | 1 | 0 | | |
thiouracil | [no description available] | medium | 2 | 0 | nucleobase analogue; thiocarbonyl compound | antithyroid drug; metabolite |
aporphine | [no description available] | medium | 1 | 0 | aporphine alkaloid; isoquinoline alkaloid fundamental parent; tertiary amino compound | |
1-hexene | [no description available] | medium | 1 | 0 | alkene | |
sildenafil citrate | [no description available] | medium | 7 | 1 | citrate salt | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
aminotadalafil | [no description available] | medium | 1 | 0 | | |
d-alpha tocopherol | [no description available] | medium | 15 | 0 | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite |
dimethyl phthalate | [no description available] | medium | 1 | 0 | diester; methyl ester; phthalate ester | |
4-nitrothiophenolate | [no description available] | medium | 1 | 0 | | |
tetrabutoxy titanium | [no description available] | medium | 1 | 0 | | |
propionitrile | [no description available] | high | 15 | 0 | aliphatic nitrile; volatile organic compound | polar aprotic solvent |
lactamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; secondary alcohol | |
caprolactam | [no description available] | medium | 2 | 0 | caprolactams | human blood serum metabolite |
propionamide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; primary fatty amide | |
acetohydroxamic acid | [no description available] | medium | 1 | 0 | acetohydroxamic acids; carbohydroximic acid | algal metabolite; EC 3.5.1.5 (urease) inhibitor |
rhenium | [no description available] | medium | 4 | 0 | manganese group element atom | |
carbon monoxide | [no description available] | medium | 7 | 0 | carbon oxide; gas molecular entity; one-carbon compound | biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent |
mianserin | [no description available] | medium | 4 | 0 | dibenzoazepine | adrenergic uptake inhibitor; alpha-adrenergic antagonist; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; H1-receptor antagonist; histamine agonist; sedative; serotonergic antagonist |
demethylmirtazapine | [no description available] | medium | 1 | 0 | benzazepine; tetracyclic antidepressant | alpha-adrenergic antagonist; anxiolytic drug; H1-receptor antagonist; histamine antagonist; human xenobiotic metabolite; serotonergic antagonist |
carboxymethyl-beta-cyclodextrin | [no description available] | medium | 2 | 0 | | |
8-hydroxymirtazapine | [no description available] | medium | 1 | 0 | | |
2,5-dihydroxybenzoic acid | [no description available] | medium | 3 | 0 | dihydroxybenzoic acid | EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite |
pyrene | [no description available] | medium | 5 | 0 | ortho- and peri-fused polycyclic arene | fluorescent probe; persistent organic pollutant |
fumonisin b1 | [no description available] | medium | 4 | 0 | diester; fumonisin; primary amino compound; triol | carcinogenic agent; metabolite |
t-2 toxin | [no description available] | medium | 4 | 0 | | |
oxyluciferin | [no description available] | medium | 1 | 0 | Photinus luciferin | oxidized luciferins |
2-dodecylcyclobutanone | [no description available] | medium | 2 | 0 | cyclic ketone | |
iodoacetamide | [no description available] | medium | 1 | 0 | | |
fenthion | [no description available] | medium | 2 | 0 | organic thiophosphate | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide |
perchlorate | [no description available] | medium | 4 | 0 | chlorine oxoanion; monovalent inorganic anion | |
ethinyl estradiol | [no description available] | medium | 2 | 0 | 17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound | xenoestrogen |
estrone | [no description available] | medium | 2 | 0 | 17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols | antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite |
2-(1-piperidinylmethyl)phenol | [no description available] | medium | 1 | 0 | | |
rhodamine 6g | [no description available] | medium | 4 | 0 | | |
pyrazolone | [no description available] | medium | 1 | 0 | | |
eprosartan | [no description available] | medium | 1 | 0 | dicarboxylic acid; imidazoles; thiophenes | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
methylphenidate | [no description available] | medium | 1 | 0 | beta-amino acid ester; methyl ester; piperidines | |
ethylphenidate | [no description available] | medium | 1 | 0 | | |
6-(2-aminopropyl)benzofuran | [no description available] | medium | 1 | 0 | | |
aliskiren | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; monomethoxybenzene | antihypertensive agent |
fumarates | [no description available] | medium | 3 | 0 | butenedioate; C4-dicarboxylate | human metabolite; metabolite; Saccharomyces cerevisiae metabolite |
nifenazone | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
trimetazidine | [no description available] | medium | 2 | 0 | aromatic amine | |
hydroxide ion | [no description available] | medium | 2 | 0 | oxygen hydride | mouse metabolite |
cyclopentane | [no description available] | medium | 1 | 0 | cycloalkane; cyclopentanes; volatile organic compound | non-polar solvent |
cephalosporin c | [no description available] | medium | 4 | 0 | cephalosporin | fungal metabolite |
dinitrobenzenes | [no description available] | medium | 5 | 0 | | |
clindamycin | [no description available] | medium | 3 | 0 | | |
clindamycin phosphate | [no description available] | medium | 2 | 0 | | |
cycloserine | [no description available] | medium | 2 | 0 | 4-amino-1,2-oxazolidin-3-one; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic; zwitterion | antiinfective agent; antimetabolite; antitubercular agent; metabolite; NMDA receptor agonist |
2,2'-dipyridyl | [no description available] | medium | 5 | 0 | bipyridine | chelator; ferroptosis inhibitor |
acetylacetone | [no description available] | medium | 1 | 0 | beta-diketone | |
(3z,6alpha,7alpha)-isomer of 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3h)-isobenzofuranone | [no description available] | medium | 1 | 0 | 2-benzofurans | |
4-butyrolactone | [no description available] | medium | 3 | 0 | butan-4-olide | metabolite; neurotoxin |
ligustilide | [no description available] | medium | 2 | 0 | butenolide | metabolite |
senkyunolide i | [no description available] | medium | 2 | 0 | | |
3-n-butyl-4,5-dihydrophthalide | [no description available] | medium | 2 | 0 | | |
dipicolinic acid | [no description available] | medium | 2 | 0 | pyridinedicarboxylic acid | bacterial metabolite |
epiafzelechin | [no description available] | medium | 1 | 0 | catechin | plant metabolite |
silver nitrate | [no description available] | medium | 2 | 0 | inorganic nitrate salt; silver salt | astringent |
mycophenolic acid | [no description available] | medium | 4 | 0 | 2-benzofurans; gamma-lactone; monocarboxylic acid; phenols | anticoronaviral agent; antimicrobial agent; antineoplastic agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; environmental contaminant; immunosuppressive agent; mycotoxin; Penicillium metabolite; xenobiotic |
nivalenol | [no description available] | medium | 3 | 0 | trichothecene | |
rifampin | [no description available] | medium | 2 | 0 | cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion | angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor |
scutellarin | [no description available] | medium | 2 | 0 | glucosiduronic acid; glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone | antineoplastic agent; proteasome inhibitor |
caffeic acid | [no description available] | medium | 3 | 0 | caffeic acid | geroprotector; mouse metabolite |
protocatechuic acid | [no description available] | medium | 3 | 0 | catechols; dihydroxybenzoic acid | antineoplastic agent; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; human xenobiotic metabolite; plant metabolite |
molybdenum trioxide | [no description available] | medium | 1 | 0 | molybdenum oxide | |
molybdenum | [no description available] | medium | 9 | 0 | chromium group element atom | micronutrient |
arsine | [no description available] | medium | 1 | 0 | arsanes; arsine; mononuclear parent hydride | |
ditiocarb | [no description available] | medium | 2 | 0 | dithiocarbamic acids | chelator; copper chelator |
silver diethyldithiocarbamate | [no description available] | medium | 1 | 0 | | |
trifolirhizin | [no description available] | medium | 1 | 0 | pterocarpans | |
inermin | [no description available] | medium | 1 | 0 | maackiain | |
sophoranone | [no description available] | medium | 1 | 0 | 4'-hydroxyflavanones; dihydroxyflavanone | plant metabolite |
a 82846a | [no description available] | medium | 1 | 0 | | |
camptothecin | [no description available] | medium | 7 | 0 | delta-lactone; pyranoindolizinoquinoline; quinoline alkaloid; tertiary alcohol | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; genotoxin; plant metabolite |
irinotecan | [no description available] | medium | 5 | 0 | carbamate ester; delta-lactone; N-acylpiperidine; pyranoindolizinoquinoline; ring assembly; tertiary alcohol; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug |
silicon carbide | [no description available] | medium | 1 | 0 | organosilicon compound | |
triacetylguanosine | [no description available] | medium | 1 | 0 | | |
7-methylguanosine | [no description available] | medium | 1 | 0 | methylguanosine; organic cation | metabolite |
guanosine | [no description available] | medium | 3 | 0 | guanosines; purines D-ribonucleoside | fundamental metabolite |
bathocuproine disulfonate | [no description available] | medium | 2 | 0 | arenesulfonic acid; phenanthrolines | chelator |
temozolomide | [no description available] | medium | 1 | 0 | imidazotetrazine; monocarboxylic acid amide; triazene derivative | alkylating agent; antineoplastic agent; prodrug |
dacarbazine | [no description available] | medium | 1 | 0 | dacarbazine | |
1,2-distearoylphosphatidylethanolamine | [no description available] | medium | 1 | 0 | phosphatidylethanolamine zwitterion; phosphatidylethanolamine | human metabolite |
tabun | [no description available] | medium | 1 | 0 | | |
soman | [no description available] | medium | 1 | 0 | phosphonic ester | |
sarin | [no description available] | medium | 1 | 0 | fluorine molecular entity; phosphinic ester | |
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | [no description available] | medium | 3 | 0 | BODIPY compound | |
dapoxetine | [no description available] | medium | 1 | 0 | naphthalenes | |
acrolein | [no description available] | medium | 4 | 0 | enal | herbicide; human xenobiotic metabolite; toxin |
formamide | [no description available] | medium | 11 | 0 | carboximidic acid; formamides; monocarboxylic acid amide; one-carbon compound | solvent |
hydroxyl radical | [no description available] | medium | 9 | 0 | oxygen hydride; oxygen radical; reactive oxygen species | |
nitenpyram | [no description available] | medium | 1 | 0 | chloropyridyl insecticide; nitenpyram | |
thiamethoxam | [no description available] | medium | 2 | 0 | 1,3-thiazoles; 2-nitroguanidine derivative; organochlorine compound; oxadiazane | antifeedant; carcinogenic agent; environmental contaminant; neonicotinoid insectide; xenobiotic |
clothianidin | [no description available] | medium | 1 | 0 | 1,3-thiazoles; 2-nitroguanidine derivative; clothianidin; organochlorine compound | environmental contaminant; neonicotinoid insectide; nicotinic acetylcholine receptor agonist; xenobiotic |
prizes | [no description available] | medium | 2 | 0 | carboxamidine; monochloropyridine; nitrile | environmental contaminant; neonicotinoid insectide; xenobiotic |
thiacloprid | [no description available] | medium | 1 | 0 | monochloropyridine; nitrile; thiazolidines | environmental contaminant; neonicotinoid insectide; xenobiotic |
2,2'-dipicolylamine | [no description available] | medium | 2 | 0 | | |
paliperidone palmitate | [no description available] | medium | 1 | 0 | 1,2-benzoxazoles; fatty acid ester; heteroarylpiperidine; organofluorine compound; pyridopyrimidine | |
polidocanol | [no description available] | medium | 1 | 0 | hydroxypolyether | hepatotoxic agent; nonionic surfactant; sclerotherapy agent |
pirimicarb | [no description available] | medium | 2 | 0 | aminopyrimidine; carbamate ester; tertiary amino compound | agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic |
withaferin a | [no description available] | medium | 1 | 0 | 27-hydroxy steroid; 4-hydroxy steroid; delta-lactone; enone; epoxy steroid; ergostanoid; primary alcohol; secondary alcohol; withanolide | antineoplastic agent; apoptosis inducer |
withanolides | [no description available] | medium | 1 | 0 | | |
ici 204,219 | [no description available] | medium | 1 | 0 | carbamate ester; indoles; N-sulfonylcarboxamide | anti-asthmatic agent; leukotriene antagonist |
canagliflozin | [no description available] | medium | 1 | 0 | C-glycosyl compound; organofluorine compound; thiophenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor |
acenaphthylene | [no description available] | medium | 1 | 0 | acenaphthylenes; ortho- and peri-fused polycyclic arene; ortho- and peri-fused tricyclic hydrocarbon | |
cyclopenta(c,d)pyrene | [no description available] | medium | 1 | 0 | pyrenes | |
benzo(j)fluoranthene | [no description available] | medium | 1 | 0 | naphthalenes | |
sulfuric acid | [no description available] | medium | 4 | 0 | sulfur oxoacid | catalyst |
benzotriazole | [no description available] | medium | 1 | 0 | benzotriazoles | environmental contaminant; xenobiotic |
methionine | [no description available] | medium | 3 | 0 | aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid | antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical |
penicillamine | [no description available] | medium | 1 | 0 | non-proteinogenic alpha-amino acid; penicillamine | antirheumatic drug; chelator; copper chelator; drug allergen |
2-acrylamido-2-methylpropanesulfonate | [no description available] | medium | 2 | 0 | organosulfonic acid | |
18-crown-6 2,3,11,12-tetracarboxylic acid | [no description available] | medium | 3 | 0 | | |
fendiline | [no description available] | medium | 1 | 0 | diarylmethane | |
cardiovascular agents | [no description available] | medium | 1 | 0 | | |
diethyl phthalate | [no description available] | medium | 1 | 0 | diester; ethyl ester; phthalate ester | neurotoxin; plasticiser; teratogenic agent |
neobavaisoflavone | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; plant metabolite; platelet aggregation inhibitor |
isobavachalcone | [no description available] | medium | 1 | 0 | chalcones; polyphenol | antibacterial agent; metabolite; platelet aggregation inhibitor |
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | [no description available] | medium | 1 | 0 | (6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | |
pravastatin | [no description available] | medium | 1 | 0 | 3-hydroxy carboxylic acid; carbobicyclic compound; carboxylic ester; hydroxy monocarboxylic acid; secondary alcohol; statin (semi-synthetic) | anticholesteremic drug; environmental contaminant; metabolite; xenobiotic |
olmesartan medoxomil | [no description available] | medium | 2 | 0 | biphenyls | |
cyprodinil | [no description available] | medium | 1 | 0 | aminopyrimidine; anilinopyrimidine fungicide; cyclopropanes; secondary amino compound | antifungal agrochemical; aryl hydrocarbon receptor agonist; environmental contaminant; xenobiotic |
tetrachloroisophthalonitrile | [no description available] | medium | 1 | 0 | aromatic fungicide; dinitrile; tetrachlorobenzene | antifungal agrochemical |
miconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; ether; imidazoles | |
secnidazole | [no description available] | medium | 1 | 0 | C-nitro compound; imidazoles; secondary alcohol | epitope |
tioconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; ether; imidazoles; thiophenes | |
quercetagetin | [no description available] | medium | 1 | 0 | flavonols; hexahydroxyflavone | antioxidant; antiviral agent; plant metabolite |
anandamide | [no description available] | medium | 1 | 0 | endocannabinoid; N-acylethanolamine 20:4 | human blood serum metabolite; neurotransmitter; vasodilator agent |
thymopentin | [no description available] | medium | 2 | 0 | oligopeptide | |
pyrimidine dimers | [no description available] | medium | 1 | 0 | | |
fangchinoline | [no description available] | medium | 1 | 0 | | |
tetrandrine | [no description available] | medium | 1 | 0 | bisbenzylisoquinoline alkaloid; isoquinolines | |
benzoylacetone | [no description available] | medium | 1 | 0 | | |
2-oxindole | [no description available] | medium | 1 | 0 | gamma-lactam; indolinone | |
mercury | [no description available] | medium | 9 | 0 | elemental mercury; zinc group element atom | neurotoxin |
chromium | [no description available] | medium | 4 | 0 | chromium group element atom; metal allergen | micronutrient |
4-vinylpyridine | [no description available] | medium | 3 | 0 | | |
daidzein | [no description available] | medium | 2 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; phytoestrogen; plant metabolite |
genistein | [no description available] | medium | 2 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
biochanin a | [no description available] | medium | 1 | 0 | 4'-methoxyisoflavones; 7-hydroxyisoflavones | antineoplastic agent; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
azaspiracid | [no description available] | medium | 2 | 0 | | |
yessotoxin | [no description available] | medium | 1 | 0 | ciguatoxin | |
hydroquinidine | [no description available] | medium | 1 | 0 | cinchona alkaloid | |
3,5-dimethylpyrazole | [no description available] | medium | 1 | 0 | | |
dichlorodicyanobenzoquinone | [no description available] | medium | 5 | 0 | | |
benzotrifluoride | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; fluorohydrocarbon | environmental contaminant; NMR chemical shift reference compound; solvent |
beta carotene | [no description available] | medium | 3 | 0 | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A |
alpha-carotene | [no description available] | medium | 2 | 0 | carotenoid beta-end derivative; cyclic carotene | plant metabolite; provitamin A |
lutein | [no description available] | medium | 1 | 0 | carotenol | food colouring; plant metabolite |
phthalic acid | [no description available] | medium | 4 | 0 | benzenedicarboxylic acid | human xenobiotic metabolite |
thiocyanate | [no description available] | medium | 3 | 0 | pseudohalide anion; sulfur molecular entity | human metabolite |
nitrates | [no description available] | medium | 13 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | |
malachite green | [no description available] | medium | 6 | 0 | organic chloride salt | antibacterial agent; antifungal drug; carcinogenic agent; environmental contaminant; fluorochrome; histological dye; teratogenic agent |
c.i. 42510 | [no description available] | medium | 9 | 0 | | |
leucomalachite green | [no description available] | medium | 7 | 0 | benzenoid aromatic compound | |
malonic acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid | human metabolite |
lead | [no description available] | medium | 3 | 0 | carbon group element atom; elemental lead; metal atom | neurotoxin |
tempo | [no description available] | medium | 1 | 0 | aminoxyls; piperidines | catalyst; ferroptosis inhibitor; radical scavenger |
beta-escin | [no description available] | medium | 6 | 0 | | |
araloside a | [no description available] | medium | 1 | 0 | | |
ginsenoside ro | [no description available] | medium | 1 | 0 | triterpenoid saponin | metabolite |
notoginsenoside r1 | [no description available] | medium | 1 | 0 | 12beta-hydroxy steroid; 3beta-hydroxy-4,4-dimethylsteroid; 3beta-hydroxy steroid; beta-D-glucoside; disaccharide derivative; ginsenoside; tetracyclic triterpenoid | antioxidant; apoptosis inducer; neuroprotective agent; phytoestrogen; plant metabolite |
chikusetsu saponin iva | [no description available] | medium | 1 | 0 | triterpenoid saponin | metabolite |
rosiglitazone | [no description available] | medium | 2 | 0 | aminopyridine; thiazolidinediones | EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; insulin-sensitizing drug |
pioglitazone | [no description available] | medium | 2 | 0 | aromatic ether; pyridines; thiazolidinediones | antidepressant; cardioprotective agent; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; geroprotector; hypoglycemic agent; insulin-sensitizing drug; PPARgamma agonist; xenobiotic |
benzo(a)pyrene | [no description available] | medium | 6 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mouse metabolite |
berberine | [no description available] | medium | 6 | 0 | alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound | antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker |
gamma-sitosterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; phytosterols | marine metabolite; plant metabolite |
cytellin | [no description available] | medium | 1 | 0 | | |
ubiquinone | [no description available] | medium | 4 | 0 | | |
antroquinonol d | [no description available] | medium | 1 | 0 | enol ether; enone; secondary alcohol | antineoplastic agent; fungal metabolite |
harmine | [no description available] | medium | 3 | 0 | harmala alkaloid | anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; metabolite |
timolol | [no description available] | medium | 2 | 0 | timolol | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
deuterium oxide | [no description available] | medium | 7 | 0 | deuterated compound; water | NMR solvent |
niacin | [no description available] | medium | 1 | 0 | pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3 | antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent |
ascorbic acid | [no description available] | medium | 11 | 0 | ascorbic acid; vitamin C | coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent |
naphthoquinones | [no description available] | medium | 8 | 0 | | |
astragalin | [no description available] | medium | 1 | 0 | beta-D-glucoside; kaempferol O-glucoside; monosaccharide derivative; trihydroxyflavone | plant metabolite; trypanocidal drug |
quercitrin | [no description available] | medium | 1 | 0 | alpha-L-rhamnoside; monosaccharide derivative; quercetin O-glycoside; tetrahydroxyflavone | antileishmanial agent; antioxidant; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite |
isoquercitrin | [no description available] | medium | 2 | 0 | | |
kaempferol-3-o-rutinoside | [no description available] | medium | 3 | 0 | disaccharide derivative; kaempferol O-glucoside; rutinoside; trihydroxyflavone | metabolite; plant metabolite; radical scavenger |
spectinomycin | [no description available] | medium | 1 | 0 | cyclic acetal; cyclic hemiketal; cyclic ketone; pyranobenzodioxin; secondary alcohol; secondary amino compound | antibacterial drug; antimicrobial agent; bacterial metabolite |
lincomycin | [no description available] | medium | 2 | 0 | carbohydrate-containing antibiotic; L-proline derivative; monocarboxylic acid amide; pyrrolidinecarboxamide; S-glycosyl compound | antimicrobial agent; bacterial metabolite |
boranes | [no description available] | medium | 6 | 0 | boranes; mononuclear parent hydride | |
niclosamide | [no description available] | medium | 1 | 0 | benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide | anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor |
leucogentian violet | [no description available] | medium | 3 | 0 | benzenoid aromatic compound | |
sodium borohydride | [no description available] | medium | 1 | 0 | inorganic sodium salt; metal tetrahydridoborate | |
2,3-dimethyl-1,3-butadiene | [no description available] | medium | 1 | 0 | | |
benzophenone | [no description available] | medium | 2 | 0 | benzophenones | photosensitizing agent; plant metabolite |
coenzyme f420 | [no description available] | medium | 1 | 0 | | |
riboflavin | [no description available] | medium | 3 | 0 | flavin; vitamin B2 | anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite |
zanamivir | [no description available] | medium | 1 | 0 | guanidines | antiviral agent; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor |
pamabrom | [no description available] | medium | 1 | 0 | | |
theophylline | [no description available] | medium | 7 | 0 | dimethylxanthine | adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent |
vanillic acid | [no description available] | medium | 1 | 0 | methoxybenzoic acid; monohydroxybenzoic acid | plant metabolite |
malathion | [no description available] | medium | 6 | 0 | diester; ethyl ester; organic thiophosphate | |
vanadium | [no description available] | medium | 2 | 0 | elemental vanadium; vanadium group element atom | micronutrient |
febuxostat | [no description available] | medium | 1 | 0 | 1,3-thiazolemonocarboxylic acid; aromatic ether; nitrile | EC 1.17.3.2 (xanthine oxidase) inhibitor |
losartan | [no description available] | medium | 2 | 0 | biphenylyltetrazole; imidazoles | angiotensin receptor antagonist; anti-arrhythmia drug; antihypertensive agent; endothelin receptor antagonist |
carnosine | [no description available] | medium | 1 | 0 | amino acid zwitterion; dipeptide | anticonvulsant; antineoplastic agent; antioxidant; Daphnia magna metabolite; geroprotector; human metabolite; mouse metabolite; neuroprotective agent |
1-hydroxypyrene | [no description available] | medium | 1 | 0 | pyrenes | |
pheophytin a | [no description available] | medium | 3 | 0 | | |
chlorophyll a | [no description available] | medium | 5 | 0 | chlorophyll; methyl ester | cofactor |
ibandronic acid | [no description available] | medium | 1 | 0 | | |
periplocin | [no description available] | medium | 1 | 0 | | |
periplogenin | [no description available] | medium | 1 | 0 | | |
periplocymarin | [no description available] | medium | 1 | 0 | | |
digitoxigenin | [no description available] | medium | 1 | 0 | 14beta-hydroxy steroid; 3beta-hydroxy steroid | |
diflubenzuron | [no description available] | medium | 1 | 0 | benzoylurea insecticide; monochlorobenzenes | insect sterilant |
1-(2-chlorobenzoyl)-3-(4-chlorophenyl)urea | [no description available] | medium | 1 | 0 | | |
apocarotenal | [no description available] | medium | 1 | 0 | apo carotenoid triterpenoid; enal | |
ampelopsin | [no description available] | medium | 1 | 0 | dihydromyricetin; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; metabolite |
alpha-lapachone | [no description available] | medium | 1 | 0 | organic heterotricyclic compound; organooxygen compound | |
1,2-naphthoquinone | [no description available] | medium | 1 | 0 | 1,2-naphthoquinones | aryl hydrocarbon receptor agonist; carcinogenic agent |
beta-lapachone | [no description available] | medium | 2 | 0 | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
2-(trifluoromethyl)acrylic acid | [no description available] | medium | 1 | 0 | | |
indapamide | [no description available] | medium | 1 | 0 | indoles; organochlorine compound; sulfonamide | antihypertensive agent; diuretic |
7-hydroxycoumarin | [no description available] | medium | 1 | 0 | hydroxycoumarin | fluorescent probe; food component; plant metabolite |
perindopril | [no description available] | medium | 2 | 0 | alpha-amino acid ester; dicarboxylic acid monoester; ethyl ester; organic heterobicyclic compound | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
luminol | [no description available] | medium | 2 | 0 | | |
4-(1h-imidazol-4-ylmethyl)piperidine | [no description available] | medium | 1 | 0 | piperidines | |
amantadine | [no description available] | medium | 3 | 0 | adamantanes; primary aliphatic amine | analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic |
chloroacetamide | [no description available] | medium | 1 | 0 | | |
chloramine | [no description available] | medium | 2 | 0 | halide | |
heptakis(2,6-o-dimethyl)beta-cyclodextrin | [no description available] | medium | 2 | 0 | | |
thorium | [no description available] | medium | 1 | 0 | actinoid atom; f-block element atom | |
uranium | [no description available] | medium | 1 | 0 | actinoid atom; f-block element atom; monoatomic uranium | |
1,10-phenanthroline | [no description available] | medium | 4 | 0 | phenanthroline | EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor |
thionium | [no description available] | medium | 1 | 0 | | |
4-chloro-5-sulfamoylanthranilic acid | [no description available] | medium | 1 | 0 | benzenes; sulfonamide | |
cupric chloride | [no description available] | medium | 2 | 0 | copper molecular entity; inorganic chloride | EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor |
sodium nitrite | [no description available] | medium | 1 | 0 | inorganic sodium salt; nitrite salt | antidote to cyanide poisoning; antihypertensive agent; antimicrobial food preservative; food antioxidant; poison |
fingolimod hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | immunosuppressive agent; prodrug; sphingosine-1-phosphate receptor agonist |
caseins | [no description available] | medium | 4 | 0 | | |
ampicillin | [no description available] | medium | 3 | 0 | beta-lactam antibiotic; penicillin allergen; penicillin | antibacterial drug |
protoporphyrin ix | [no description available] | medium | 1 | 0 | | |
likviriton | [no description available] | medium | 2 | 0 | beta-D-glucoside; flavanone glycoside; monohydroxyflavanone; monosaccharide derivative | anti-inflammatory agent; anticoronaviral agent; plant metabolite |
coptisine | [no description available] | medium | 2 | 0 | alkaloid | metabolite |
baicalein | [no description available] | medium | 3 | 0 | trihydroxyflavone | angiogenesis inhibitor; anti-inflammatory agent; antibacterial agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antioxidant; apoptosis inducer; EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; EC 4.1.1.17 (ornithine decarboxylase) inhibitor; ferroptosis inhibitor; geroprotector; hormone antagonist; plant metabolite; prostaglandin antagonist; radical scavenger |
wogonin | [no description available] | medium | 4 | 0 | dihydroxyflavone; monomethoxyflavone | angiogenesis inhibitor; antineoplastic agent; cyclooxygenase 2 inhibitor; plant metabolite |
palmatine | [no description available] | medium | 2 | 0 | berberine alkaloid; organic heterotetracyclic compound | plant metabolite |
glycyrrhizic acid | [no description available] | medium | 3 | 0 | enone; glucosiduronic acid; pentacyclic triterpenoid; tricarboxylic acid; triterpenoid saponin | EC 3.4.21.5 (thrombin) inhibitor; plant metabolite |
wogonoside | [no description available] | medium | 1 | 0 | beta-D-glucosiduronic acid; glycosyloxyflavone; monohydroxyflavone; monomethoxyflavone; monosaccharide derivative | |
chlorocresol | [no description available] | medium | 1 | 0 | hydroxytoluene; monochlorobenzenes | antimicrobial agent; disinfectant; ryanodine receptor agonist |
cetylpyridinium | [no description available] | medium | 1 | 0 | pyridinium ion | |
ovalbumin | [no description available] | medium | 6 | 0 | | |
pyrazole | [no description available] | medium | 2 | 0 | pyrazole | |
malvidin-3-glucoside | [no description available] | medium | 1 | 0 | anthocyanin cation; aromatic ether; beta-D-glucoside | metabolite |
indazoles | [no description available] | medium | 3 | 0 | indazole | |
dimethylaminochalcone | [no description available] | medium | 1 | 0 | | |
2,6-dichloro-4-nitrophenol | [no description available] | medium | 1 | 0 | | |
2-amino-4-picoline | [no description available] | medium | 1 | 0 | | |
phthalide | [no description available] | medium | 1 | 0 | 2-benzofurans; gamma-lactone | |
coniferyl ferulate | [no description available] | medium | 1 | 0 | | |
ethambutol | [no description available] | medium | 1 | 0 | ethanolamines; ethylenediamine derivative | antitubercular agent; environmental contaminant; xenobiotic |
pyrazinamide | [no description available] | medium | 2 | 0 | monocarboxylic acid amide; N-acylammonia; pyrazines | antitubercular agent; prodrug |
isoniazid | [no description available] | medium | 3 | 0 | carbohydrazide | antitubercular agent; drug allergen |
ranitidine | [no description available] | medium | 1 | 0 | C-nitro compound; furans; organic sulfide; tertiary amino compound | anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic |
nizatidine | [no description available] | medium | 1 | 0 | | |
famotidine | [no description available] | medium | 1 | 0 | 1,3-thiazoles; guanidines; sulfonamide | anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
carvedilol | [no description available] | medium | 2 | 0 | carbazoles; secondary alcohol; secondary amino compound | alpha-adrenergic antagonist; antihypertensive agent; beta-adrenergic antagonist; cardiovascular drug; vasodilator agent |
tetraethylammonium | [no description available] | medium | 2 | 0 | quaternary ammonium ion | |
phenacetin | [no description available] | medium | 3 | 0 | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug |
tacrine | [no description available] | medium | 3 | 0 | acridines; aromatic amine | EC 3.1.1.7 (acetylcholinesterase) inhibitor |
fluphenacur | [no description available] | medium | 1 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organofluorine compound | |
emamectin benzoate | [no description available] | medium | 2 | 0 | emamectins | |
alpha-aminopyridine | [no description available] | medium | 4 | 0 | | |
disulfiram | [no description available] | medium | 1 | 0 | organic disulfide; organosulfur acaricide | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor; EC 3.1.1.1 (carboxylesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; ferroptosis inducer; fungicide; NF-kappaB inhibitor |
aldicarb | [no description available] | medium | 1 | 0 | | |
isobutyronitrile | [no description available] | high | 3 | 0 | aliphatic nitrile; volatile organic compound | polar aprotic solvent |
triflimide | [no description available] | medium | 1 | 0 | | |
isoprene | [no description available] | medium | 1 | 0 | alkadiene; hemiterpene; volatile organic compound | plant metabolite |
carbon disulfide | [no description available] | medium | 5 | 0 | one-carbon compound; organosulfur compound | |
3-methylhexane | [no description available] | medium | 1 | 0 | alkane; volatile organic compound | human metabolite |
hydrogen sulfide | [no description available] | medium | 3 | 0 | gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride | Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent |
dipicrylamine | [no description available] | medium | 1 | 0 | | |
ortho-hydroxybenzophenone | [no description available] | medium | 1 | 0 | | |
resveratrol | [no description available] | medium | 3 | 0 | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
2,2-bis(4-glycidyloxyphenyl)propane | [no description available] | medium | 3 | 0 | diarylmethane | |
3,4-dihydroxybenzylamine | [no description available] | medium | 1 | 0 | catechols | |
3,4-dihydroxyphenylacetic acid | [no description available] | medium | 2 | 0 | catechols; dihydroxyphenylacetic acid | human metabolite |
5-hydroxytryptophan | [no description available] | medium | 1 | 0 | hydroxytryptophan | human metabolite; neurotransmitter |
3-methoxytyramine | [no description available] | medium | 1 | 0 | monomethoxybenzene; phenols; phenylethylamine; primary amino compound | biomarker; human blood serum metabolite; human urinary metabolite |
maltitol | [no description available] | medium | 1 | 0 | alpha-D-glucoside; glycosyl alditol | laxative; metabolite; sweetening agent |
xylitol | [no description available] | medium | 1 | 0 | | |
acebutolol | [no description available] | medium | 4 | 0 | alpha-D-glucosyl-(1->4)-D-mannopyranose | |
levodopa | [no description available] | medium | 1 | 0 | amino acid zwitterion; dopa; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | allelochemical; antidyskinesia agent; antiparkinson drug; dopaminergic agent; hapten; human metabolite; mouse metabolite; neurotoxin; plant growth retardant; plant metabolite; prodrug |
sulphoraphene | [no description available] | medium | 1 | 0 | | |
oryzalin | [no description available] | medium | 1 | 0 | aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound | agrochemical; antimitotic; herbicide |
stachyose | [no description available] | medium | 1 | 0 | raffinose family oligosaccharide; tetrasaccharide | mouse metabolite; plant metabolite |
benzo(c)fluorene | [no description available] | medium | 1 | 0 | carbotetracyclic compound | |
calcium acetate | [no description available] | medium | 1 | 0 | calcium salt | chelator |
2-nitrophenylhydrazine | [no description available] | medium | 2 | 0 | | |
3-chloropropionic acid | [no description available] | medium | 1 | 0 | | |
2-chloropropionic acid | [no description available] | medium | 1 | 0 | | |
2-bromopropionic acid, (dl)-isomer | [no description available] | medium | 1 | 0 | | |
pyranine | [no description available] | medium | 1 | 0 | organic sodium salt | fluorochrome |
neodymium | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom | |
oleic acid | [no description available] | medium | 3 | 0 | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent |
pinocembrin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; dihydroxyflavanone | antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent |
pinostrobin | [no description available] | medium | 1 | 0 | ether; flavonoids | |
trimethoxysilane | [no description available] | medium | 1 | 0 | | |
tetramethoxysilane | [no description available] | medium | 1 | 0 | | |
deoxyguanosine | [no description available] | medium | 3 | 0 | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
8-hydroxy-2'-deoxyguanosine | [no description available] | medium | 2 | 0 | guanosines | biomarker |
monoethylglycinexylidide | [no description available] | medium | 1 | 0 | amino acid amide | drug metabolite |
orabase | [no description available] | medium | 3 | 0 | | |
propionic anhydride | [no description available] | medium | 1 | 0 | | |
dimethylsulfonioacetate | [no description available] | medium | 3 | 0 | sulfonium betaine | |
enkephalin, leucine | [no description available] | medium | 3 | 0 | pentapeptide; peptide zwitterion | analgesic; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist; neurotransmitter; rat metabolite |
succinic acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid; C4-dicarboxylic acid | anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent |
thiobarbituric acid | [no description available] | medium | 1 | 0 | barbiturates | allergen; reagent |
desoxycorticosterone | [no description available] | medium | 1 | 0 | 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; mineralocorticoid; primary alpha-hydroxy ketone | human metabolite; mouse metabolite |
androstenedione | [no description available] | medium | 2 | 0 | 17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
cortodoxone | [no description available] | medium | 1 | 0 | deoxycortisol; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | human metabolite; mouse metabolite |
11-hydroxyprogesterone | [no description available] | medium | 1 | 0 | | |
racecadotril | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
thiorphan | [no description available] | medium | 1 | 0 | N-acyl-amino acid | |
dipyrone | [no description available] | medium | 1 | 0 | organic sodium salt | anti-inflammatory agent; antipyretic; antirheumatic drug; cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug; prodrug |
lissamine rhodamine b sulfonyl chloride | [no description available] | medium | 1 | 0 | | |
diphenhydramine | [no description available] | medium | 1 | 0 | ether; tertiary amino compound | anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative |
propylparaben | [no description available] | medium | 12 | 0 | benzoate ester; paraben; phenols | antifungal agent; antimicrobial agent |
isopropyl thiogalactoside | [no description available] | medium | 1 | 0 | S-glycosyl compound | |
eslicarbazepine | [no description available] | medium | 1 | 0 | dibenzooxazepine | |
10-hydroxycarbamazepine | [no description available] | medium | 2 | 0 | carboxamide; dibenzoazepine; ureas | anticonvulsant; drug allergen; sodium channel blocker |
carbamazepine | [no description available] | medium | 5 | 1 | dibenzoazepine; ureas | analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic |
oxcarbazepine | [no description available] | medium | 3 | 1 | cyclic ketone; dibenzoazepine | anticonvulsant; drug allergen |
eslicarbazepine acetate | [no description available] | medium | 2 | 0 | acetate ester; carboxamide; dibenzoazepine; ureas | anticonvulsant; drug allergen |
tetramethylenedisulfotetramine | [no description available] | medium | 1 | 0 | | |
sodium sulfate | [no description available] | medium | 3 | 0 | inorganic sodium salt | |
2,3,4,6-tetrachlorophenol | [no description available] | medium | 10 | 0 | tetrachlorophenol | xenobiotic metabolite |
hippuric acid | [no description available] | medium | 1 | 0 | N-acylglycine | human blood serum metabolite; uremic toxin |
durapatite | [no description available] | medium | 1 | 0 | | |
fluoxetine | [no description available] | medium | 2 | 0 | (trifluoromethyl)benzenes; aromatic ether; secondary amino compound | |
congo red | [no description available] | medium | 4 | 0 | bis(azo) compound | |
phenylguanidine | [no description available] | medium | 1 | 0 | | |
laulimalide | [no description available] | medium | 1 | 0 | carboxylic ester; epoxide; macrolide; secondary alcohol; secondary allylic alcohol | animal metabolite; antimitotic; antineoplastic agent; marine metabolite; microtubule-stabilising agent |
ergosterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols | fungal metabolite; Saccharomyces cerevisiae metabolite |
mycophenolic acid glucuronide | [no description available] | medium | 1 | 0 | | |
transferrin | [no description available] | medium | 1 | 0 | | |
xanthorrhizol | [no description available] | medium | 1 | 0 | sesquiterpenoid | |
protopanaxatriol | [no description available] | medium | 2 | 0 | | |
sapogenins | [no description available] | medium | 2 | 0 | | |
n-(4-methoxyphenyl)retinamide | [no description available] | medium | 1 | 0 | | |
fenretinide | [no description available] | medium | 1 | 0 | monocarboxylic acid amide; retinoid | antineoplastic agent; antioxidant |
lorazepam | [no description available] | medium | 3 | 1 | benzodiazepine | |
oxazepam | [no description available] | medium | 2 | 0 | 1,4-benzodiazepinone; organochlorine compound | anxiolytic drug; environmental contaminant; xenobiotic |
temazepam | [no description available] | medium | 3 | 0 | benzodiazepine | |
benzoylacrylic acid | [no description available] | medium | 1 | 0 | | |
deoxyribose | [no description available] | medium | 1 | 0 | deoxypentose | human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
thioctic acid | [no description available] | medium | 1 | 0 | dithiolanes; heterocyclic fatty acid; thia fatty acid | fundamental metabolite; geroprotector |
erlotinib hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride; terminal acetylenic compound | antineoplastic agent; protein kinase inhibitor |
linarin | [no description available] | medium | 3 | 0 | | |
laccase | [no description available] | medium | 6 | 0 | | |
trypan blue | [no description available] | medium | 2 | 0 | | |
diphenylamine | [no description available] | medium | 2 | 0 | aromatic amine; bridged diphenyl fungicide; secondary amino compound | antifungal agrochemical; antioxidant; carotogenesis inhibitor; EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor; ferroptosis inhibitor; radical scavenger |
methanesulfonic acid | [no description available] | medium | 1 | 0 | alkanesulfonic acid; one-carbon compound | Escherichia coli metabolite |
2,3,7,8-tetrachlorodibenzofuran | [no description available] | medium | 1 | 0 | polychlorinated dibenzofuran | |
bifenthrin | [no description available] | medium | 1 | 0 | carboxylic ester; cyclopropanecarboxylate ester; cyclopropanes; organochlorine compound; organofluorine compound | pyrethroid ester acaricide; pyrethroid ester insecticide |
decamethrin | [no description available] | medium | 1 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organobromine compound | agrochemical; antifeedant; calcium channel agonist; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; pyrethroid ester insecticide |
ethidium | [no description available] | medium | 2 | 0 | phenanthridines | fluorochrome; intercalator |
dihydroethidium | [no description available] | medium | 1 | 0 | | |
hydroxyurea | [no description available] | medium | 1 | 0 | one-carbon compound; ureas | antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent |
chlorophacinone | [no description available] | medium | 1 | 0 | beta-triketone; diarylmethane | |
diphenadione | [no description available] | medium | 1 | 0 | beta-triketone; diarylmethane | |
phenindione | [no description available] | medium | 1 | 0 | aromatic ketone; beta-diketone | anticoagulant |
fluoroboric acid | [no description available] | medium | 1 | 0 | boron fluoride | |
cetirizine | [no description available] | medium | 1 | 0 | ether; monocarboxylic acid; monochlorobenzenes; piperazines | anti-allergic agent; environmental contaminant; H1-receptor antagonist; xenobiotic |
3-mercaptopropionic acid | [no description available] | medium | 1 | 0 | mercaptopropanoic acid | algal metabolite |
pentaerythritol tetra(3-mercaptopropionate) | [no description available] | medium | 1 | 0 | | |
tussilagone | [no description available] | medium | 1 | 0 | | |
sesquiterpenes | [no description available] | medium | 10 | 0 | | |
serine | [no description available] | medium | 3 | 0 | L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
octanoic acid | [no description available] | medium | 1 | 0 | medium-chain fatty acid; straight-chain saturated fatty acid | antibacterial agent; Escherichia coli metabolite; human metabolite |
nitrofurazone | [no description available] | medium | 1 | 0 | | |
acephate | [no description available] | medium | 1 | 0 | mixed diacylamine; organic thiophosphate; organothiophosphate insecticide; phosphoramide | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
methyl demeton | [no description available] | medium | 1 | 0 | | |
dimethoate | [no description available] | medium | 3 | 0 | monocarboxylic acid amide; organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic |
monocrotophos | [no description available] | medium | 1 | 0 | alkenyl phosphate; dialkyl phosphate; monocarboxylic acid amide; organophosphate insecticide | acaricide; agrochemical; avicide; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
methamidophos | [no description available] | medium | 1 | 0 | organic thiophosphate; organothiophosphate insecticide; phosphoramide | acaricide; agrochemical; avicide |
dimethoxon | [no description available] | medium | 1 | 0 | organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
methyl 3,4-dihydroxybenzoate | [no description available] | medium | 1 | 0 | catechols; methyl ester | antioxidant; neuroprotective agent; plant metabolite |
pyrrolidine | [no description available] | medium | 2 | 0 | azacycloalkane; pyrrolidines; saturated organic heteromonocyclic parent | |
seratrodast | [no description available] | medium | 1 | 0 | organic molecular entity | |
1,4-naphthoquinone | [no description available] | medium | 2 | 0 | 1,4-naphthoquinones | |
oxytetracycline, anhydrous | [no description available] | medium | 5 | 0 | | |
chlortetracycline | [no description available] | medium | 2 | 0 | | |
methacycline | [no description available] | medium | 1 | 0 | | |
capsaicin | [no description available] | medium | 2 | 0 | capsaicinoid | non-narcotic analgesic; TRPV1 agonist; voltage-gated sodium channel blocker |
zeolites | [no description available] | medium | 3 | 0 | | |
3,5-di-tert-butylcatechol | [no description available] | medium | 3 | 0 | | |
3,4,5,6-tetrachlorocatechol | [no description available] | medium | 1 | 0 | chlorocatechol; tetrachlorobenzene | |
sulfoxide | [no description available] | medium | 2 | 0 | benzodioxoles | |
safrole | [no description available] | medium | 2 | 0 | benzodioxoles | flavouring agent; insecticide; metabolite; plant metabolite |
tinidazole | [no description available] | medium | 2 | 0 | imidazoles | antiamoebic agent; antibacterial drug; antiparasitic agent; antiprotozoal drug |
omeprazole | [no description available] | medium | 3 | 0 | aromatic ether; benzimidazoles; pyridines; sulfoxide | |
anastrozole | [no description available] | medium | 1 | 0 | nitrile; triazoles | antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor |
3-(2,2,2-trimethylhydrazine)propionate | [no description available] | medium | 1 | 0 | ammonium betaine | cardioprotective agent; EC 1.14.11.1 (gamma-butyrobetaine dioxygenase) inhibitor; neuroprotective agent |
dichlorvos | [no description available] | medium | 3 | 0 | alkenyl phosphate; dialkyl phosphate; organochlorine acaricide; organophosphate insecticide | anthelminthic drug; antibacterial agent; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
carbofuran | [no description available] | medium | 1 | 0 | 1-benzofurans; carbamate ester | acaricide; agrochemical; avicide; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nematicide |
methylparaoxon | [no description available] | medium | 1 | 0 | C-nitro compound | |
paraoxon | [no description available] | medium | 2 | 0 | aryl dialkyl phosphate; organophosphate insecticide | EC 3.1.1.7 (acetylcholinesterase) inhibitor; mouse metabolite |
carbaryl | [no description available] | medium | 2 | 0 | carbamate ester; naphthalenes | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant growth retardant |
althiazide | [no description available] | medium | 1 | 0 | benzothiadiazine | |
emodin | [no description available] | medium | 1 | 0 | trihydroxyanthraquinone | antineoplastic agent; laxative; plant metabolite; tyrosine kinase inhibitor |
isosteviol | [no description available] | medium | 1 | 0 | diterpenoid | |
piroxicam | [no description available] | medium | 6 | 0 | benzothiazine; monocarboxylic acid amide; pyridines | analgesic; antirheumatic drug; cyclooxygenase 1 inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
reboxetine | [no description available] | medium | 1 | 0 | aromatic ether | |
sodium perchlorate | [no description available] | medium | 7 | 0 | inorganic sodium salt | |
n-phenylpyrrole | [no description available] | medium | 1 | 0 | | |
mobiflex | [no description available] | medium | 3 | 0 | heteroaryl hydroxy compound; monocarboxylic acid amide; pyridines; thienothiazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
apaflurane | [no description available] | medium | 1 | 0 | | |
dimethyl sulfate | [no description available] | medium | 3 | 0 | alkyl sulfate | alkylating agent; immunosuppressive agent |
safranine t | [no description available] | medium | 1 | 0 | organic chloride salt | fluorochrome; histological dye |
phenosafranine | [no description available] | medium | 1 | 0 | organic chloride salt | fluorochrome; histological dye; photosensitizing agent |
3,4-dihydroxyphenylethanol | [no description available] | medium | 1 | 0 | catechols; primary alcohol | antineoplastic agent; antioxidant; metabolite |
ritonavir | [no description available] | medium | 2 | 0 | 1,3-thiazoles; carbamate ester; carboxamide; L-valine derivative; ureas | antiviral drug; environmental contaminant; HIV protease inhibitor; xenobiotic |
granite | [no description available] | medium | 1 | 0 | triazolopyrimidines | |
cysteamine | [no description available] | medium | 1 | 0 | amine; thiol | geroprotector; human metabolite; mouse metabolite; radiation protective agent |
oxalates | [no description available] | medium | 3 | 0 | | |
bis(2,4,5-trichloro-6-carbopentoxyphenyl)oxalate | [no description available] | medium | 1 | 0 | | |
melatonin | [no description available] | medium | 2 | 0 | acetamides; tryptamines | anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger |
chlorothiazide | [no description available] | medium | 1 | 0 | benzothiadiazine | antihypertensive agent; diuretic |
bisoprolol | [no description available] | medium | 1 | 0 | secondary alcohol; secondary amine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
argon | [no description available] | medium | 2 | 0 | monoatomic argon; noble gas atom; p-block element atom | food packaging gas; neuroprotective agent |
chloranil | [no description available] | medium | 3 | 0 | 1,4-benzoquinones; organochlorine compound | EC 2.7.1.33 (pantothenate kinase) inhibitor; metabolite |
2-hydroxy-1,4-benzoquinone | [no description available] | medium | 1 | 0 | monohydroxy-1,4-benzoquinones | mouse metabolite |
porphycene | [no description available] | medium | 2 | 0 | | |
abt 869 | [no description available] | medium | 1 | 0 | aromatic amine; indazoles; phenylureas | angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
bromide | [no description available] | medium | 8 | 0 | halide anion; monoatomic bromine | |
proline | [no description available] | medium | 6 | 0 | amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid | algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
prodan | [no description available] | medium | 1 | 0 | 2-acyl-6-dimethylaminonaphthalene | |
2-naphthylamine | [no description available] | medium | 1 | 0 | naphthylamine | carcinogenic agent |
fluorouracil | [no description available] | medium | 6 | 0 | nucleobase analogue; organofluorine compound | antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic |
bryostatin 1 | [no description available] | medium | 1 | 0 | | |
dithiane | [no description available] | medium | 1 | 0 | dithiane | |
spirastrellolide a | [no description available] | medium | 1 | 0 | | |
azauracil | [no description available] | medium | 3 | 0 | 1,2,4-triazines; nucleobase analogue | antimetabolite |
etravirine | [no description available] | medium | 1 | 0 | aminopyrimidine; aromatic ether; dinitrile; organobromine compound | antiviral agent; HIV-1 reverse transcriptase inhibitor |
zinc sulfate | [no description available] | medium | 4 | 0 | metal sulfate; zinc molecular entity | fertilizer |
trinitrotoluene | [no description available] | medium | 7 | 0 | trinitrotoluene | explosive |
tripropylamine | [no description available] | medium | 1 | 0 | tertiary amine | |
succinylcholine | [no description available] | medium | 1 | 0 | quaternary ammonium ion; succinate ester | drug allergen; muscle relaxant; neuromuscular agent |
tromethamine | [no description available] | medium | 8 | 0 | primary amino compound; triol | buffer |
raltegravir potassium | [no description available] | medium | 1 | 0 | | |
2,2,2-trifluoroethyl methacrylate | [no description available] | medium | 1 | 0 | | |
biotin | [no description available] | medium | 3 | 0 | biotins; vitamin B7 | coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite |
pqq cofactor | [no description available] | medium | 1 | 0 | orthoquinones; pyrroloquinoline cofactor; tricarboxylic acid | anti-inflammatory agent; antioxidant; cofactor; water-soluble vitamin (role) |
boric acid | [no description available] | medium | 6 | 0 | boric acids | astringent |
piperazine | [no description available] | medium | 1 | 0 | azacycloalkane; piperazines; saturated organic heteromonocyclic parent | anthelminthic drug |
octahydroindole-2-carboxylic acid | [no description available] | medium | 1 | 0 | | |
sodium hydride | [no description available] | medium | 1 | 0 | | |
floxuridine | [no description available] | medium | 3 | 0 | nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent |
gemcitabine | [no description available] | medium | 1 | 0 | organofluorine compound; pyrimidine 2'-deoxyribonucleoside | antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic |
2',2'-difluoro-2'-deoxyuridine | [no description available] | medium | 1 | 0 | | |
iron perchlorate | [no description available] | medium | 1 | 0 | | |
chlorpromazine | [no description available] | medium | 1 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
dimyristoylphosphatidylcholine | [no description available] | medium | 1 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine; phosphatidylcholine 28:0; tetradecanoate ester | antigen; mouse metabolite |
lanatoside c | [no description available] | medium | 1 | 0 | | |
vitexin | [no description available] | medium | 1 | 0 | C-glycosyl compound; trihydroxyflavone | antineoplastic agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; plant metabolite; platelet aggregation inhibitor |
lanatosides | [no description available] | medium | 1 | 0 | | |
4-toluenesulfonic acid | [no description available] | medium | 1 | 0 | arenesulfonic acid; toluenes | |
avapro | [no description available] | medium | 2 | 0 | azaspiro compound; biphenylyltetrazole | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
biliverdine | [no description available] | medium | 1 | 0 | | |
simvastatin | [no description available] | medium | 5 | 0 | delta-lactone; fatty acid ester; hexahydronaphthalenes; statin (semi-synthetic) | EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; ferroptosis inducer; geroprotector; prodrug |
valine | [no description available] | medium | 3 | 0 | L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
valsartan | [no description available] | medium | 2 | 0 | biphenylyltetrazole; monocarboxylic acid amide; monocarboxylic acid | angiotensin receptor antagonist; antihypertensive agent; environmental contaminant; xenobiotic |
simvastatin acid | [no description available] | medium | 2 | 0 | carbonyl compound | |
gallamine triethiodide | [no description available] | medium | 1 | 0 | | |
acetylthiocholine | [no description available] | medium | 2 | 0 | | |
xylose | [no description available] | medium | 2 | 0 | D-xylose | |
carnitine | [no description available] | medium | 5 | 0 | amino-acid betaine | human metabolite; mouse metabolite |
s-adenosylmethionine | [no description available] | medium | 4 | 0 | sulfonium betaine | human metabolite |
glycolipids | [no description available] | medium | 2 | 0 | | |
sulfamethazine | [no description available] | medium | 3 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
divinyl benzene | [no description available] | medium | 3 | 0 | styrenes | |
3-(trimethoxysilyl)propyl methacrylate | [no description available] | medium | 1 | 0 | | |
dehydrocorydalin | [no description available] | medium | 1 | 0 | alkaloid | |
tetrahydropalmatine | [no description available] | medium | 4 | 0 | | |
albuterol | [no description available] | medium | 3 | 0 | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic |
clenbuterol | [no description available] | medium | 2 | 0 | amino alcohol; dichlorobenzene; ethanolamines; primary arylamine; secondary amino compound; substituted aniline | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent |
ractopamine | [no description available] | medium | 1 | 0 | benzyl alcohols; polyphenol; secondary alcohol; secondary amino compound | |
phosphatidylcholines | [no description available] | medium | 10 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
sodium taurodeoxycholate | [no description available] | medium | 1 | 0 | bile acid taurine conjugate | human metabolite |
octylamine | [no description available] | medium | 2 | 1 | primary aliphatic amine | metabolite |
povidone-iodine | [no description available] | medium | 1 | 0 | | |
tiliroside | [no description available] | medium | 1 | 0 | cinnamate ester; glycosyloxyflavone; monosaccharide derivative; trihydroxyflavone | plant metabolite |
oleuropein | [no description available] | medium | 1 | 0 | beta-D-glucoside; catechols; diester; methyl ester; pyrans; secoiridoid glycoside | anti-inflammatory agent; antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; NF-kappaB inhibitor; nutraceutical; plant metabolite; radical scavenger |
iridoids | [no description available] | medium | 3 | 0 | | |
dalteparin | [no description available] | medium | 2 | 0 | | |
alpha-naphthyl isocyanate | [no description available] | medium | 1 | 0 | | |
cyanates | [no description available] | medium | 3 | 0 | | |
dehydroevodiamine | [no description available] | medium | 1 | 0 | | |
rhodamine 123 | [no description available] | medium | 1 | 0 | organic cation; xanthene dye | fluorochrome |
2-ethylhexyl salicylate | [no description available] | medium | 1 | 0 | benzoate ester; phenols | |
camphor, (+-)-isomer | [no description available] | medium | 2 | 0 | bornane monoterpenoid; cyclic monoterpene ketone | plant metabolite |
enzacamene | [no description available] | medium | 1 | 0 | | |
octocrylene | [no description available] | medium | 1 | 0 | diarylmethane | |
homosalate | [no description available] | medium | 1 | 0 | benzoate ester; phenols | |
octylmethoxycinnamate | [no description available] | medium | 1 | 0 | cinnamate ester | |
n-hexadecane | [no description available] | medium | 2 | 0 | long-chain alkane | non-polar solvent; plant metabolite; volatile oil component |
2,2,4-trimethylpentane | [no description available] | medium | 2 | 0 | alkane; volatile organic compound | fuel additive; nephrotoxin; non-polar solvent |
calix(4)arene | [no description available] | medium | 5 | 0 | | |
iron(iii)-deuteroporphyrin | [no description available] | medium | 1 | 0 | | |
dexmedetomidine | [no description available] | medium | 1 | 1 | medetomidine | alpha-adrenergic agonist; analgesic; non-narcotic analgesic; sedative |
4-(4-nitrobenzyl)pyridine | [no description available] | medium | 2 | 0 | | |
troglitazone | [no description available] | medium | 1 | 0 | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent |
oxazoles | [no description available] | medium | 4 | 0 | 1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
tungsten | [no description available] | medium | 3 | 0 | chromium group element atom | micronutrient |
fludarabine | [no description available] | medium | 1 | 0 | purine nucleoside | |
5-chlorouracil | [no description available] | medium | 1 | 0 | organochlorine compound | |
5-fluorodihydrouracil | [no description available] | medium | 1 | 0 | pyrimidone | |
5'-deoxy-5-fluorocytidine | [no description available] | medium | 1 | 0 | N-glycosyl compound | |
doxifluridine | [no description available] | medium | 1 | 0 | organofluorine compound; pyrimidine 5'-deoxyribonucleoside | antimetabolite; antineoplastic agent; prodrug |
capecitabine | [no description available] | medium | 1 | 0 | carbamate ester; cytidines; organofluorine compound | antimetabolite; antineoplastic agent; prodrug |
vidarabine | [no description available] | medium | 1 | 0 | beta-D-arabinoside; purine nucleoside | antineoplastic agent; bacterial metabolite; nucleoside antibiotic |
decabromobiphenyl ether | [no description available] | medium | 1 | 0 | polybromodiphenyl ether | neurotoxin |
butyraldehyde | [no description available] | medium | 1 | 0 | butanals | biomarker; Escherichia coli metabolite; mouse metabolite |
dicyanmethane | [no description available] | medium | 3 | 0 | aliphatic nitrile; dinitrile | |
1,4-dihydropyridine | [no description available] | medium | 2 | 0 | | |
dihydropyridines | [no description available] | medium | 4 | 0 | | |
nitric acid | [no description available] | medium | 3 | 0 | nitrogen oxoacid | protic solvent; reagent |
chlorprothixene | [no description available] | medium | 2 | 0 | chlorprothixene | |
lead nitrate | [no description available] | medium | 1 | 0 | inorganic nitrate salt; lead coordination entity | |
mercuric chloride | [no description available] | medium | 2 | 0 | mercury coordination entity | sensitiser |
2,3,4,5,6-pentafluorophenol | [no description available] | medium | 1 | 0 | | |
aminosalicylic acid | [no description available] | medium | 2 | 0 | aminobenzoic acid; phenols | antitubercular agent |
p-aminohippuric acid | [no description available] | medium | 2 | 0 | N-acylglycine | Daphnia magna metabolite |
mebeverine | [no description available] | medium | 1 | 0 | | |
coumarin 153 | [no description available] | medium | 3 | 0 | 7-aminocoumarins | fluorochrome |
8-azaadenine | [no description available] | medium | 1 | 0 | aromatic amine; nucleobase analogue; triazolopyrimidines | EC 1.17.3.2 (xanthine oxidase) inhibitor; Mycoplasma genitalium metabolite |
azaguanine | [no description available] | medium | 1 | 0 | nucleobase analogue; triazolopyrimidines | antimetabolite; antineoplastic agent; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor |
5-azacytosine | [no description available] | medium | 1 | 0 | monoamino-1,3,5-triazine | |
sperm motility inhibitor 2 | [no description available] | medium | 2 | 0 | | |
samarium | [no description available] | medium | 2 | 0 | f-block element atom; lanthanoid atom | |
ethylene oxide | [no description available] | medium | 1 | 0 | gas molecular entity; oxacycle; saturated organic heteromonocyclic parent | allergen; mouse metabolite; mutagen |
folic acid | [no description available] | medium | 4 | 0 | folic acids; N-acyl-amino acid | human metabolite; mouse metabolite; nutrient |
benzimidazole | [no description available] | medium | 1 | 0 | benzimidazole; polycyclic heteroarene | |
indoline | [no description available] | medium | 1 | 0 | indoles | |
nordazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative |
meldrum's acid | [no description available] | medium | 1 | 0 | | |
4-chloro-7-nitrobenzofurazan | [no description available] | medium | 6 | 0 | benzoxadiazole; C-nitro compound; organochlorine compound | EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome |
paroxetine | [no description available] | medium | 3 | 0 | aromatic ether; benzodioxoles; organofluorine compound; piperidines | antidepressant; anxiolytic drug; hepatotoxic agent; P450 inhibitor; serotonin uptake inhibitor |
rabeprazole | [no description available] | medium | 1 | 0 | benzimidazoles; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
phenolsulfonphthalein | [no description available] | medium | 2 | 0 | 2,1-benzoxathiole; arenesulfonate ester; phenols; sultone | acid-base indicator; diagnostic agent; two-colour indicator |
hymecromone | [no description available] | medium | 1 | 0 | hydroxycoumarin | antineoplastic agent; hyaluronic acid synthesis inhibitor |
brevetoxin | [no description available] | medium | 1 | 0 | | |
andrographolide | [no description available] | medium | 1 | 0 | carbobicyclic compound; gamma-lactone; labdane diterpenoid; primary alcohol; secondary alcohol | anti-HIV agent; anti-inflammatory drug; antineoplastic agent; metabolite |
dodine | [no description available] | medium | 1 | 0 | acetate salt; aliphatic nitrogen antifungal agent | antibacterial agent; antifungal agrochemical |
glutaral | [no description available] | medium | 5 | 0 | dialdehyde | cross-linking reagent; disinfectant; fixative |
simetryn | [no description available] | medium | 1 | 0 | diamino-1,3,5-triazine; methylthio-1,3,5-triazine | herbicide |
2,4-dinitrophenylhydrazine | [no description available] | medium | 3 | 0 | C-nitro compound; phenylhydrazines | reagent |
enrofloxacin | [no description available] | medium | 6 | 0 | cyclopropanes; N-alkylpiperazine; N-arylpiperazine; organofluorine compound; quinolinemonocarboxylic acid; quinolone | antibacterial agent; antimicrobial agent; antineoplastic agent |
methyl linoleate | [no description available] | medium | 5 | 0 | fatty acid methyl ester | plant metabolite |
4-oxo-2-nonenal | [no description available] | medium | 1 | 0 | enal; enone | human metabolite |
furan | [no description available] | medium | 2 | 0 | furans; mancude organic heteromonocyclic parent; monocyclic heteroarene | carcinogenic agent; hepatotoxic agent; Maillard reaction product |
gamma-tocopherol | [no description available] | medium | 1 | 0 | tocopherol; vitamin E | algal metabolite; food antioxidant; plant metabolite |
cynarine | [no description available] | medium | 1 | 0 | alkyl caffeate ester; quinic acid | plant metabolite |
veliparib | [no description available] | medium | 1 | 0 | benzimidazoles | EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor |
cocaethylene | [no description available] | medium | 2 | 0 | benzoate ester | |
benzoylecgonine | [no description available] | medium | 2 | 0 | benzoate ester; tropane alkaloid | epitope; human xenobiotic metabolite; marine xenobiotic metabolite; plant metabolite |
promazine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amine | antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist |
fenton's reagent | [no description available] | medium | 2 | 0 | | |
cesium | [no description available] | medium | 5 | 0 | alkali metal atom | |
cesium chloride | [no description available] | medium | 2 | 0 | inorganic caesium salt; inorganic chloride | phase-transfer catalyst; vasoconstrictor agent |
technetium | [no description available] | medium | 1 | 0 | manganese group element atom | |
cyclosporine | [no description available] | medium | 4 | 1 | | |
sepharose | [no description available] | medium | 6 | 0 | | |
glycylglycine | [no description available] | medium | 1 | 0 | dipeptide zwitterion; dipeptide | human metabolite |
thioflavin t | [no description available] | medium | 4 | 0 | organic chloride salt | fluorochrome; geroprotector; histological dye |
pefloxacin | [no description available] | medium | 1 | 0 | fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; N-arylpiperazine; quinolone antibiotic; quinolone | antibacterial drug; antiinfective agent; DNA synthesis inhibitor |
butyl methacrylate | [no description available] | medium | 2 | 0 | enoate ester | |
benzeneboronic acid | [no description available] | medium | 2 | 0 | boronic acids | |
diphenylborinic acid | [no description available] | medium | 1 | 0 | | |
phosphatidylethanol | [no description available] | medium | 1 | 0 | | |
angiotensin i | [no description available] | medium | 2 | 0 | angiotensin; peptide zwitterion | human metabolite; neurotransmitter agent |
zopiclone | [no description available] | medium | 2 | 0 | monochloropyridine; pyrrolopyrazine | central nervous system depressant; sedative |
oxiracetam | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
piracetam | [no description available] | medium | 2 | 0 | organonitrogen compound; organooxygen compound | |
maleopimaric acid | [no description available] | medium | 1 | 0 | | |
1-methyl-3-ethylimidazolium | [no description available] | medium | 2 | 0 | 1-alkyl-3-methylimidazolium | |
perylene | [no description available] | medium | 2 | 0 | ortho- and peri-fused polycyclic arene; perylenes | |
lithium perchlorate | [no description available] | medium | 5 | 0 | | |
hydroxyflutamide | [no description available] | medium | 1 | 0 | | |
flutamide | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; monocarboxylic acid amide | androgen antagonist; antineoplastic agent |
tegafur | [no description available] | medium | 1 | 0 | organohalogen compound; pyrimidines | |
1-methylnaphthalene | [no description available] | medium | 1 | 0 | methylnaphthalene | carcinogenic agent; plant metabolite |
chrysene | [no description available] | medium | 1 | 0 | ortho-fused polycyclic arene | plant metabolite |
diphenyl | [no description available] | medium | 3 | 0 | aromatic fungicide; benzenes; biphenyls | antifungal agrochemical; antimicrobial food preservative |
triphenylene | [no description available] | medium | 1 | 0 | ortho-fused polycyclic arene | |
phenanthrenes | [no description available] | medium | 7 | 0 | | |
omega-n-methylarginine | [no description available] | medium | 1 | 0 | amino acid zwitterion; arginine derivative; guanidines; L-arginine derivative; non-proteinogenic L-alpha-amino acid | |
dimethylarginine | [no description available] | medium | 1 | 0 | | |
dimethyl methylphosphonate | [no description available] | medium | 2 | 0 | | |
memantine | [no description available] | medium | 1 | 0 | adamantanes; primary aliphatic amine | antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist |
erythrosine | [no description available] | medium | 4 | 0 | | |
2-(methacryloyloxy)ethyl phosphate | [no description available] | medium | 1 | 0 | | |
nitrilotriacetic acid | [no description available] | medium | 2 | 0 | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent |
ferric nitrilotriacetate | [no description available] | medium | 1 | 0 | iron chelate | carcinogenic agent; mutagen |
bms 754807 | [no description available] | medium | 1 | 0 | pyrazoles; pyridines; pyrrolidines; pyrrolotriazine | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
1,2-dichloroethylene | [no description available] | medium | 1 | 0 | chloroethenes | |
3,4-methylenedioxyethamphetamine | [no description available] | medium | 1 | 0 | benzodioxoles; secondary amino compound | |
3,4-methylenedioxyamphetamine | [no description available] | medium | 2 | 0 | benzodioxoles | |
n-methyl-3,4-methylenedioxyamphetamine | [no description available] | medium | 3 | 0 | amphetamines; benzodioxoles | neurotoxin |
methamphetamine | [no description available] | medium | 3 | 0 | amphetamines; secondary amine | central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic |
fumonisin b2 | [no description available] | medium | 3 | 0 | diester; diol; fumonisin; primary amino compound | Aspergillus metabolite; carcinogenic agent |
octadecyl palmitate | [no description available] | medium | 1 | 0 | hexadecanoate ester; wax ester | coral metabolite; cosmetic |
nicosulfuron | [no description available] | medium | 1 | 0 | N-sulfonylurea; pyridines; pyrimidines | environmental contaminant; herbicide; xenobiotic |
diethyl chlorophosphate | [no description available] | medium | 1 | 0 | | |
isoflurophate | [no description available] | medium | 1 | 0 | dialkyl phosphate | |
acid fuchsin | [no description available] | medium | 1 | 0 | | |
heme | [no description available] | medium | 6 | 0 | | |
2,2',3',4,4',5-hexachlorobiphenyl | [no description available] | medium | 1 | 0 | polychlorobiphenyl | |
methylene blue | [no description available] | medium | 5 | 0 | organic chloride salt | acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer |
2-chlorophenol | [no description available] | medium | 1 | 0 | 2-halophenol; monochlorophenol | |
goethite | [no description available] | medium | 1 | 0 | | |
trimethylolpropane trimethacrylate | [no description available] | medium | 1 | 0 | carbonyl compound | |
lithium hydroxide | [no description available] | medium | 1 | 0 | alkali metal hydroxide | |
mannitol | [no description available] | medium | 1 | 0 | mannitol | allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent |
duloxetine hydrochloride | [no description available] | medium | 1 | 0 | duloxetine hydrochloride | antidepressant |
sifuvirtide | [no description available] | medium | 1 | 0 | | |
prohexadione-ca | [no description available] | medium | 1 | 0 | | |
cyanuric acid | [no description available] | medium | 1 | 0 | 1,3,5-triazinanes; 1,3,5-triazines; heteroaryl hydroxy compound | xenobiotic |
cyromazine | [no description available] | medium | 3 | 0 | triamino-1,3,5-triazine | mouse metabolite; triazine insecticide |
lumiflavin | [no description available] | medium | 1 | 0 | flavin | |
rosiglitazone | [no description available] | medium | 1 | 0 | acetate ester; coumarins; diester | pro-angiogenic agent; radical scavenger |
quinone | [no description available] | medium | 6 | 0 | 1,4-benzoquinones | cofactor; human xenobiotic metabolite; mouse metabolite |
sarafloxacin | [no description available] | medium | 3 | 0 | quinolines | |
ciprofloxacin | [no description available] | medium | 6 | 0 | aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion | antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic |
aluminum oxide | [no description available] | medium | 5 | 0 | | |
oxolinic acid | [no description available] | medium | 3 | 0 | aromatic carboxylic acid; organic heterotricyclic compound; oxacycle; quinolinemonocarboxylic acid; quinolone antibiotic | antibacterial drug; antifungal agent; antiinfective agent; antimicrobial agent; enzyme inhibitor |
potassium iodide | [no description available] | medium | 2 | 0 | potassium salt | expectorant; radical scavenger |
1-methylindole | [no description available] | medium | 1 | 0 | | |
2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | [no description available] | medium | 2 | 0 | aromatic amine; imidazoquinoxaline | carcinogenic agent; genotoxin; Maillard reaction product; mutagen |
methyl parathion | [no description available] | medium | 2 | 0 | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; genotoxin |
procymidone | [no description available] | medium | 2 | 0 | | |
endosulfan | [no description available] | medium | 2 | 0 | cyclic sulfite ester; cyclodiene organochlorine insecticide | acaricide; agrochemical; GABA-gated chloride channel antagonist; persistent organic pollutant |
bms 708163 | [no description available] | medium | 2 | 0 | oxadiazole; ring assembly | |
fructooligosaccharide | [no description available] | medium | 1 | 0 | oligosaccharide | |
n-dodecane | [no description available] | medium | 2 | 0 | alkane | plant metabolite |
solanesol | [no description available] | medium | 1 | 0 | nonaprenol; primary alcohol | plant metabolite |
4-cyanobenzoic acid | [no description available] | medium | 1 | 0 | | |
1,1-diphenylethylene | [no description available] | medium | 1 | 0 | | |
methylcyclohexane | [no description available] | medium | 1 | 0 | cycloalkane; volatile organic compound | aprotic solvent; human metabolite; plant metabolite |
2-hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine | [no description available] | medium | 1 | 0 | hydroxylamine; imidazopyridine | carcinogenic agent; genotoxin; human xenobiotic metabolite; mouse metabolite; mutagen; neurotoxin; rat metabolite |
2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | [no description available] | medium | 2 | 0 | imidazopyridine; primary amino compound | carcinogenic agent; mutagen |
lomustine | [no description available] | medium | 1 | 0 | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent |
deoxycholic acid | [no description available] | medium | 5 | 0 | bile acid; C24-steroid; dihydroxy-5beta-cholanic acid | human blood serum metabolite |
thymoquinone | [no description available] | medium | 1 | 0 | 1,4-benzoquinones | adjuvant; anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; cardioprotective agent; plant metabolite |
lansoprazole | [no description available] | medium | 1 | 0 | benzimidazoles; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
citral | [no description available] | medium | 1 | 0 | enal; monoterpenoid; polyprenal | plant metabolite; volatile oil component |
hydroxycitronellal | [no description available] | medium | 1 | 0 | tertiary alcohol | allergen; fragrance |
digitonin | [no description available] | medium | 1 | 0 | | |
digitoxin | [no description available] | medium | 1 | 0 | cardenolide glycoside | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor |
gitoxin | [no description available] | medium | 1 | 0 | cardenolide glycoside | |
digoxin | [no description available] | medium | 3 | 0 | cardenolide glycoside; steroid saponin | anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope |
limonene | [no description available] | medium | 1 | 0 | cycloalkene; p-menthadiene | human metabolite |
octylonium | [no description available] | medium | 1 | 0 | benzamides | |
potassium fluoride | [no description available] | medium | 1 | 0 | fluoride salt; potassium salt | NMR chemical shift reference compound; poison |
octadecane | [no description available] | medium | 1 | 0 | long-chain alkane | bacterial metabolite; plant metabolite |
cefazedone | [no description available] | medium | 1 | 1 | 4-pyridones; carboxylic acid; cephalosporin; semisynthetic derivative; thiadiazoles | antibacterial drug |
cefazolin | [no description available] | medium | 2 | 1 | beta-lactam antibiotic allergen; cephalosporin; tetrazoles; thiadiazoles | antibacterial drug |
gambogic acid | [no description available] | medium | 1 | 0 | pyranoxanthones | metabolite |
10-hydroxygambogic acid | [no description available] | medium | 1 | 0 | | |
olmesartan | [no description available] | medium | 1 | 0 | biphenylyltetrazole | angiotensin receptor antagonist; antihypertensive agent |
lovastatin | [no description available] | medium | 3 | 0 | delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring) | anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug |
copper sulfate | [no description available] | medium | 1 | 0 | metal sulfate | emetic; fertilizer; sensitiser |
1,8-diazabicyclo(5.4.0)undec-7-ene | [no description available] | medium | 1 | 0 | | |
oxaceprol | [no description available] | medium | 1 | 0 | | |
hydroxyproline | [no description available] | medium | 1 | 0 | 4-hydroxyproline; L-alpha-amino acid zwitterion | human metabolite; mouse metabolite; plant metabolite |
1,2-dipalmitoylphosphatidylcholine | [no description available] | medium | 3 | 0 | | |
neocuproine | [no description available] | medium | 1 | 0 | phenanthrolines | chelator; copper chelator |
2,6-dimethoxybenzoic acid | [no description available] | medium | 1 | 0 | benzenes; carbonyl compound | |
threonine | [no description available] | medium | 2 | 0 | amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
delanzomib | [no description available] | medium | 1 | 0 | C-terminal boronic acid peptide; phenylpyridine; secondary alcohol; threonine derivative | antineoplastic agent; apoptosis inducer; proteasome inhibitor |
1,2-dimethylimidazole | [no description available] | medium | 1 | 0 | imidazoles | |
trimethyl phosphite | [no description available] | medium | 1 | 0 | organophosphorus compound | alkylating agent |
phosphites | [no description available] | medium | 2 | 0 | phosphite ion; trivalent inorganic anion | |
propionic acid | [no description available] | medium | 1 | 0 | saturated fatty acid; short-chain fatty acid | antifungal drug |
busulfan | [no description available] | medium | 1 | 0 | methanesulfonate ester | alkylating agent; antineoplastic agent; carcinogenic agent; insect sterilant; teratogenic agent |
n-methylpyrrolidone | [no description available] | medium | 2 | 0 | lactam; N-alkylpyrrolidine; pyrrolidin-2-ones | polar aprotic solvent |
fluorescamine | [no description available] | medium | 2 | 0 | | |
vesamicol | [no description available] | medium | 1 | 0 | piperidines | |
2-(4-(6-chloro-1,3-benzoxazol-2-yloxy)phenoxy)-2'-fluoro-n-methylpropionanilide | [no description available] | medium | 1 | 0 | 2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}-N-(2-fluorophenyl)-N-methylpropanamide | EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; phenoxy herbicide |
beta-endorphin | [no description available] | medium | 4 | 0 | | |
nitrovin | [no description available] | medium | 1 | 0 | C-nitro compound; furans | |
lysophosphatidylcholines | [no description available] | medium | 3 | 0 | 1-O-acyl-sn-glycero-3-phosphocholine | |
perfluorohexanesulfonic acid | [no description available] | medium | 1 | 0 | perfluoroalkanesulfonic acid | |
cilostazol | [no description available] | medium | 2 | 0 | lactam; tetrazoles | anticoagulant; bronchodilator agent; EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor; fibrin modulating drug; neuroprotective agent; platelet aggregation inhibitor; vasodilator agent |
dapagliflozin | [no description available] | medium | 1 | 0 | aromatic ether; C-glycosyl compound; monochlorobenzenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor |
15-crown-5 | [no description available] | medium | 3 | 0 | crown ether; saturated organic heteromonocyclic parent | |
12-crown-4 | [no description available] | medium | 1 | 0 | crown ether; saturated organic heteromonocyclic parent | |
meclizine | [no description available] | medium | 1 | 0 | diarylmethane | |
flunarizine | [no description available] | medium | 1 | 0 | diarylmethane | |
nitrosonium tetrafluoroborate | [no description available] | medium | 1 | 0 | | |
oxophenylarsine | [no description available] | medium | 1 | 0 | arsine oxides | antineoplastic agent; apoptosis inducer; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
vasotocin | [no description available] | medium | 1 | 0 | | |
pituitrin | [no description available] | medium | 1 | 0 | | |
mannich bases | [no description available] | medium | 2 | 0 | | |
stannic chloride | [no description available] | medium | 2 | 0 | | |
zithromax | [no description available] | medium | 2 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; xenobiotic |
indigo carmine | [no description available] | medium | 1 | 0 | | |
indirubin | [no description available] | medium | 1 | 0 | | |
6,6'-dibromoindigo | [no description available] | medium | 1 | 0 | | |
trifluralin | [no description available] | medium | 3 | 0 | (trifluoromethyl)benzenes; C-nitro compound; substituted aniline | agrochemical; environmental contaminant; herbicide; xenobiotic |
monobromobimane | [no description available] | medium | 1 | 0 | organobromine compound; pyrazolopyrazole | fluorochrome |
angiotensin ii | [no description available] | medium | 4 | 0 | amino acid zwitterion; angiotensin II | human metabolite |
bismuth | [no description available] | medium | 2 | 0 | metal atom; pnictogen | |
bismuth iodide | [no description available] | medium | 1 | 0 | | |
4,4'-bipyridyl | [no description available] | medium | 1 | 0 | bipyridine | |
methyl nitrite | [no description available] | medium | 1 | 0 | | |
n(6),n(6)-dimethyladenine | [no description available] | medium | 1 | 0 | tertiary amine | |
phenethylamine | [no description available] | medium | 2 | 0 | alkaloid; aralkylamine; phenylethylamine | Escherichia coli metabolite; human metabolite; mouse metabolite |
octopamine | [no description available] | medium | 1 | 0 | phenylethanolamines; tyramines | neurotransmitter |
spermine | [no description available] | medium | 1 | 0 | polyazaalkane; tetramine | antioxidant; fundamental metabolite; immunosuppressive agent |
leuprolide | [no description available] | medium | 1 | 0 | oligopeptide | anti-estrogen; antineoplastic agent; gonadotropin releasing hormone agonist |
dimethyl sulfone | [no description available] | medium | 2 | 0 | sulfone | |
phosphorus | [no description available] | medium | 3 | 0 | monoatomic phosphorus; nonmetal atom; pnictogen | macronutrient |
n-acetyl-4-benzoquinoneimine | [no description available] | medium | 1 | 0 | ketoimine; quinone imine | |
pentafluorobenzyl bromide | [no description available] | medium | 1 | 0 | benzyl bromides; fluorobenzenes | |
albiflorin | [no description available] | medium | 1 | 0 | benzoate ester; beta-D-glucoside; bridged compound; gamma-lactone; monoterpene glycoside; secondary alcohol | neuroprotective agent; plant metabolite |
acetyl coenzyme a | [no description available] | medium | 1 | 0 | acyl-CoA | acyl donor; coenzyme; effector; fundamental metabolite |
malonyl coenzyme a | [no description available] | medium | 2 | 0 | malonyl-CoAs | EC 2.3.1.21 (carnitine O-palmitoyltransferase) inhibitor; Escherichia coli metabolite; metabolite; mouse metabolite |
1-(2-pyridylazo)-2-naphthol | [no description available] | medium | 1 | 0 | | |
6-thioguanosine | [no description available] | medium | 1 | 0 | purine nucleoside | |
ziprasidone | [no description available] | medium | 1 | 0 | 1,2-benzisothiazole; indolones; organochlorine compound; piperazines | antipsychotic agent; dopaminergic antagonist; histamine antagonist; muscarinic antagonist; psychotropic drug; serotonergic antagonist |
lurasidone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | adrenergic antagonist; dopaminergic antagonist; second generation antipsychotic; serotonergic antagonist |
clozapine | [no description available] | medium | 1 | 0 | benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound | adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic |
tetrabutylammonium chloride | [no description available] | medium | 2 | 0 | organic chloride salt; tetrabutylammonium salt | |
bumetanide | [no description available] | medium | 2 | 0 | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
zinc tetraphenylporphyrin | [no description available] | medium | 1 | 0 | | |
lignin | [no description available] | medium | 1 | 0 | | |
vasoactive intestinal peptide | [no description available] | medium | 1 | 0 | | |
flubendiamide | [no description available] | medium | 1 | 0 | organofluorine insecticide | ryanodine receptor modulator |
thiazolidines | [no description available] | medium | 3 | 0 | thiazolidine | |
cumene hydroperoxide | [no description available] | medium | 1 | 0 | peroxol | environmental contaminant; Mycoplasma genitalium metabolite; oxidising agent |
pyrachlostrobin | [no description available] | medium | 2 | 0 | aromatic ether; carbamate ester; carbanilate fungicide; methoxycarbanilate strobilurin antifungal agent; monochlorobenzenes; pyrazoles | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic |
diethylene glycol | [no description available] | medium | 1 | 0 | hydroxyether | |
triethylene glycol | [no description available] | medium | 1 | 0 | diol; poly(ethylene glycol); primary alcohol | plasticiser |
1-dodecyl-3-methylimidazolium | [no description available] | medium | 1 | 0 | 1-alkyl-3-methylimidazolium | |
boron trichloride | [no description available] | medium | 1 | 0 | | |
propionaldehyde | [no description available] | medium | 2 | 0 | alpha-CH2-containing aldehyde; propanals | Escherichia coli metabolite |
phenylisothiocyanate | [no description available] | medium | 4 | 0 | isothiocyanate | allergen; reagent |
succinonitrile | [no description available] | medium | 1 | 0 | | |
acetyl chloride | [no description available] | medium | 1 | 0 | acyl chloride | |
tetrahydropyrimidinone | [no description available] | medium | 1 | 0 | | |
2,4,6-tri-tert-butylphenol | [no description available] | medium | 1 | 0 | | |
2,4,6-trimethylphenol | [no description available] | medium | 1 | 0 | hydroxytoluene | |
2,6-di-tert-butyl-4-hydroxymethylphenol | [no description available] | medium | 1 | 0 | alkylbenzene | |
pipemidic acid | [no description available] | medium | 1 | 0 | amino acid; monocarboxylic acid; N-arylpiperazine; pyridopyrimidine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
hesperidin | [no description available] | medium | 2 | 0 | 3'-hydroxyflavanones; 4'-methoxyflavanones; dihydroxyflavanone; disaccharide derivative; flavanone glycoside; monomethoxyflavanone; rutinoside | mutagen |
diosmin | [no description available] | medium | 1 | 0 | dihydroxyflavanone; disaccharide derivative; glycosyloxyflavone; monomethoxyflavone; rutinoside | anti-inflammatory agent; antioxidant |
eriocitrin | [no description available] | medium | 2 | 0 | 3'-hydroxyflavanones; 4'-hydroxyflavanones; disaccharide derivative; flavanone glycoside; rutinoside; trihydroxyflavanone | antioxidant |
ramifenazone | [no description available] | medium | 1 | 0 | pyrazoles; ring assembly | |
firocoxib | [no description available] | medium | 1 | 0 | butenolide; cyclopropanes; enol ether; sulfone | antineoplastic agent; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
merocyanine dye | [no description available] | medium | 2 | 0 | | |
thioxanthone | [no description available] | medium | 3 | 0 | | |
telmisartan | [no description available] | medium | 1 | 0 | benzimidazoles; biphenyls; carboxybiphenyl | angiotensin receptor antagonist; antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; environmental contaminant; xenobiotic |
limestone | [no description available] | medium | 1 | 0 | calcium salt; carbonate salt; inorganic calcium salt; one-carbon compound | antacid; fertilizer; food colouring; food firming agent |
hydroxylamine | [no description available] | medium | 2 | 0 | hydroxylamines | algal metabolite; bacterial xenobiotic metabolite; EC 1.1.3.13 (alcohol oxidase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; nitric oxide donor; nucleophilic reagent |
isatin | [no description available] | medium | 1 | 0 | indoledione | EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite |
9-mesityl-10-methylacridinium | [no description available] | medium | 1 | 0 | | |
zinc chloride | [no description available] | medium | 1 | 0 | inorganic chloride; zinc molecular entity | astringent; disinfectant; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; Lewis acid |
tocopheroxy radical | [no description available] | medium | 2 | 0 | tocopherol | |
trifluoroacetic anhydride | [no description available] | medium | 1 | 0 | | |
(3-mercaptopropyl)trimethoxysilane | [no description available] | medium | 1 | 0 | | |
pseudoephedrine | [no description available] | medium | 3 | 1 | phenylethanolamines; secondary alcohol; secondary amino compound | anti-asthmatic drug; bronchodilator agent; central nervous system drug; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
vitamin b 12 | [no description available] | medium | 2 | 0 | | |
n-methylpiperidine | [no description available] | medium | 1 | 0 | | |
methylparaben | [no description available] | medium | 6 | 0 | paraben | antifungal agent; antimicrobial food preservative; neuroprotective agent; plant metabolite |
praziquantel | [no description available] | medium | 2 | 0 | isoquinolines | |
sebacic acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | human metabolite; plant metabolite |
4-cyano-n,n-dimethylaniline | [no description available] | medium | 1 | 0 | | |
ethoxyquin | [no description available] | medium | 2 | 0 | aromatic ether; quinolines | antifungal agrochemical; food antioxidant; genotoxin; geroprotector; herbicide; Hsp90 inhibitor; neuroprotective agent; UDP-glucuronosyltransferase activator |
raloxifene hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | bone density conservation agent; estrogen antagonist; estrogen receptor modulator |
epicocconone | [no description available] | medium | 1 | 0 | organic heterotricyclic compound | fluorochrome |
zerumbone | [no description available] | medium | 1 | 0 | cyclic ketone; sesquiterpenoid | anti-inflammatory agent; glioma-associated oncogene inhibitor; plant metabolite |
norbuprenorphine | [no description available] | medium | 1 | 0 | phenanthrenes | |
methadone | [no description available] | medium | 2 | 0 | benzenes; diarylmethane; ketone; tertiary amino compound | |
buprenorphine | [no description available] | medium | 1 | 0 | morphinane alkaloid | delta-opioid receptor antagonist; kappa-opioid receptor antagonist; mu-opioid receptor agonist; opioid analgesic |
naloxone | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary alcohol | antidote to opioid poisoning; central nervous system depressant; mu-opioid receptor antagonist |
3,4-dimethoxyphenylacetonitrile | [no description available] | medium | 1 | 0 | | |
metoprolol | [no description available] | medium | 6 | 0 | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic |
ropivacaine | [no description available] | medium | 2 | 0 | piperidinecarboxamide; ropivacaine | local anaesthetic |
aldrin | [no description available] | medium | 1 | 0 | | |
4-hydroxycyclophosphamide | [no description available] | medium | 1 | 0 | nitrogen mustard; organochlorine compound; phosphorodiamide | alkylating agent; metabolite |
ribose | [no description available] | medium | 2 | 0 | D-ribose; ribopyranose | |
arabinose | [no description available] | medium | 1 | 0 | L-arabinose | Escherichia coli metabolite; mouse metabolite |
galactose | [no description available] | medium | 3 | 0 | D-galactose; galactopyranose | Escherichia coli metabolite; mouse metabolite |
azomycin | [no description available] | medium | 2 | 0 | C-nitro compound; imidazoles | antitubercular agent |
xanthone | [no description available] | medium | 1 | 0 | xanthones | insecticide |
esculetin | [no description available] | medium | 2 | 0 | hydroxycoumarin | antioxidant; plant metabolite; ultraviolet filter |
ochratoxin b | [no description available] | medium | 2 | 0 | isochromanes; monocarboxylic acid; N-acyl-L-phenylalanine; phenylalanine derivative | Aspergillus metabolite; calcium channel blocker; mycotoxin; Penicillium metabolite |
naphthalimides | [no description available] | medium | 2 | 0 | | |
peridinin | [no description available] | medium | 1 | 0 | | |
nitrofurantoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione; nitrofuran antibiotic; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic | antibacterial drug; antiinfective agent; hepatotoxic agent |
alpha-carboline | [no description available] | medium | 1 | 0 | pyridoindole | |
2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid | [no description available] | medium | 1 | 0 | aminoxyls; piperidinemonocarboxylic acid | |
triethylenediamine | [no description available] | medium | 1 | 0 | bridged compound; diamine; saturated organic heterobicyclic parent; tertiary amino compound | antioxidant; catalyst; reagent |
1,5-diazabicyclo(4.3.0)non-5-ene | [no description available] | medium | 1 | 0 | pyrrolopyrimidine | |
lithium chloride | [no description available] | medium | 2 | 0 | inorganic chloride; lithium salt | antimanic drug; geroprotector |
glycidyl methacrylate | [no description available] | medium | 2 | 0 | enoate ester; epoxide | |
1,4-phenylene diisocyanide | [no description available] | medium | 1 | 0 | | |
10-n-nonylacridinium orange | [no description available] | medium | 1 | 0 | | |
atractylenolide i | [no description available] | medium | 1 | 0 | | |
buspirone | [no description available] | medium | 2 | 0 | azaspiro compound; N-alkylpiperazine; N-arylpiperazine; organic heteropolycyclic compound; piperidones; pyrimidines | anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist |
ofloxacin | [no description available] | medium | 6 | 0 | 3-oxo monocarboxylic acid; N-arylpiperazine; N-methylpiperazine; organofluorine compound; oxazinoquinoline | |
tricarballylic acid | [no description available] | medium | 1 | 0 | tricarboxylic acid | |
2-cyclohexen-1-one | [no description available] | medium | 1 | 0 | cyclohexenone | |
4-stilbazole | [no description available] | medium | 1 | 0 | | |
sodium carbonate | [no description available] | medium | 1 | 0 | carbonate salt; organic sodium salt | |
benzofurazan | [no description available] | medium | 1 | 0 | benzoxadiazole | |
2-fluorophenol | [no description available] | medium | 1 | 0 | | |
dodecylamine | [no description available] | medium | 1 | 0 | primary aliphatic amine | |
fusidic acid | [no description available] | medium | 1 | 0 | 11alpha-hydroxy steroid; 3alpha-hydroxy steroid; alpha,beta-unsaturated monocarboxylic acid; steroid acid; steroid antibiotic; sterol ester | EC 2.7.1.33 (pantothenate kinase) inhibitor; Escherichia coli metabolite; protein synthesis inhibitor |
taurine | [no description available] | medium | 4 | 0 | amino sulfonic acid; zwitterion | antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite |
7-fluoro-4-nitrobenzo-2-oxa-1,3-diazole | [no description available] | medium | 5 | 0 | | |
triacetin | [no description available] | medium | 2 | 0 | triglyceride | adjuvant; antifungal drug; food additive carrier; food emulsifier; food humectant; fuel additive; plant metabolite; solvent |
mandelic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid; benzenes | antibacterial agent; human xenobiotic metabolite |
methyl mandelate | [no description available] | medium | 1 | 0 | benzenes | |
nadp | [no description available] | medium | 6 | 0 | | |
pentachlorophenol | [no description available] | medium | 1 | 0 | aromatic fungicide; chlorophenol; organochlorine pesticide; pentachlorobenzenes | human xenobiotic metabolite |
phenylthiourea | [no description available] | medium | 1 | 0 | thioureas | EC 1.14.18.1 (tyrosinase) inhibitor |
cidofovir anhydrous | [no description available] | medium | 1 | 0 | phosphonic acids; pyrimidone | anti-HIV agent; antineoplastic agent; antiviral drug; photosensitizing agent |
coumarin 314 | [no description available] | medium | 1 | 0 | 7-aminocoumarins; ethyl ester | fluorochrome |
stannic oxide | [no description available] | medium | 1 | 0 | tin oxide | |
n,n'-diphenyl-4-phenylenediamine | [no description available] | medium | 2 | 0 | N-substituted diamine; secondary amino compound | antioxidant |
cyhalofop-butyl | [no description available] | medium | 1 | 0 | aromatic ether | |
vanadates | [no description available] | medium | 1 | 0 | trivalent inorganic anion; vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
bumadizone | [no description available] | medium | 1 | 0 | carbohydrazide; monocarboxylic acid | antipyretic; non-steroidal anti-inflammatory drug |
molybdate ion | [no description available] | medium | 1 | 0 | divalent inorganic anion; molybdenum oxoanion | Escherichia coli metabolite |
1,4-dinitrobenzene | [no description available] | medium | 1 | 0 | dinitrobenzene | |
triacetone triperoxide | [no description available] | medium | 1 | 0 | | |
atazanavir sulfate | [no description available] | medium | 2 | 1 | organic sulfate salt | |
indinavir sulfate | [no description available] | medium | 2 | 1 | dicarboxylic acid diamide; N-(2-hydroxyethyl)piperazine; piperazinecarboxamide | HIV protease inhibitor |
7-hydroxyflavone | [no description available] | medium | 1 | 0 | hydroxyflavonoid | |
cefuroxime | [no description available] | medium | 1 | 0 | carbamate ester; cephalosporin | |
cefuroxime lysine | [no description available] | medium | 1 | 0 | | |
oxymetholone | [no description available] | medium | 1 | 0 | | |
ubiquinol | [no description available] | medium | 1 | 0 | polyprenylhydroquinone; ubiquinol | biomarker; metabolite |
fluorescein | [no description available] | medium | 3 | 0 | 2-benzofurans; gamma-lactone; organic heteropentacyclic compound; oxaspiro compound; polyphenol; xanthene dye | fluorescent dye; radioopaque medium |
propofol | [no description available] | medium | 3 | 0 | phenols | anticonvulsant; antiemetic; intravenous anaesthetic; radical scavenger; sedative |
6-aminoquinolyl-n-hydroxysuccinimidyl carbamate | [no description available] | medium | 2 | 0 | | |
nobiletin | [no description available] | medium | 1 | 0 | methoxyflavone | antineoplastic agent; plant metabolite |
carisoprodol | [no description available] | medium | 1 | 0 | carbamate ester | muscle relaxant |
oxacillin | [no description available] | medium | 1 | 0 | penicillin | antibacterial agent; antibacterial drug |
cloxacillin | [no description available] | medium | 3 | 0 | penicillin allergen; penicillin; semisynthetic derivative | antibacterial agent; antibacterial drug |
4-(3-isothiocyanatopyrrolidin-1-yl)-7-(n,n-dimethylaminosulfonyl)-2,1,3-benzoxadiazole | [no description available] | medium | 1 | 0 | | |
deferasirox | [no description available] | medium | 1 | 0 | benzoic acids; monocarboxylic acid; phenols; triazoles | iron chelator |
aminacrine | [no description available] | medium | 2 | 0 | aminoacridines; primary amino compound | acid-base indicator; antiinfective agent; antiseptic drug; fluorescent dye; MALDI matrix material; mutagen |
harmaline | [no description available] | medium | 1 | 0 | harmala alkaloid | oneirogen |
methyldopa | [no description available] | medium | 1 | 0 | L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | alpha-adrenergic agonist; antihypertensive agent; hapten; peripheral nervous system drug; sympatholytic agent |
2-chloranil | [no description available] | medium | 1 | 0 | | |
1-ethyl-3-methylimidazolium tetrafluoroborate | [no description available] | medium | 3 | 0 | | |
heptanal | [no description available] | medium | 1 | 0 | medium-chain fatty aldehyde; n-alkanal; saturated fatty aldehyde | biomarker |
n-hexanal | [no description available] | medium | 2 | 0 | medium-chain fatty aldehyde; n-alkanal; saturated fatty aldehyde | human urinary metabolite |
benzoin | [no description available] | medium | 6 | 0 | benzoins; secondary alpha-hydroxy ketone | EC 3.1.1.1 (carboxylesterase) inhibitor |
2-pyrrolidone | [no description available] | medium | 1 | 0 | pyrrolidin-2-ones | metabolite; polar solvent |
n-hydroxysuccinimide | [no description available] | medium | 2 | 0 | | |
1-methylhydantoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | bacterial metabolite |
creatine | [no description available] | medium | 1 | 0 | glycine derivative; guanidines; zwitterion | geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical |
cefdinir | [no description available] | medium | 1 | 0 | | |
mesalamine | [no description available] | medium | 1 | 0 | amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols | non-steroidal anti-inflammatory drug |
trifluoromethanesulfonic acid | [no description available] | medium | 2 | 0 | one-carbon compound; perfluoroalkanesulfonic acid | |
sorbitol | [no description available] | medium | 1 | 0 | glucitol | cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent |
cannabidiol | [no description available] | medium | 1 | 0 | olefinic compound; phytocannabinoid; resorcinols | antimicrobial agent; plant metabolite |
ephedrine | [no description available] | medium | 7 | 0 | phenethylamine alkaloid; phenylethanolamines | bacterial metabolite; environmental contaminant; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic |
squaric acid | [no description available] | medium | 1 | 0 | alicyclic ketone; carbon oxoacid | metabolite |
3-hydroxychromone | [no description available] | medium | 1 | 0 | | |
hydroxymethylmethacrylate | [no description available] | medium | 1 | 0 | | |
vardenafil dihydrochloride | [no description available] | medium | 1 | 0 | | |
lignans | [no description available] | medium | 2 | 0 | | |
sotalol | [no description available] | medium | 2 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
topotecan | [no description available] | medium | 2 | 0 | pyranoindolizinoquinoline | antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor |
sodium nitrate | [no description available] | medium | 2 | 0 | inorganic nitrate salt; inorganic sodium salt | fertilizer; NMR chemical shift reference compound |
bupropion | [no description available] | medium | 2 | 0 | aromatic ketone; monochlorobenzenes; secondary amino compound | antidepressant; environmental contaminant; xenobiotic |
gatifloxacin | [no description available] | medium | 3 | 0 | N-arylpiperazine; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antiinfective agent; antimicrobial agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
norfloxacin | [no description available] | medium | 4 | 0 | fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antibacterial drug; DNA synthesis inhibitor; environmental contaminant; xenobiotic |
delta(9)-tetrahydrocannabinolic acid | [no description available] | medium | 1 | 0 | benzochromene; diterpenoid; hydroxy monocarboxylic acid; phytocannabinoid; polyketide | anti-inflammatory agent; biomarker; metabolite; neuroprotective agent |
indican | [no description available] | medium | 1 | 0 | beta-D-glucoside; exopolysaccharide; indolyl carbohydrate | |
nitroaniline | [no description available] | medium | 3 | 0 | | |
danofloxacin | [no description available] | medium | 2 | 0 | quinolines | |
n-acetyltryptophan | [no description available] | medium | 1 | 0 | N-acetyl-amino acid; tryptophan derivative | metabolite |
sinigrin | [no description available] | medium | 1 | 0 | alkenylglucosinolic acid | |
pantoprazole | [no description available] | medium | 4 | 0 | aromatic ether; benzimidazoles; organofluorine compound; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; environmental contaminant; xenobiotic |
hypoxanthine | [no description available] | medium | 1 | 0 | nucleobase analogue; oxopurine; purine nucleobase | fundamental metabolite |
4-vinylphenyl boronic acid | [no description available] | medium | 2 | 0 | | |
artemisin | [no description available] | medium | 1 | 0 | | |
pyridoxine | [no description available] | medium | 3 | 0 | hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
pantothenic acid | [no description available] | medium | 1 | 0 | pantothenic acid; vitamin B5 | antidote to curare poisoning; geroprotector; human blood serum metabolite |
thiamine | [no description available] | medium | 2 | 0 | primary alcohol; vitamin B1 | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
cyanine dye 3 | [no description available] | medium | 1 | 0 | | |
triptolide | [no description available] | medium | 1 | 0 | diterpenoid; epoxide; gamma-lactam; organic heteroheptacyclic compound | antispermatogenic agent; plant metabolite |
vx | [no description available] | medium | 1 | 0 | organic thiophosphate; tertiary amino compound | EC 3.1.1.7 (acetylcholinesterase) inhibitor; neurotoxin |
tyrosinamide | [no description available] | medium | 1 | 0 | amino acid amide; L-tyrosine derivative | |
l-phenylalanine ethylester | [no description available] | medium | 1 | 0 | | |
ampyrone | [no description available] | medium | 1 | 0 | primary amino compound; pyrazolone | antipyretic; antirheumatic drug; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; marine xenobiotic metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug |
glipizide | [no description available] | medium | 1 | 0 | aromatic amide; monocarboxylic acid amide; N-sulfonylurea; pyrazines | EC 2.7.1.33 (pantothenate kinase) inhibitor; hypoglycemic agent; insulin secretagogue |
gliclazide | [no description available] | medium | 1 | 0 | N-sulfonylurea | hypoglycemic agent; insulin secretagogue; radical scavenger |
glyburide | [no description available] | medium | 2 | 0 | monochlorobenzenes; N-sulfonylurea | anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent |
gliquidone | [no description available] | medium | 1 | 0 | isoquinolines | |
aflatoxin g1 | [no description available] | medium | 2 | 0 | | |
aflatoxin b | [no description available] | medium | 3 | 0 | aflatoxin | |
aflatoxin g2 | [no description available] | medium | 2 | 0 | coumarins | |
1-naphthol | [no description available] | medium | 1 | 0 | naphthol | genotoxin; human xenobiotic metabolite |
bisphenol b | [no description available] | medium | 1 | 0 | bisphenol | |
naphazoline | [no description available] | medium | 1 | 0 | naphthalenes | |
ketamine | [no description available] | medium | 1 | 0 | cyclohexanones; monochlorobenzenes; secondary amino compound | analgesic; environmental contaminant; intravenous anaesthetic; neurotoxin; NMDA receptor antagonist; xenobiotic |
2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone | [no description available] | medium | 1 | 0 | | |
tris(2-pyridylmethyl)amine | [no description available] | medium | 1 | 0 | | |
n-methyl-n-(tert-butyldimethylsilyl)trifluoroacetamide | [no description available] | medium | 2 | 0 | monocarboxylic acid amide; N-silyl compound; trifluoroacetamide | chromatographic reagent |
D-fructopyranose | [no description available] | medium | 2 | 0 | cyclic hemiketal; D-fructose; fructopyranose | sweetening agent |
benzyne | [no description available] | medium | 1 | 0 | aryne; benzyne | |
corydaline | [no description available] | medium | 1 | 0 | isoquinoline alkaloid; isoquinolines | |
jatrorrhizine | [no description available] | medium | 1 | 0 | alkaloid | |
(+-)stylopine | [no description available] | medium | 1 | 0 | | |
n,n-dimethyltryptamine | [no description available] | medium | 1 | 0 | tryptamine alkaloid; tryptamines | |
oxyquinoline | [no description available] | medium | 2 | 0 | monohydroxyquinoline | antibacterial agent; antifungal agrochemical; antiseptic drug; iron chelator |
cystine | [no description available] | medium | 2 | 0 | | |
fenofibric acid | [no description available] | medium | 1 | 0 | aromatic ketone; chlorobenzophenone; monocarboxylic acid | drug metabolite; marine xenobiotic metabolite |
fenofibrate | [no description available] | medium | 1 | 0 | aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic |
propylene carbonate | [no description available] | medium | 6 | 0 | | |
enalaprilat anhydrous | [no description available] | medium | 1 | 0 | dicarboxylic acid; dipeptide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor |
enalapril | [no description available] | medium | 2 | 0 | dicarboxylic acid monoester; dipeptide | antihypertensive agent; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; geroprotector; prodrug |
felodipine | [no description available] | medium | 1 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
1-butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide | [no description available] | medium | 1 | 0 | | |
phenylephrine | [no description available] | medium | 2 | 0 | phenols; phenylethanolamines; secondary amino compound | alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent |
tosylarginine methyl ester | [no description available] | medium | 1 | 0 | guanidines; L-arginine ester; methyl ester; sulfonamide | |
benzoylarginine ethyl ester | [no description available] | medium | 1 | 0 | | |
purine | [no description available] | medium | 1 | 0 | purine | |
4-aminoimidazole | [no description available] | medium | 1 | 0 | aminoimidazole | |
mogroside v | [no description available] | medium | 1 | 0 | | |
diethylstilbestrol | [no description available] | medium | 4 | 0 | olefinic compound; polyphenol | antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen |
estriol | [no description available] | medium | 2 | 0 | 16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid | estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite |
tris(2,2'-bipyridine)ruthenium iii | [no description available] | medium | 1 | 0 | | |
strontium | [no description available] | medium | 1 | 0 | alkaline earth metal atom | |
methylmalondialdehyde | [no description available] | medium | 1 | 0 | | |
tetradecyltrimethylammonium | [no description available] | medium | 1 | 0 | | |
ibuprofen | [no description available] | medium | 8 | 0 | monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic |
kanamycin a | [no description available] | medium | 1 | 0 | kanamycins | bacterial metabolite |
bekanamycin | [no description available] | medium | 1 | 0 | kanamycins | |
tobramycin | [no description available] | medium | 1 | 0 | amino cyclitol glycoside | antibacterial agent; antimicrobial agent; toxin |
chlorfenvinphos | [no description available] | medium | 1 | 0 | dichlorobenzene; organic phosphate; organochlorine acaricide; organochlorine insecticide; organophosphate insecticide | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
7-dehydrocholesterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; cholestanoid; Delta(5),Delta(7)-sterol | human metabolite; mouse metabolite |
rosmanol | [no description available] | medium | 1 | 0 | | |
salvin | [no description available] | medium | 1 | 0 | abietane diterpenoid; carbotricyclic compound; catechols; monocarboxylic acid | angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; food preservative; HIV protease inhibitor; plant metabolite |
n-methylaspartate | [no description available] | medium | 1 | 0 | amino dicarboxylic acid; D-alpha-amino acid; D-aspartic acid derivative; secondary amino compound | neurotransmitter agent |
thallium | [no description available] | medium | 1 | 0 | boron group element atom | |
fusaproliferin | [no description available] | medium | 1 | 0 | | |
aluminum chloride | [no description available] | medium | 1 | 0 | aluminium coordination entity | Lewis acid |
bentazone | [no description available] | medium | 1 | 0 | benzothiadiazine | environmental contaminant; herbicide; xenobiotic |
2,4-d n-butyl ester | [no description available] | medium | 1 | 0 | | |
hydromethylthionine | [no description available] | medium | 1 | 0 | aromatic amine; phenothiazines; tertiary amino compound | bacterial xenobiotic metabolite; fluorochrome; mouse metabolite; rat metabolite |
triethylammonium cation | [no description available] | medium | 2 | 0 | ammonium ion derivative | |
chloroterpyridineplatinum(ii) | [no description available] | medium | 1 | 0 | | |
pivaloyl chloride | [no description available] | medium | 1 | 0 | | |
gallium | [no description available] | medium | 1 | 0 | boron group element atom | |
gallium chloride | [no description available] | medium | 1 | 0 | | |
13-hydroxy-9,11-octadecadienoic acid | [no description available] | medium | 2 | 0 | octadecadienoic acid | |
hydrofluoric acid | [no description available] | medium | 2 | 0 | hydrogen halide; mononuclear parent hydride | NMR chemical shift reference compound |
selenious acid | [no description available] | medium | 1 | 0 | selenium oxoacid | |
beta-carboline-3-carboxylic acid methyl ester | [no description available] | medium | 1 | 0 | beta-carbolines | |
cyclonite | [no description available] | medium | 4 | 0 | 1,3,5-triazinanes; N-nitro compound | explosive |
aziridine | [no description available] | medium | 1 | 0 | azacycloalkane; aziridines; saturated organic heteromonocyclic parent | alkylating agent |
saccharin | [no description available] | medium | 2 | 0 | 1,2-benzisothiazole; N-sulfonylcarboxamide | environmental contaminant; sweetening agent; xenobiotic |
thyroxine | [no description available] | medium | 2 | 0 | 2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine | antithyroid drug; human metabolite; mouse metabolite; thyroid hormone |
codeine | [no description available] | medium | 5 | 0 | morphinane alkaloid; organic heteropentacyclic compound | antitussive; drug allergen; environmental contaminant; opioid analgesic; opioid receptor agonist; prodrug; xenobiotic |
bxl628 | [no description available] | medium | 1 | 0 | | |
1,1'-binaphthyl-2,2'-diyl hydrogen phosphate | [no description available] | medium | 2 | 0 | | |
2,4-dihydroxybenzophenone | [no description available] | medium | 1 | 0 | benzophenones | |
4-hydroxybenzophenone | [no description available] | medium | 1 | 0 | benzophenones | |
ferric chloride | [no description available] | medium | 2 | 0 | iron coordination entity | astringent; Lewis acid |
trenbolone acetate | [no description available] | medium | 1 | 0 | steroid ester | |
gentamicin | [no description available] | medium | 1 | 0 | | |
gentamicin c | [no description available] | medium | 1 | 0 | | |
procyanidin b2 | [no description available] | medium | 1 | 0 | biflavonoid; hydroxyflavan; polyphenol; proanthocyanidin | antioxidant; metabolite |
procyanidin | [no description available] | medium | 1 | 0 | proanthocyanidin | |
phenoxyethanol | [no description available] | medium | 1 | 0 | aromatic ether; glycol ether; primary alcohol | antiinfective agent; central nervous system depressant |
cyanazine | [no description available] | medium | 1 | 0 | 1,3,5-triazinylamino nitrile; chloro-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
simazine | [no description available] | medium | 1 | 0 | chloro-1,3,5-triazine; diamino-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
3-amino-5-mercapto-1,2,4-triazole | [no description available] | medium | 1 | 0 | | |
1-phenylpropanol | [no description available] | medium | 2 | 0 | organic molecular entity | |
trifluoroethylamine | [no description available] | medium | 1 | 0 | | |
benzyldihydronicotinamide | [no description available] | medium | 2 | 0 | | |
etoposide | [no description available] | medium | 1 | 0 | beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound | antineoplastic agent; DNA synthesis inhibitor |
cytarabine | [no description available] | medium | 1 | 0 | beta-D-arabinoside; monosaccharide derivative; pyrimidine nucleoside | antimetabolite; antineoplastic agent; antiviral agent; immunosuppressive agent |
methacrylonitrile | [no description available] | medium | 2 | 0 | | |
2-chloroacrylonitrile | [no description available] | medium | 2 | 0 | | |
2-pentenenitrile | [no description available] | medium | 1 | 0 | | |
1,2-o-isopropylidene-d-glucofuranose | [no description available] | medium | 1 | 0 | | |
uridine diphosphate | [no description available] | medium | 1 | 0 | pyrimidine ribonucleoside 5'-diphosphate; uridine 5'-phosphate | Escherichia coli metabolite; mouse metabolite |
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride | [no description available] | medium | 1 | 0 | | |
methyl salicylate | [no description available] | medium | 1 | 0 | benzoate ester; methyl ester; salicylates | flavouring agent; insect attractant; metabolite |
danazol | [no description available] | medium | 2 | 0 | 17beta-hydroxy steroid; terminal acetylenic compound | anti-estrogen; estrogen antagonist; geroprotector |
ribavirin | [no description available] | medium | 1 | 0 | 1-ribosyltriazole; aromatic amide; monocarboxylic acid amide; primary carboxamide | anticoronaviral agent; antiinfective agent; antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
2-chloro-1,4-dimethoxybenzene | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
2,4-dichlorophenol | [no description available] | medium | 2 | 0 | dichlorophenol | |
phosphoramidite | [no description available] | medium | 3 | 0 | | |
lucanthone hydrochloride | [no description available] | medium | 1 | 0 | | |
thiamylal | [no description available] | medium | 1 | 0 | barbiturates; organosulfur compound | sedative |
tetramethylthiourea | [no description available] | medium | 1 | 0 | thioureas | |
3,3',4,5'-tetrahydroxystilbene | [no description available] | medium | 1 | 0 | catechols; polyphenol; resorcinols; stilbenol | antineoplastic agent; apoptosis inducer; geroprotector; hypoglycemic agent; plant metabolite; protein kinase inhibitor; tyrosine kinase inhibitor |
abacavir | [no description available] | medium | 1 | 0 | 2,6-diaminopurines | antiviral drug; drug allergen; HIV-1 reverse transcriptase inhibitor |
brucine | [no description available] | medium | 2 | 0 | monoterpenoid indole alkaloid; organic heteroheptacyclic compound | |
2-amino-2-methyl-1-propanol | [no description available] | medium | 1 | 0 | | |
morphinans | [no description available] | medium | 1 | 0 | isoquinoline alkaloid fundamental parent; morphinane alkaloid | |
dextromethorphan | [no description available] | medium | 3 | 0 | 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene | antitussive; environmental contaminant; neurotoxin; NMDA receptor antagonist; oneirogen; prodrug; xenobiotic |
diphenhydramine hydrochloride | [no description available] | medium | 2 | 0 | hydrochloride; organoammonium salt | anti-allergic agent; antiemetic; antiparkinson drug; antipruritic drug; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; sedative |
salvianolic acid B | [no description available] | medium | 1 | 0 | 1-benzofurans; catechols; dicarboxylic acid; enoate ester; polyphenol | anti-inflammatory agent; antidepressant; antineoplastic agent; antioxidant; apoptosis inducer; autophagy inhibitor; cardioprotective agent; hepatoprotective agent; hypoglycemic agent; neuroprotective agent; osteogenesis regulator; plant metabolite |
n-butoxyethanol | [no description available] | medium | 1 | 0 | glycol ether; primary alcohol | protic solvent |
tolbutamide | [no description available] | medium | 3 | 0 | N-sulfonylurea | human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker |
puerarin | [no description available] | medium | 1 | 0 | C-glycosyl compound; isoflavonoid | |
darunavir | [no description available] | medium | 1 | 0 | carbamate ester; furofuran; sulfonamide | antiviral drug; HIV protease inhibitor |
naproxen | [no description available] | medium | 3 | 0 | methoxynaphthalene; monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; gout suppressant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
ethyl bromoacetate | [no description available] | medium | 1 | 0 | | |
acetylcarnitine | [no description available] | medium | 1 | 0 | O-acylcarnitine | human metabolite |
palmitoylcarnitine | [no description available] | medium | 1 | 0 | O-palmitoylcarnitine; saturated fatty acyl-L-carnitine | EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; human metabolite; mouse metabolite |
4'-bromophenacyl triflate | [no description available] | medium | 1 | 0 | | |
stearic acid | [no description available] | medium | 3 | 0 | long-chain fatty acid; saturated fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; human metabolite; plant metabolite |
methylmercaptan | [no description available] | medium | 1 | 0 | alkanethiol | human metabolite; Saccharomyces cerevisiae metabolite |
dimethyl disulfide | [no description available] | medium | 1 | 0 | organic disulfide | xenobiotic metabolite |
cerium | [no description available] | medium | 4 | 0 | f-block element atom; lanthanoid atom | |
amiloride | [no description available] | medium | 1 | 0 | aromatic amine; guanidines; organochlorine compound; pyrazines | diuretic; sodium channel blocker |
2,2'-azobis(2,4-dimethylvaleronitrile) | [no description available] | medium | 4 | 0 | | |
fraxin | [no description available] | medium | 1 | 0 | aromatic ether; beta-D-glucoside; hydroxycoumarin | anti-inflammatory agent; hepatoprotective agent; plant metabolite |
esculin | [no description available] | medium | 1 | 0 | beta-D-glucoside; hydroxycoumarin | antioxidant; metabolite |
hyperolactone c | [no description available] | medium | 1 | 0 | | |
helium | [no description available] | medium | 1 | 0 | monoatomic helium; noble gas atom; s-block element atom | food packaging gas |
2-amino-3,4-dimethylimidazo(4,5-f)quinoline | [no description available] | medium | 1 | 0 | aminoquinoline | |
2-amino-9h-pyrido(2,3-b)indole | [no description available] | medium | 1 | 0 | pyridoindole | |
2-amino-3-methylimidazo(4,5-f)quinoline | [no description available] | medium | 1 | 0 | imidazoquinoline | carcinogenic agent |
norharman | [no description available] | medium | 1 | 0 | beta-carbolines; mancude organic heterotricyclic parent | fungal metabolite; marine metabolite |
harman | [no description available] | medium | 1 | 0 | harmala alkaloid; indole alkaloid fundamental parent; indole alkaloid | anti-HIV agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite |
zolmitriptan | [no description available] | medium | 1 | 0 | oxazolidinone; tryptamines | anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
hexestrol | [no description available] | medium | 1 | 0 | stilbenoid | |
dienestrol | [no description available] | medium | 1 | 0 | | |
tetramethylammonium | [no description available] | medium | 3 | 0 | quaternary ammonium ion | |
tetracaine | [no description available] | medium | 1 | 0 | benzoate ester; tertiary amino compound | local anaesthetic |
sodium benzoate | [no description available] | medium | 2 | 0 | organic sodium salt | algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite |
arctiin | [no description available] | medium | 1 | 0 | glycoside; lignan | |
bupivacaine | [no description available] | medium | 2 | 0 | aromatic amide; piperidinecarboxamide; tertiary amino compound | |
nevirapine | [no description available] | medium | 1 | 0 | cyclopropanes; dipyridodiazepine | antiviral drug; HIV-1 reverse transcriptase inhibitor |
lamivudine | [no description available] | medium | 1 | 0 | monothioacetal; nucleoside analogue; oxacycle; primary alcohol | allergen; anti-HBV agent; antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor; HIV-1 reverse transcriptase inhibitor; prodrug |
stavudine | [no description available] | medium | 1 | 0 | dihydrofuran; nucleoside analogue; organic molecular entity | antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
benzo(e)pyrene | [no description available] | medium | 1 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mutagen |
moniliformin | [no description available] | medium | 1 | 0 | | |
pyriproxyfen | [no description available] | medium | 1 | 0 | aromatic ether; pyridines | juvenile hormone mimic |
dichlorotetrakis(dimethyl sulfoxide)ruthenium ii | [no description available] | medium | 1 | 0 | | |
cinnamaldehyde | [no description available] | medium | 1 | 0 | 3-phenylprop-2-enal; cinnamaldehydes | antifungal agent; EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor; flavouring agent; hypoglycemic agent; plant metabolite; sensitiser; vasodilator agent |
nequinate | [no description available] | medium | 1 | 0 | quinolines | |
isonaringin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; rutinoside | anti-inflammatory agent; antioxidant; metabolite |
naringin | [no description available] | medium | 2 | 0 | (2S)-flavan-4-one; 4'-hydroxyflavanones; dihydroxyflavanone; disaccharide derivative; neohesperidoside | anti-inflammatory agent; antineoplastic agent; metabolite |
scopoletin | [no description available] | medium | 1 | 0 | hydroxycoumarin | plant growth regulator; plant metabolite |
dimethyl sulfide | [no description available] | medium | 1 | 0 | aliphatic sulfide | algal metabolite; bacterial xenobiotic metabolite; EC 3.5.1.4 (amidase) inhibitor; Escherichia coli metabolite; marine metabolite |
n-octadecyl mercaptan | [no description available] | medium | 2 | 0 | | |
3-(trimethoxysilyl)propylamine | [no description available] | medium | 1 | 0 | | |
dodecylmercaptan | [no description available] | medium | 1 | 0 | | |
n-octanethiol | [no description available] | medium | 1 | 0 | alkanethiol | |
mitomycin | [no description available] | medium | 1 | 0 | mitomycin | alkylating agent; antineoplastic agent |
sertindole | [no description available] | medium | 1 | 0 | heteroarylpiperidine; imidazolidinone; organochlorine compound; organofluorine compound; phenylindole | alpha-adrenergic antagonist; H1-receptor antagonist; second generation antipsychotic; serotonergic antagonist |
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid | [no description available] | medium | 1 | 0 | | |
carnosol | [no description available] | medium | 1 | 0 | diterpenoid | |
ecdysterone | [no description available] | medium | 1 | 0 | 14alpha-hydroxy steroid; 20-hydroxy steroid; 22-hydroxy steroid; 25-hydroxy steroid; 2beta-hydroxy steroid; 3beta-sterol; ecdysteroid; phytoecdysteroid | animal metabolite; plant metabolite |
pectins | [no description available] | medium | 2 | 0 | D-galactopyranuronic acid | |
pulmicort | [no description available] | medium | 2 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; cyclic acetal; glucocorticoid; primary alpha-hydroxy ketone | anti-inflammatory drug; bronchodilator agent; drug allergen |
chlorpheniramine | [no description available] | medium | 1 | 0 | monochlorobenzenes; pyridines; tertiary amino compound | anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor |
avermectin | [no description available] | medium | 2 | 0 | | |
difloxacin | [no description available] | medium | 2 | 0 | fluoroquinolone antibiotic; monocarboxylic acid; monofluorobenzenes; N-alkylpiperazine; N-arylpiperazine; quinolone antibiotic; quinolone | antibacterial drug; Mycoplasma genitalium metabolite |
ciprofloxacin-7-ethylenediamine | [no description available] | medium | 1 | 0 | | |
orbifloxacin | [no description available] | medium | 1 | 0 | quinolines | |
butylscopolammonium bromide | [no description available] | medium | 1 | 0 | | |
benzo(k)fluoranthene | [no description available] | medium | 1 | 0 | naphthalenes | |
4-phenylpyridine | [no description available] | medium | 1 | 0 | phenylpyridine | |
1-methylimidazole | [no description available] | medium | 1 | 0 | imidazoles | |
scutellarein | [no description available] | medium | 1 | 0 | tetrahydroxyflavone | metabolite |
glutaric acid | [no description available] | medium | 1 | 0 | alpha,omega-dicarboxylic acid; dicarboxylic fatty acid | Daphnia magna metabolite; human metabolite |
hexafluoroisopropanol | [no description available] | medium | 4 | 0 | organofluorine compound; secondary alcohol | drug metabolite |
lorazepam glucuronide | [no description available] | medium | 1 | 1 | glucosiduronic acid | |
morpholine | [no description available] | medium | 1 | 0 | morpholines; saturated organic heteromonocyclic parent | NMR chemical shift reference compound |
metsulfuron methyl | [no description available] | medium | 1 | 0 | 1,3,5-triazines; benzoate ester; N-sulfonylurea | environmental contaminant; herbicide; xenobiotic |
leucine | [no description available] | medium | 1 | 0 | amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
bianthrone | [no description available] | medium | 1 | 0 | | |
citric acid, anhydrous | [no description available] | medium | 3 | 0 | tricarboxylic acid | antimicrobial agent; chelator; food acidity regulator; fundamental metabolite |
neutral red | [no description available] | medium | 1 | 0 | hydrochloride | acid-base indicator; dye; two-colour indicator |
phenylpropanolamine | [no description available] | medium | 2 | 0 | amphetamines; phenethylamine alkaloid | plant metabolite |
triazolam | [no description available] | medium | 1 | 0 | triazolobenzodiazepine | sedative |
bistrifluron | [no description available] | medium | 1 | 0 | | |
catechol | [no description available] | medium | 3 | 0 | catechols | allelochemical; genotoxin; plant metabolite |
trioctyl phosphine oxide | [no description available] | medium | 1 | 0 | | |
artemisinin | [no description available] | medium | 1 | 0 | organic peroxide; sesquiterpene lactone | antimalarial; plant metabolite |
arginyl-glycyl-aspartyl-serine | [no description available] | medium | 1 | 0 | | |
5-cyanouracil | [no description available] | medium | 1 | 0 | | |
2-amino-1-methylbenzimidazole | [no description available] | medium | 1 | 0 | benzimidazoles | |
tris(4-bromophenyl)ammoniumyl hexachloroantimonate | [no description available] | medium | 1 | 0 | | |
1-methylcytosine | [no description available] | medium | 1 | 0 | aminopyrimidine; methylcytosine; pyrimidone | metabolite |
acenocoumarol | [no description available] | medium | 2 | 0 | C-nitro compound; hydroxycoumarin; methyl ketone | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor |
ytterbium | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom | |
1-ethyl-3-(3-dimethylaminoethyl)carbodiimide | [no description available] | medium | 1 | 0 | | |
1-phenyl-2-propanol | [no description available] | medium | 1 | 0 | | |
valerenic acid | [no description available] | medium | 1 | 0 | carbobicyclic compound; monocarboxylic acid; sesquiterpenoid | GABA modulator; plant metabolite; sedative; volatile oil component |
triprolidine | [no description available] | medium | 1 | 0 | N-alkylpyrrolidine; olefinic compound; pyridines | H1-receptor antagonist |
mequitazine | [no description available] | medium | 1 | 0 | phenothiazines | |
tetracyanoquinodimethane | [no description available] | medium | 4 | 0 | alicyclic compound; nitrile; quinodimethane | |
acrivastine | [no description available] | medium | 1 | 0 | alpha,beta-unsaturated monocarboxylic acid; N-alkylpyrrolidine; olefinic compound; pyridines | H1-receptor antagonist |
isomaltose | [no description available] | medium | 1 | 0 | | |
ha 1100 | [no description available] | medium | 1 | 0 | | |
1-(5-isoquinolinesulfonyl)-2-methylpiperazine | [no description available] | medium | 1 | 0 | isoquinolines; N-sulfonylpiperazine | EC 2.7.11.13 (protein kinase C) inhibitor |
tartaric acid | [no description available] | medium | 2 | 0 | tartaric acid | Escherichia coli metabolite |
docusate | [no description available] | medium | 2 | 0 | diester; organosulfonic acid | |
usnic acid | [no description available] | medium | 1 | 0 | benzofurans | |
l 683590 | [no description available] | medium | 2 | 0 | ether; lactol; macrolide; secondary alcohol | antifungal agent; bacterial metabolite; immunosuppressive agent |
tacrolimus | [no description available] | medium | 3 | 0 | macrolide lactam | bacterial metabolite; immunosuppressive agent |
methyl n-butyl ketone | [no description available] | medium | 1 | 0 | ketone | |
protopine | [no description available] | medium | 1 | 0 | dibenzazecine alkaloid | plant metabolite |
bicuculline | [no description available] | medium | 1 | 0 | benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines | agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin |
dinitrochlorobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; monochlorobenzenes | allergen; epitope; sensitiser |
mocetinostat | [no description available] | medium | 2 | 0 | aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline | antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent |
13-oxo-9,11-octadecadienoic acid | [no description available] | medium | 1 | 0 | 13-oxo-9,11-octadecadienoic acid; oxo fatty acid | metabolite |
13-hydroperoxy-9,11-octadecadienoic acid | [no description available] | medium | 1 | 0 | hydroperoxy polyunsaturated fatty acid; octadecadienoic acid | |
rhamnose | [no description available] | medium | 1 | 0 | L-rhamnose | |
n-butylamine | [no description available] | medium | 2 | 0 | primary aliphatic amine | |
microcystin | [no description available] | medium | 2 | 0 | peptide | |
4,4'-azobis(4-cyanovaleric acid) | [no description available] | medium | 1 | 0 | | |
valerates | [no description available] | medium | 1 | 0 | short-chain fatty acid anion; straight-chain saturated fatty acid anion | plant metabolite |
desonide | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; corticosteroid; cyclic ketal; primary alpha-hydroxy ketone | anti-inflammatory drug |
guazatine | [no description available] | medium | 1 | 0 | aliphatic nitrogen antifungal agent; guanidines; secondary amino compound | antifungal agrochemical |
imidazolidines | [no description available] | medium | 1 | 0 | azacycloalkane; imidazolidines; saturated organic heteromonocyclic parent | |
dodecyltrimethylammonium | [no description available] | medium | 1 | 0 | quaternary ammonium ion | |
sinapine | [no description available] | medium | 1 | 0 | acylcholine | antioxidant; photosynthetic electron-transport chain inhibitor; plant metabolite |
methylcellulose | [no description available] | medium | 1 | 0 | | |
butane | [no description available] | medium | 1 | 0 | alkane; gas molecular entity | food propellant; refrigerant |
1,8-bis(dimethylamino)naphthalene | [no description available] | medium | 1 | 0 | naphthalenes | |
1-naphthylamine | [no description available] | medium | 1 | 0 | naphthylamine | human xenobiotic metabolite |
morphine | [no description available] | medium | 4 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
cupric acetate | [no description available] | medium | 1 | 0 | | |
n-phenylformamide | [no description available] | medium | 1 | 0 | aromatic amide; formamides | |
rhodanine | [no description available] | medium | 1 | 0 | thiazolidinone | |
aristolochic acid i | [no description available] | medium | 1 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
moxidectin | [no description available] | medium | 1 | 0 | | |
benzoyl peroxide | [no description available] | medium | 2 | 0 | carbonyl compound | |
terfenadine | [no description available] | medium | 1 | 1 | diarylmethane | |
fexofenadine | [no description available] | medium | 1 | 1 | piperidines; tertiary amine | anti-allergic agent; H1-receptor antagonist |
tetraethoxysilane | [no description available] | medium | 2 | 0 | | |
octyltriethoxysilane | [no description available] | medium | 1 | 0 | organosilicon compound | |
10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide | [no description available] | medium | 1 | 1 | dibenzoazepine | |
hexamethylsilazane | [no description available] | medium | 1 | 0 | N-silyl compound | chromatographic reagent |
celecoxib | [no description available] | medium | 2 | 0 | organofluorine compound; pyrazoles; sulfonamide; toluenes | cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
1,4-dimethoxybenzene | [no description available] | medium | 1 | 0 | dimethoxybenzene | |
entinostat | [no description available] | medium | 1 | 0 | benzamides; carbamate ester; primary amino compound; pyridines; substituted aniline | antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor |
troeger's base | [no description available] | medium | 1 | 0 | | |
4-(dicyanomethylene)-2-methyl-6-(4-(dimethylamino)styryl)-4h-pyran | [no description available] | medium | 1 | 0 | | |
3-hydroxy-5-estrane-17-carbonitrile | [no description available] | medium | 1 | 0 | | |
isotretinoin | [no description available] | medium | 2 | 0 | retinoic acid | antineoplastic agent; keratolytic drug; teratogenic agent |
coenzyme q10 | [no description available] | medium | 2 | 0 | ubiquinones | antioxidant; ferroptosis inhibitor; human metabolite |
dicamba | [no description available] | medium | 1 | 0 | dichlorobenzene; methoxybenzoic acid | agrochemical; environmental contaminant; herbicide; synthetic auxin; xenobiotic |
ddt | [no description available] | medium | 1 | 0 | benzenoid aromatic compound; chlorophenylethane; monochlorobenzenes; organochlorine insecticide | bridged diphenyl acaricide; carcinogenic agent; endocrine disruptor; persistent organic pollutant |
4-chloroaniline | [no description available] | medium | 1 | 0 | chloroaniline; monochlorobenzenes | |
chlorhexidine | [no description available] | medium | 1 | 0 | biguanides; monochlorobenzenes | antibacterial agent; antiinfective agent |
1,1-bis(4-hydroxyphenyl)cyclohexane | [no description available] | medium | 1 | 0 | diarylmethane | |
3-bromopyridine | [no description available] | medium | 1 | 0 | monobromopyridine | |
phenylmethanesulfonic acid | [no description available] | medium | 1 | 0 | | |
on 01210.na | [no description available] | medium | 1 | 0 | | |
nickel nitrate | [no description available] | medium | 1 | 0 | | |
5-iodoacetamidofluorescein | [no description available] | medium | 1 | 0 | | |
domperidone | [no description available] | medium | 1 | 0 | benzimidazoles; heteroarylpiperidine | antiemetic; dopaminergic antagonist |
dibenzo(a,c)phenazine | [no description available] | medium | 1 | 0 | | |
phenoxy radical | [no description available] | medium | 1 | 0 | organic radical | |
riluzole | [no description available] | medium | 1 | 0 | benzothiazoles | |
garenoxacin | [no description available] | medium | 1 | 0 | aromatic ether; cyclopropanes; isoindoles; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic | antibacterial drug; non-steroidal anti-inflammatory drug |
ruthenium chloride (rucl3) | [no description available] | medium | 1 | 0 | | |
flavoxate | [no description available] | medium | 1 | 0 | carboxylic ester; flavones; piperidines; tertiary amino compound | antispasmodic drug; muscarinic antagonist; parasympatholytic |
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate | [no description available] | medium | 2 | 0 | 1,1-diunsubstituted alkanesulfonate | |
triethanolamine | [no description available] | medium | 2 | 0 | amino alcohol; tertiary amino compound; triol | buffer; surfactant |
amanitins | [no description available] | medium | 1 | 0 | | |
azaperone | [no description available] | medium | 2 | 0 | aminopyridine; aromatic ketone; monofluorobenzenes; N-alkylpiperazine; N-arylpiperazine; tertiary amino compound | antipsychotic agent; dopaminergic antagonist |
letrozole | [no description available] | medium | 1 | 0 | nitrile; triazoles | antineoplastic agent; EC 1.14.14.14 (aromatase) inhibitor |
chlorophyll d | [no description available] | medium | 1 | 0 | | |
chlorophyll b | [no description available] | medium | 1 | 0 | chlorophyll | cofactor |
alizarin | [no description available] | medium | 1 | 0 | dihydroxyanthraquinone | chromophore; dye; plant metabolite |
phenylpyruvic acid | [no description available] | medium | 1 | 0 | 2-oxo monocarboxylic acid | chromogenic compound; EC 6.4.1.1 (pyruvate carboxylase) inhibitor; fundamental metabolite |
desloratadine | [no description available] | medium | 1 | 0 | benzocycloheptapyridine | anti-allergic agent; cholinergic antagonist; drug metabolite; H1-receptor antagonist |
loratadine | [no description available] | medium | 1 | 0 | benzocycloheptapyridine; ethyl ester; N-acylpiperidine; organochlorine compound; tertiary carboxamide | anti-allergic agent; cholinergic antagonist; geroprotector; H1-receptor antagonist |
morroniside | [no description available] | medium | 1 | 0 | | |
paeonol | [no description available] | medium | 1 | 0 | methoxybenzenes; phenols | metabolite |
loganin | [no description available] | medium | 1 | 0 | beta-D-glucoside; cyclopentapyran; enoate ester; iridoid monoterpenoid; methyl ester; monosaccharide derivative; secondary alcohol | anti-inflammatory agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; EC 3.4.23.46 (memapsin 2) inhibitor; neuroprotective agent; plant metabolite |
tianeptine | [no description available] | medium | 1 | 0 | dibenzothiazepine; monocarboxylic acid; organochlorine compound | |
4-chloro-7-nitrobenzofuran | [no description available] | medium | 2 | 0 | | |
carbitol | [no description available] | medium | 1 | 0 | diether; glycol ether; hydroxypolyether; primary alcohol | protic solvent |
droperidol | [no description available] | medium | 1 | 0 | aromatic ketone; benzimidazoles; organofluorine compound | anaesthesia adjuvant; antiemetic; dopaminergic antagonist; first generation antipsychotic |
e 4031 | [no description available] | medium | 1 | 0 | sulfonamide | |
stearates | [no description available] | medium | 1 | 0 | | |
cephalexin | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; cephalosporin; semisynthetic derivative | antibacterial drug |
fropenem | [no description available] | medium | 1 | 0 | faropenem | |
suplatast tosilate | [no description available] | medium | 1 | 0 | | |
hexadimethrine bromide | [no description available] | medium | 2 | 0 | | |
glimepiride | [no description available] | medium | 1 | 0 | sulfonamide | |
cloprostenol | [no description available] | medium | 1 | 0 | prostanoid | |
ferrous chloride | [no description available] | medium | 1 | 0 | iron coordination entity | |
acridine orange | [no description available] | medium | 2 | 0 | aminoacridines; aromatic amine; tertiary amino compound | fluorochrome; histological dye |
radafaxine | [no description available] | medium | 1 | 0 | | |
6-hydroxytaxol | [no description available] | medium | 2 | 0 | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent |
2-nitrophenol | [no description available] | medium | 1 | 0 | 2-nitrophenols | |
teicoplanin aglycone | [no description available] | medium | 1 | 0 | | |
ropinirole | [no description available] | medium | 1 | 0 | indolones; tertiary amine | antidyskinesia agent; antiparkinson drug; central nervous system drug; dopamine agonist |
15-acetyldeoxynivalenol | [no description available] | medium | 1 | 0 | trichothecene | epitope; mycotoxin |
fluometuron | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; 3-(3,4-substituted-phenyl)-1,1-dimethylurea | agrochemical; environmental contaminant; herbicide; photosystem-II inhibitor; xenobiotic |
palmitoyl coenzyme a | [no description available] | medium | 2 | 0 | 11,12-saturated fatty acyl-CoA; 3-substituted propionyl-CoA; long-chain fatty acyl-CoA; palmitoyl bioconjugate | Escherichia coli metabolite; mouse metabolite |
mepivacaine | [no description available] | medium | 1 | 0 | piperidinecarboxamide | drug allergen; local anaesthetic |
norcantharidin | [no description available] | medium | 1 | 0 | furofuran | |
harpagoside | [no description available] | medium | 1 | 0 | terpene glycoside | |
5,6-diamino-2,4-dihydroxypyrimidine | [no description available] | medium | 1 | 0 | aminouracil; diamine; pyrimidone | |
glyoxal | [no description available] | medium | 1 | 0 | dialdehyde | agrochemical; allergen; pesticide; plant growth regulator |
lumazine | [no description available] | medium | 1 | 0 | 2,4-dihydroxypteridine | |
pyruvaldehyde | [no description available] | medium | 1 | 0 | 2-oxo aldehyde; propanals | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
pteridines | [no description available] | medium | 1 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; pteridines | |
2,6-diaminoanthraquinone | [no description available] | medium | 1 | 0 | | |
gabapentin-lactam | [no description available] | medium | 1 | 0 | azaspiro compound | |
dinitrofluorobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; organofluorine compound | agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent |
shogaol | [no description available] | medium | 1 | 0 | enone; monomethoxybenzene; phenols | |
gingerol | [no description available] | medium | 1 | 0 | beta-hydroxy ketone; guaiacols | antineoplastic agent; plant metabolite |
oxyphenonium | [no description available] | medium | 1 | 0 | acylcholine | |
2-aminopyrazine | [no description available] | medium | 1 | 0 | pyrazines | |
4-isothiocyanatobenzenesulfonate | [no description available] | medium | 1 | 0 | | |
tetrathiafulvalene | [no description available] | medium | 1 | 0 | fulvalenes; organosulfur heterocyclic compound | |
desethylamodiaquine | [no description available] | medium | 1 | 0 | | |
amodiaquine | [no description available] | medium | 1 | 0 | aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug |
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | [no description available] | medium | 1 | 0 | 1,2,4-triazines | |
3-methylhistamine | [no description available] | medium | 1 | 0 | | |
ubiquinone 9 | [no description available] | medium | 1 | 0 | ubiquinones | antioxidant; human metabolite |
1,10-phenanthroline-5,6-dione | [no description available] | medium | 1 | 0 | | |
n-hydroxyphthalimide | [no description available] | medium | 1 | 0 | | |
angiotensin ii, des-phe(8)- | [no description available] | medium | 1 | 0 | amino acid zwitterion; angiotensin | vasodilator agent |
hepes | [no description available] | medium | 1 | 0 | HEPES; organosulfonic acid | |
antimony | [no description available] | medium | 1 | 0 | metalloid atom; pnictogen | |
clopidogrel | [no description available] | medium | 1 | 1 | methyl ester; monochlorobenzenes; thienopyridine | anticoagulant; P2Y12 receptor antagonist; platelet aggregation inhibitor |
ticlopidine | [no description available] | medium | 2 | 1 | monochlorobenzenes; thienopyridine | anticoagulant; fibrin modulating drug; hematologic agent; P2Y12 receptor antagonist; platelet aggregation inhibitor |
corilagin | [no description available] | medium | 1 | 0 | ellagitannin; gallate ester | antihypertensive agent; antioxidant; EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor; non-steroidal anti-inflammatory drug |
fullerene c60 | [no description available] | medium | 2 | 0 | fullerene | geroprotector |
ethyldimethylaminopropyl carbodiimide | [no description available] | medium | 1 | 0 | | |
thionyl chloride | [no description available] | medium | 1 | 0 | chlorine molecular entity; sulfinyl halide | |
1-hydroxybenzotriazole | [no description available] | medium | 1 | 0 | benzotriazoles | |
etodolac | [no description available] | medium | 1 | 0 | monocarboxylic acid; organic heterotricyclic compound | antipyretic; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
arachidonyl-coenzyme a | [no description available] | medium | 1 | 0 | arachidonoyl bioconjugate; unsaturated fatty acyl-CoA | |
methylene iodide | [no description available] | medium | 1 | 0 | | |
2-hydroxy-7-nitrofluorene | [no description available] | medium | 1 | 0 | | |
2-amino-7-nitrofluorene | [no description available] | medium | 1 | 0 | | |
4-aminophthalimide | [no description available] | medium | 1 | 0 | | |
1-(3-chlorophenyl)piperazine | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-arylpiperazine | drug metabolite; environmental contaminant; serotonergic agonist; xenobiotic |
trazodone | [no description available] | medium | 2 | 0 | monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazolopyridine | adrenergic antagonist; antidepressant; anxiolytic drug; H1-receptor antagonist; sedative; serotonin uptake inhibitor |
tributylamine | [no description available] | medium | 1 | 0 | tertiary amine | |
4-cyano-4'-pentylbiphenyl | [no description available] | medium | 1 | 0 | | |
plagiochin e | [no description available] | medium | 1 | 0 | | |
carbamylhydrazine | [no description available] | medium | 2 | 0 | carbohydrazide; monocarboxylic acid amide; one-carbon compound; ureas | |
lomefloxacin | [no description available] | medium | 1 | 0 | fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antimicrobial agent; antitubercular agent; photosensitizing agent |
citalopram | [no description available] | medium | 2 | 0 | 2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound | |
musk tibetine | [no description available] | medium | 1 | 0 | | |
potassium nitrate | [no description available] | medium | 1 | 0 | inorganic nitrate salt; potassium salt | fertilizer |
pentaerythritol tetranitrate | [no description available] | medium | 1 | 0 | pentaerythritol nitrate | explosive; vasodilator agent |
isosorbide dinitrate | [no description available] | medium | 1 | 0 | glucitol derivative; nitrate ester | nitric oxide donor; vasodilator agent |
nitroglycerin | [no description available] | medium | 1 | 0 | nitroglycerol | explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic |
p-dimethylaminoazobenzene | [no description available] | medium | 1 | 0 | azobenzenes | |
thiohydantoins | [no description available] | medium | 1 | 0 | | |
dabth | [no description available] | medium | 1 | 0 | | |
dibenzo-18-crown-6 | [no description available] | medium | 1 | 0 | benzenes; crown ether | phase-transfer catalyst |
4-bromomethyl-7-acetoxycoumarin | [no description available] | medium | 1 | 0 | | |
lasalocid | [no description available] | medium | 1 | 0 | beta-hydroxy ketone; monocarboxylic acid; monohydroxybenzoic acid; oxanes; oxolanes; polyether antibiotic; secondary alcohol; tertiary alcohol | bacterial metabolite; coccidiostat; ionophore |
cellobiose | [no description available] | medium | 1 | 0 | cellobiose | epitope |
cellobiosyl fluoride | [no description available] | medium | 1 | 0 | | |
4-amino-4,6-dideoxymannose | [no description available] | medium | 1 | 0 | deoxymannose derivative; mannosamine | |
mannose | [no description available] | medium | 2 | 0 | D-aldohexose; D-mannose; mannopyranose | metabolite |
1-(9-fluorenyl)ethyl chloroformate | [no description available] | medium | 1 | 0 | | |
cyclolinopeptide a | [no description available] | medium | 1 | 0 | | |
am 580 | [no description available] | medium | 1 | 0 | amidobenzoic acid; tetralins | antineoplastic agent; retinoic acid receptor alpha/beta agonist |
verapamil | [no description available] | medium | 3 | 0 | aromatic ether; nitrile; polyether; tertiary amino compound | |
norverapamil | [no description available] | medium | 2 | 0 | aromatic ether; nitrile; polyether; secondary amino compound | |
sodium chlorate | [no description available] | medium | 1 | 0 | chlorate salt; inorganic sodium salt | herbicide |
chlorates | [no description available] | medium | 1 | 0 | chlorine oxoanion; monovalent inorganic anion | |
methyleugenol | [no description available] | medium | 1 | 0 | phenylpropanoid | |
2'-deoxyguanosine 5'-phosphate | [no description available] | medium | 2 | 0 | deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-monophosphate | Escherichia coli metabolite; mouse metabolite |
potassium superoxide | [no description available] | medium | 1 | 0 | | |
fluvoxamine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; 5-methoxyvalerophenone O-(2-aminoethyl)oxime | antidepressant; anxiolytic drug; serotonin uptake inhibitor |
aspartame | [no description available] | medium | 1 | 0 | carboxylic acid; dipeptide zwitterion; dipeptide; methyl ester | apoptosis inhibitor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; environmental contaminant; micronutrient; nutraceutical; sweetening agent; xenobiotic |
fullerene c70 | [no description available] | medium | 1 | 0 | fullerene | |
felbamate | [no description available] | medium | 1 | 0 | carbamate ester | anticonvulsant; neuroprotective agent |
peroxynitric acid | [no description available] | medium | 1 | 0 | nitrogen oxoacid | |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | [no description available] | medium | 1 | 0 | chromanol; monocarboxylic acid; phenols | antioxidant; ferroptosis inhibitor; neuroprotective agent; radical scavenger; Wnt signalling inhibitor |
2,5-hexanedione | [no description available] | medium | 1 | 0 | diketone; methyl ketone | human xenobiotic metabolite; neurotoxin |
dmp 728 | [no description available] | medium | 1 | 0 | | |
7 alpha-hydroxy-4-cholesten-3-one | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; 7alpha-hydroxy steroid; cholestanoid | human metabolite; mouse metabolite |
retinol | [no description available] | medium | 4 | 0 | retinol; vitamin A | human metabolite; mouse metabolite; plant metabolite |
amphetamine | [no description available] | medium | 2 | 0 | primary amine | |
2',6'-pipecoloxylidide | [no description available] | medium | 1 | 0 | amino acid amide | |
4'-hydroxybupivacaine | [no description available] | medium | 1 | 0 | | |
centchroman | [no description available] | medium | 1 | 0 | | |
nicardipine | [no description available] | medium | 1 | 0 | benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound | |
alprazolam | [no description available] | medium | 2 | 0 | organochlorine compound; triazolobenzodiazepine | anticonvulsant; anxiolytic drug; GABA agonist; muscle relaxant; sedative; xenobiotic |
chlorambucil | [no description available] | medium | 1 | 0 | aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound | alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent |
9-fluoreneacetic acid | [no description available] | medium | 1 | 0 | | |
simmondsin | [no description available] | medium | 1 | 0 | glycoside | |
genistin | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones 7-O-beta-D-glucoside | |
rhoifolin | [no description available] | medium | 1 | 0 | dihydroxyflavone; glycosyloxyflavone; neohesperidoside | metabolite |
daidzin | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones 7-O-beta-D-glucoside; hydroxyisoflavone; monosaccharide derivative | plant metabolite |
2-thioxo-4-thiazolidinecarboxylic acid | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
u 74006f | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
u 89678 | [no description available] | medium | 1 | 0 | | |
1-hexadecyl-2-acetyl-glycero-3-phosphocholine | [no description available] | medium | 1 | 0 | 2-acetyl-1-alkyl-sn-glycero-3-phosphocholine | antihypertensive agent; beta-adrenergic antagonist; bronchoconstrictor agent; hematologic agent; vasodilator agent |
pentafluoropropionic anhydride | [no description available] | medium | 1 | 0 | | |
debrisoquin | [no description available] | medium | 1 | 0 | carboxamidine; isoquinolines | adrenergic agent; antihypertensive agent; human metabolite; sympatholytic agent |
4-hydroxydebrisoquin | [no description available] | medium | 1 | 0 | carboxamidine; isoquinolines; secondary alcohol | metabolite |
bicinchoninic acid | [no description available] | medium | 2 | 0 | | |
ethylnitrosourea | [no description available] | medium | 1 | 0 | N-nitrosoureas | alkylating agent; carcinogenic agent; genotoxin; mutagen |
n-nitrosobutylurea | [no description available] | medium | 1 | 0 | | |
sodium sulfide | [no description available] | medium | 1 | 0 | | |
n-acetyl-1-aminopyrene | [no description available] | medium | 1 | 0 | | |
1-nitrosopyrene | [no description available] | medium | 1 | 0 | | |
1-aminopyrene | [no description available] | medium | 1 | 0 | | |
1-nitropyrene | [no description available] | medium | 1 | 0 | nitroarene | carcinogenic agent |
diltiazem | [no description available] | medium | 1 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
nebularine | [no description available] | medium | 1 | 0 | purine ribonucleoside; purines D-ribonucleoside | fungal metabolite |
neuropeptide y | [no description available] | medium | 1 | 0 | | |
neuropeptide y (18-36) | [no description available] | medium | 1 | 0 | | |
4-hydroxycoumarin | [no description available] | medium | 1 | 0 | hydroxycoumarin | |
pyridoxal phosphate | [no description available] | medium | 2 | 0 | methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 phosphate | coenzyme; cofactor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
fibrinogen | [no description available] | medium | 1 | 0 | iditol | fungal metabolite |
phenylalanyl-prolyl-arginine-chloromethyl ketone | [no description available] | medium | 1 | 0 | | |
proxicromil | [no description available] | medium | 1 | 0 | | |
cephradine | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; cephalosporin | antibacterial drug |
bosentan anhydrous | [no description available] | medium | 1 | 0 | primary alcohol; pyrimidines; sulfonamide | antihypertensive agent; endothelin receptor antagonist |
methionine sulfoxide | [no description available] | medium | 1 | 0 | amino acid zwitterion; L-methionine S-oxide | Escherichia coli metabolite |
n-nitrosodiphenylamine | [no description available] | medium | 1 | 0 | phenylhydrazines | |
ouabain | [no description available] | medium | 1 | 0 | 11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone | anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite |
glycolic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid; primary alcohol | keratolytic drug; metabolite |
metaperiodate | [no description available] | medium | 1 | 0 | iodine oxoacid | |
calcitriol | [no description available] | medium | 2 | 0 | D3 vitamins; hydroxycalciol; triol | antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical |
metaperiodate | [no description available] | medium | 1 | 0 | iodine oxoanion; monovalent inorganic anion | |
acetonitrile anion | [no description available] | medium | 1 | 0 | | |
arachidonic acid | [no description available] | medium | 2 | 0 | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
4-fluorohexahydrosiladifenidol | [no description available] | medium | 1 | 0 | | |
amrinone | [no description available] | medium | 1 | 0 | bipyridines | EC 3.1.4.* (phosphoric diester hydrolase) inhibitor |
florisil | [no description available] | medium | 2 | 0 | | |
poloxalene | [no description available] | medium | 1 | 0 | epoxide | |
ethosuximide | [no description available] | medium | 1 | 0 | dicarboximide; pyrrolidinone | anticonvulsant; geroprotector; T-type calcium channel blocker |
ethyl 2-cyanoacrylate | [no description available] | medium | 1 | 0 | | |
dmp 450 | [no description available] | medium | 1 | 0 | | |
beta-hydroxy-beta-ethyl-phenylpropionamide | [no description available] | medium | 1 | 0 | | |
cefadroxil anhydrous | [no description available] | medium | 1 | 0 | cephalosporin | antibacterial drug |
7-hydroxymethotrexate | [no description available] | medium | 1 | 0 | folic acids | |
bromophenophos | [no description available] | medium | 1 | 0 | | |
oxyclozanide | [no description available] | medium | 1 | 0 | | |
tribromsalan | [no description available] | medium | 1 | 0 | salicylanilides | |
bithionol | [no description available] | medium | 1 | 0 | aryl sulfide; bridged diphenyl antifungal drug; bridged diphenyl fungicide; dichlorobenzene; organochlorine pesticide; polyphenol | antifungal agrochemical; antiplatyhelmintic drug |
dichloroacetic acid | [no description available] | medium | 1 | 0 | monocarboxylic acid; organochlorine compound | astringent; marine metabolite |
dermatan sulfate | [no description available] | medium | 1 | 0 | amino disaccharide; glycosylgalactose derivative; iduronic acids; oligosaccharide sulfate | |
pirlimycin | [no description available] | medium | 1 | 0 | | |
3'-p-hydroxypaclitaxel | [no description available] | medium | 1 | 0 | | |
8-chlorotheophylline | [no description available] | medium | 1 | 0 | organochlorine compound; purines | central nervous system stimulant |
o(6)-benzylguanine | [no description available] | medium | 1 | 0 | | |
enkephalin, d-penicillamine (2,5)- | [no description available] | medium | 1 | 0 | heterodetic cyclic peptide | delta-opioid receptor agonist |
hydroxyzine | [no description available] | medium | 1 | 0 | hydroxyether; monochlorobenzenes; N-alkylpiperazine | anticoronaviral agent; antipruritic drug; anxiolytic drug; dermatologic drug; H1-receptor antagonist |
lycopene | [no description available] | medium | 1 | 0 | acyclic carotene | antioxidant; plant metabolite |
melengestrol acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
chlormadinone acetate | [no description available] | medium | 1 | 0 | corticosteroid hormone | |
megestrol acetate | [no description available] | medium | 1 | 0 | 20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; steroid ester | antineoplastic agent; appetite enhancer; contraceptive drug; progestin; synthetic oral contraceptive |
docetaxel anhydrous | [no description available] | medium | 1 | 0 | secondary alpha-hydroxy ketone; tetracyclic diterpenoid | antimalarial; antineoplastic agent; photosensitizing agent |
5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate) | [no description available] | medium | 1 | 0 | | |
4-aminobenzoic acid | [no description available] | medium | 2 | 0 | aminobenzoic acid; aromatic amino-acid zwitterion | allergen; Escherichia coli metabolite; plant metabolite |
troleandomycin | [no description available] | medium | 1 | 0 | acetate ester; epoxide; macrolide antibiotic; monosaccharide derivative; polyketide; semisynthetic derivative | EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor; xenobiotic |
clarithromycin | [no description available] | medium | 1 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic |
brequinar | [no description available] | medium | 1 | 0 | biphenyls; monocarboxylic acid; monofluorobenzenes; quinolinemonocarboxylic acid | anticoronaviral agent; antimetabolite; antineoplastic agent; antiviral agent; EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor; immunosuppressive agent; pyrimidine synthesis inhibitor |
noribogaine | [no description available] | medium | 1 | 0 | monoterpenoid indole alkaloid; organic heteropentacyclic compound; secondary amino compound; tertiary amino compound | kappa-opioid receptor agonist; NMDA receptor antagonist; psychotropic drug; serotonin uptake inhibitor |
ibogaine | [no description available] | medium | 1 | 0 | | |
tiaramide | [no description available] | medium | 1 | 0 | benzothiazoles | |
diphenoxylate | [no description available] | medium | 1 | 0 | ethyl ester; nitrile; piperidinecarboxylate ester; tertiary amine | antidiarrhoeal drug |
atropine | [no description available] | medium | 2 | 0 | | |
tricyclazole | [no description available] | medium | 1 | 0 | triazolobenzothiazole | antifungal agrochemical; melanin synthesis inhibitor |
permethrin | [no description available] | medium | 1 | 0 | cyclopropanecarboxylate ester; cyclopropanes | agrochemical; ectoparasiticide; pyrethroid ester acaricide; pyrethroid ester insecticide; scabicide |
cyhalothrin | [no description available] | medium | 1 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide |
fluvalinate | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; nitrile; organochlorine acaricide; organochlorine insecticide; organofluorine acaricide; organofluorine insecticide | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide |
fenpropathrin, (+-)-isomer | [no description available] | medium | 1 | 0 | aromatic ether; cyclopropanecarboxylate ester | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide |
sodium borate | [no description available] | medium | 1 | 0 | | |
ninhydrin | [no description available] | medium | 1 | 0 | aromatic ketone; beta-diketone; indanones; ketone hydrate | colour indicator; human metabolite |
argininal | [no description available] | medium | 1 | 0 | | |
heparitin sulfate | [no description available] | medium | 1 | 0 | | |
enkephalin, methionine | [no description available] | medium | 1 | 0 | | |
propiomazine | [no description available] | medium | 1 | 0 | aromatic ketone; phenothiazines; tertiary amino compound | dopaminergic antagonist; histamine antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; sedative; serotonergic antagonist |
lypressin | [no description available] | medium | 1 | 0 | cyclic peptide | |
felypressin | [no description available] | medium | 1 | 0 | heterodetic cyclic peptide | vasoconstrictor agent; vasopressin receptor agonist |
4-oxoretinoic acid | [no description available] | medium | 1 | 0 | enone; retinoid | human xenobiotic metabolite |
alitretinoin | [no description available] | medium | 1 | 0 | retinoic acid | antineoplastic agent; keratolytic drug; metabolite; retinoid X receptor agonist |
artenimol | [no description available] | medium | 1 | 0 | | |
lurtotecan | [no description available] | medium | 2 | 0 | | |
dehydroepiandrosterone | [no description available] | medium | 2 | 0 | 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid | androgen; human metabolite; mouse metabolite |
estradiol-6-(o-carboxymethyl)oxime | [no description available] | medium | 1 | 0 | | |
6-o-monoacetylmorphine | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
heroin | [no description available] | medium | 1 | 0 | morphinane alkaloid | mu-opioid receptor agonist; opioid analgesic; prodrug |
gamma-linolenic acid | [no description available] | medium | 1 | 0 | linolenic acid; omega-6 fatty acid | human metabolite; mouse metabolite; plant metabolite |
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | [no description available] | medium | 1 | 0 | HPETE | human xenobiotic metabolite |
(nitrilotris(methylene))triphosphonic acid | [no description available] | medium | 1 | 0 | phosphonoacetic acid | |
etidronate | [no description available] | medium | 1 | 0 | 1,1-bis(phosphonic acid) | antineoplastic agent; bone density conservation agent; chelator |
(ethylenedinitrilo)-tetramethylenephosphonic acid | [no description available] | medium | 1 | 0 | | |
diethylenetriaminepenta(methylenephosphonic) acid | [no description available] | medium | 1 | 0 | | |
thalidomide | [no description available] | medium | 1 | 0 | phthalimides; piperidones | |
butyric acid | [no description available] | medium | 1 | 0 | fatty acid 4:0; straight-chain saturated fatty acid | human urinary metabolite; Mycoplasma genitalium metabolite |
bisphenol a-glycidyl methacrylate | [no description available] | medium | 1 | 0 | diarylmethane | |
triethylene glycol dimethacrylate | [no description available] | medium | 1 | 0 | | |
chitosan | [no description available] | medium | 1 | 0 | | |
ethacrynic acid | [no description available] | medium | 1 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
arbutin | [no description available] | medium | 1 | 0 | beta-D-glucoside; monosaccharide derivative | Escherichia coli metabolite; plant metabolite |
dioleoyl phosphatidylethanolamine | [no description available] | medium | 1 | 0 | phosphatidylethanolamine | |
sincalide | [no description available] | medium | 1 | 0 | oligopeptide | |
cholecystokinin | [no description available] | medium | 2 | 0 | | |
v 70 | [no description available] | medium | 1 | 0 | | |
iodamide | [no description available] | medium | 1 | 0 | benzoic acids; organoiodine compound | radioopaque medium |
dynorphin a, destyr(1)-destrp(14)-desasp(15)-desasn(16)-desglu(17)- | [no description available] | medium | 1 | 0 | | |
dynorphin a(1-12) | [no description available] | medium | 1 | 0 | | |
dynorphins | [no description available] | medium | 1 | 0 | | |
ganciclovir | [no description available] | medium | 1 | 0 | 2-aminopurines; oxopurine | antiinfective agent; antiviral drug |
cremophor el | [no description available] | medium | 1 | 0 | | |
methylene violet | [no description available] | medium | 1 | 0 | | |
naringenin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; naringenin | expectorant; plant metabolite |
20-alpha-dihydroprogesterone | [no description available] | medium | 1 | 0 | 20-hydroxypregn-4-en-3-one | human metabolite; mouse metabolite |
norethindrone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; terminal acetylenic compound; tertiary alcohol | progestin; synthetic oral contraceptive |
17-alpha-hydroxyprogesterone | [no description available] | medium | 1 | 0 | 17alpha-hydroxy-C21-steroid; 17alpha-hydroxy steroid; tertiary alpha-hydroxy ketone | human metabolite; metabolite; mouse metabolite; progestin |
lamotrigine | [no description available] | medium | 1 | 1 | 1,2,4-triazines; dichlorobenzene; primary arylamine | anticonvulsant; antidepressant; antimanic drug; calcium channel blocker; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; excitatory amino acid antagonist; geroprotector; non-narcotic analgesic; xenobiotic |
alprenolol | [no description available] | medium | 1 | 0 | secondary alcohol; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
pindolol | [no description available] | medium | 2 | 0 | indoles; secondary amine | antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; serotonergic antagonist; vasodilator agent |
acebutolol | [no description available] | medium | 1 | 0 | aromatic amide; ethanolamines; ether; monocarboxylic acid amide; propanolamine; secondary amino compound | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; sympathomimetic agent |
oxprenolol | [no description available] | medium | 1 | 0 | aromatic ether | |
octogen | [no description available] | medium | 1 | 0 | N-nitro compound; tetrazocane | explosive |
chloroquine | [no description available] | medium | 2 | 0 | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug |
beta-lysine | [no description available] | medium | 1 | 0 | | |
calcipotriene | [no description available] | medium | 1 | 0 | hydrate | antipsoriatic |
benzyl cyanide | [no description available] | medium | 1 | 0 | benzenes; nitrile | animal metabolite; pheromone |
4-nitrophenyl alpha-glucoside | [no description available] | medium | 1 | 0 | alpha-D-glucoside; C-nitro compound; monosaccharide derivative | chromogenic compound |
flumequine | [no description available] | medium | 1 | 0 | 3-oxo monocarboxylic acid; organofluorine compound; pyridoquinoline; quinolone antibiotic | |
fleroxacin | [no description available] | medium | 1 | 0 | difluorobenzene; fluoroquinolone antibiotic; monocarboxylic acid; N-alkylpiperazine; quinolines | antibacterial drug; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor |
enoxacin | [no description available] | medium | 1 | 0 | 1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
4-hydroxyifosfamide | [no description available] | medium | 1 | 0 | ifosfamides | |
ifosfamide | [no description available] | medium | 1 | 0 | ifosfamides | alkylating agent; antineoplastic agent; environmental contaminant; immunosuppressive agent; xenobiotic |
iothalamic acid | [no description available] | medium | 1 | 0 | organic molecular entity | |
4-acetylaminohippuric acid | [no description available] | medium | 1 | 0 | | |
paraquat | [no description available] | medium | 2 | 0 | organic cation | geroprotector; herbicide |
acetic anhydride | [no description available] | medium | 1 | 0 | acyclic carboxylic anhydride | metabolite; reagent |
1,2,4-triazole | [no description available] | medium | 1 | 0 | 1,2,4-triazole | |
n-methylephedrine | [no description available] | medium | 1 | 0 | amphetamines | |
synephrine | [no description available] | medium | 1 | 0 | ethanolamines; phenethylamine alkaloid; phenols | alpha-adrenergic agonist; plant metabolite |
benzphetamine | [no description available] | medium | 1 | 0 | amphetamines; tertiary amine | adrenergic uptake inhibitor; appetite depressant; dopamine uptake inhibitor; sympathomimetic agent |
pirlindole | [no description available] | medium | 1 | 0 | carbazoles | |
3,3a-dehydropyrazidol | [no description available] | medium | 1 | 0 | | |
salicylurate | [no description available] | medium | 1 | 0 | N-acylglycine; secondary carboxamide | human xenobiotic metabolite; uremic toxin |
erythritol | [no description available] | medium | 1 | 0 | butane-1,2,3,4-tetrol | antioxidant; human metabolite; plant metabolite |
dextromoramide | [no description available] | medium | 1 | 0 | morpholines; N-acylpyrrolidine | opioid analgesic |
ammonium bromide | [no description available] | medium | 1 | 0 | ammonium salt; bromide salt | NMR chemical shift reference compound |
potassium acetate | [no description available] | medium | 1 | 0 | potassium salt | food acidity regulator |
ammonium chloride | [no description available] | medium | 2 | 0 | ammonium salt; inorganic chloride | ferroptosis inhibitor |
levorphanol | [no description available] | medium | 1 | 0 | morphinane alkaloid | |
methylformamide | [no description available] | medium | 2 | 0 | formamides | |
imipramine n-oxide | [no description available] | medium | 1 | 0 | dibenzooxazepine | |
tolfenamic acid | [no description available] | medium | 1 | 0 | aminobenzoic acid; organochlorine compound; secondary amino compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; EC 2.7.1.33 (pantothenate kinase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
7-methoxytacrine | [no description available] | medium | 1 | 0 | | |
glycarbylamide | [no description available] | medium | 1 | 0 | | |
lactose | [no description available] | medium | 1 | 0 | lactose | |
acetylcellulose | [no description available] | medium | 1 | 0 | | |
selegiline | [no description available] | medium | 1 | 0 | selegiline; terminal acetylenic compound | geroprotector |
phalloidine | [no description available] | medium | 1 | 0 | homodetic cyclic peptide | |
antamanide | [no description available] | medium | 1 | 0 | | |
potassium cyanide | [no description available] | medium | 2 | 0 | cyanide salt; one-carbon compound; potassium salt | EC 1.15.1.1 (superoxide dismutase) inhibitor; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; neurotoxin |
gamma-cyclodextrin | [no description available] | medium | 3 | 0 | cyclodextrin | |
alpha-glutamyltryptophan | [no description available] | medium | 1 | 0 | dipeptide | angiogenesis modulating agent; antineoplastic agent; immunomodulator; metabolite |
azaperol | [no description available] | medium | 1 | 0 | | |
bromoacetate | [no description available] | medium | 1 | 0 | carboxylic acid; organohalogen compound | |
chloroacetic acid | [no description available] | medium | 1 | 0 | chlorocarboxylic acid; haloacetic acid | alkylating agent; herbicide |
imazethapyr | [no description available] | medium | 1 | 0 | aromatic carboxylic acid; pyridines | |
glucagon | [no description available] | medium | 1 | 0 | peptide hormone | |
n-acetylphenylalanine ethyl ester | [no description available] | medium | 1 | 0 | | |
oxybutynin | [no description available] | medium | 1 | 0 | acetylenic compound; carboxylic ester; racemate; tertiary alcohol; tertiary amino compound | antispasmodic drug; calcium channel blocker; local anaesthetic; muscarinic antagonist; muscle relaxant; parasympatholytic |
flunitrazepam | [no description available] | medium | 2 | 0 | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative |
alpha-naphthoflavone | [no description available] | medium | 1 | 0 | extended flavonoid; naphtho-gamma-pyrone; organic heterotricyclic compound | aryl hydrocarbon receptor agonist; aryl hydrocarbon receptor antagonist; EC 1.14.14.14 (aromatase) inhibitor |
dithianone | [no description available] | medium | 1 | 0 | dinitrile; naphthodithiin; p-quinones | antifungal agrochemical |
menthyl chloroformate | [no description available] | medium | 1 | 0 | | |
3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide | [no description available] | medium | 1 | 0 | | |
5-methyltetrahydrofolate | [no description available] | medium | 1 | 0 | | |
levoleucovorin | [no description available] | medium | 1 | 0 | 5-formyltetrahydrofolic acid | antineoplastic agent; metabolite |
5,6,7,8-tetrahydrofolic acid | [no description available] | medium | 1 | 0 | tetrahydrofolic acid | |
irganox 1076 | [no description available] | medium | 1 | 0 | | |
nystatin a1 | [no description available] | medium | 1 | 0 | nystatins | |
nicorandil | [no description available] | medium | 1 | 0 | nitrate ester; pyridinecarboxamide | potassium channel opener; vasodilator agent |
cyclopropane | [no description available] | medium | 1 | 0 | cycloalkane; cyclopropanes | inhalation anaesthetic |
nosiheptide | [no description available] | medium | 1 | 0 | polyol | |
florfenicol amine | [no description available] | medium | 1 | 0 | | |
n-butyronitrile | [no description available] | medium | 1 | 0 | aliphatic nitrile | |
allyl cyanide | [no description available] | medium | 2 | 0 | aliphatic nitrile; olefinic compound | antifeedant; neurotoxin; plant metabolite |
sodium cyanide | [no description available] | medium | 1 | 0 | cyanide salt; one-carbon compound; sodium salt | EC 1.15.1.1 (superoxide dismutase) inhibitor |
crotononitrile | [no description available] | medium | 1 | 0 | nitrile | |
artelinic acid | [no description available] | medium | 1 | 0 | | |
artesunic acid | [no description available] | medium | 1 | 0 | | |
daunorubicin | [no description available] | medium | 1 | 0 | aminoglycoside antibiotic; anthracycline; p-quinones; tetracenequinones | antineoplastic agent; bacterial metabolite |
homovanillic acid | [no description available] | medium | 2 | 0 | guaiacols; monocarboxylic acid | human metabolite; mouse metabolite |
lithocholic acid | [no description available] | medium | 1 | 0 | bile acid; C24-steroid; monohydroxy-5beta-cholanic acid | geroprotector; human metabolite; mouse metabolite |
atovaquone | [no description available] | medium | 1 | 0 | hydroxy-1,2-naphthoquinone | |
proguanil | [no description available] | medium | 1 | 0 | biguanides; monochlorobenzenes | antimalarial; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor |
metallothionein | [no description available] | medium | 2 | 0 | | |
iohexol | [no description available] | medium | 2 | 0 | benzenedicarboxamide; organoiodine compound | environmental contaminant; radioopaque medium; xenobiotic |
gallocatechol | [no description available] | medium | 1 | 0 | gallocatechin | antioxidant; metabolite; radical scavenger |
epicatechin gallate | [no description available] | medium | 1 | 0 | catechin; gallate ester; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; EC 3.2.1.20 (alpha-glucosidase) inhibitor; metabolite |
gallocatechin-3-gallate | [no description available] | medium | 1 | 0 | catechin; gallate ester; polyphenol | plant metabolite |
catechin gallate | [no description available] | medium | 1 | 0 | flavans; gallate ester; polyphenol | metabolite |
amphotericin b | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic | antiamoebic agent; antiprotozoal drug; bacterial metabolite |
decalin | [no description available] | medium | 1 | 0 | ortho-fused bicyclic hydrocarbon | solvent |
pseudohypericin | [no description available] | medium | 1 | 0 | | |
hypericin | [no description available] | medium | 1 | 0 | | |
hyperforin | [no description available] | medium | 1 | 0 | | |
phloroglucinol | [no description available] | medium | 1 | 0 | benzenetriol; phenolic donor | algal metabolite |
tryptophan octyl ester | [no description available] | medium | 1 | 0 | | |
tanshinone | [no description available] | medium | 1 | 0 | abietane diterpenoid | anticoronaviral agent |
4-coumaroyl-coenzyme a | [no description available] | medium | 1 | 0 | 4-coumaroyl-CoA | |
s-adenosylmethionine | [no description available] | medium | 1 | 0 | organic cation; sulfonium compound | coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite |
feruloyl-coa | [no description available] | medium | 1 | 0 | feruloyl-CoA(4-) | |
caffeoyl-coenzyme a | [no description available] | medium | 1 | 0 | | |
shikonin | [no description available] | medium | 1 | 0 | hydroxy-1,4-naphthoquinone | |
naphthazarin | [no description available] | medium | 1 | 0 | hydroxy-1,4-naphthoquinone | acaricide; antibacterial agent; antineoplastic agent; apoptosis inducer; geroprotector; plant metabolite |
anthraquinone sulfonate | [no description available] | medium | 1 | 0 | | |
guanidine thiocyanate | [no description available] | medium | 1 | 0 | | |
pyridoxal | [no description available] | medium | 1 | 0 | hydroxymethylpyridine; methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
pyridoxamine | [no description available] | medium | 1 | 0 | aminoalkylpyridine; hydroxymethylpyridine; monohydroxypyridine; vitamin B6 | Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite |
pyridoxamine phosphate | [no description available] | medium | 1 | 0 | aminoalkylpyridine; methylpyridines; monohydroxypyridine; vitamin B6 phosphate | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
aminopropionitrile | [no description available] | medium | 2 | 0 | aminopropionitrile | antineoplastic agent; antirheumatic drug; collagen cross-linking inhibitor; plant metabolite |
sodium iodate | [no description available] | medium | 1 | 0 | organic molecular entity | |
4-methylcatechol | [no description available] | medium | 1 | 0 | methylcatechol | antioxidant; carcinogenic agent; hapten; human metabolite; plant metabolite |
lysine tyrosylquinone | [no description available] | medium | 1 | 0 | 1,2-benzoquinones; L-lysine derivative; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid | |
captafol | [no description available] | medium | 1 | 0 | isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical |
captan | [no description available] | medium | 1 | 0 | isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical |
aminoimidazole carboxamide | [no description available] | medium | 1 | 0 | aminoimidazole; monocarboxylic acid amide | mouse metabolite |
iprodione | [no description available] | medium | 1 | 0 | benzenes; dichlorophenyl dicarboximide fungicide; imidazole fungicide; imidazolidine-2,4-dione; ureas | antifungal agrochemical; nematicide |
vinclozolin | [no description available] | medium | 1 | 0 | dicarboximide; dichlorobenzene; olefinic compound; oxazolidinone | |
folpet | [no description available] | medium | 1 | 0 | organochlorine compound; organosulfur compound; phthalimide fungicide | antifungal agrochemical |
1-phenyl-5-mercaptotetrazole | [no description available] | medium | 1 | 0 | tetrazoles | |
ro 31-8220 | [no description available] | medium | 1 | 0 | imidothiocarbamic ester; indoles; maleimides | EC 2.7.11.13 (protein kinase C) inhibitor |
endothelin-1 | [no description available] | medium | 1 | 0 | | |
dinoprost | [no description available] | medium | 1 | 0 | monocarboxylic acid; prostaglandins Falpha | human metabolite; mouse metabolite |
tiaprofenic acid | [no description available] | medium | 1 | 0 | aromatic ketone; monocarboxylic acid; thiophenes | drug allergen; non-steroidal anti-inflammatory drug |
sulindac | [no description available] | medium | 1 | 0 | monocarboxylic acid; organofluorine compound; sulfoxide | analgesic; antineoplastic agent; antipyretic; apoptosis inducer; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug; tocolytic agent |
galactomannan | [no description available] | medium | 1 | 0 | oligosaccharide | |
mannans | [no description available] | medium | 1 | 0 | | |
syringaldazine | [no description available] | medium | 1 | 0 | | |
cerous chloride | [no description available] | medium | 1 | 0 | cerium coordination entity | |
fenfluramine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; secondary amino compound | appetite depressant; serotonergic agonist; serotonin uptake inhibitor |
tamoxifen | [no description available] | medium | 1 | 0 | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator |
clonixin | [no description available] | medium | 1 | 0 | aminopyridine; organochlorine compound; pyridinemonocarboxylic acid | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; platelet aggregation inhibitor; vasodilator agent |
flunixin | [no description available] | medium | 1 | 0 | aminopyridine; organofluorine compound; pyridinemonocarboxylic acid | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
dehydroascorbic acid | [no description available] | medium | 1 | 0 | dehydroascorbic acid; vitamin C | coenzyme; mouse metabolite |
2-chloroethyl ethyl sulfide | [no description available] | medium | 1 | 0 | | |
spiraeoside | [no description available] | medium | 1 | 0 | beta-D-glucoside; flavonols; monosaccharide derivative; quercetin O-glucoside; tetrahydroxyflavone | antineoplastic agent; antioxidant; plant metabolite |
s-nitrosomercaptoethanol | [no description available] | medium | 1 | 0 | | |
alpha-synuclein | [no description available] | medium | 1 | 0 | | |
1,2-benzisoxazole | [no description available] | medium | 1 | 0 | 1,2-benzoxazoles; mancude organic heterobicyclic parent | |
coproporphyrin i | [no description available] | medium | 1 | 0 | | |
zinc coproporphyrin iii | [no description available] | medium | 1 | 0 | | |
1,2-dioxetane | [no description available] | medium | 1 | 0 | | |
potassium chloride | [no description available] | medium | 2 | 0 | inorganic chloride; inorganic potassium salt; potassium salt | fertilizer |
ketoconazole | [no description available] | medium | 1 | 0 | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
clotrimazole | [no description available] | medium | 1 | 0 | conazole antifungal drug; imidazole antifungal drug; imidazoles; monochlorobenzenes | antiinfective agent; environmental contaminant; xenobiotic |
clay | [no description available] | medium | 1 | 0 | | |
methylisonitrile | [no description available] | medium | 1 | 0 | isocyanide | |
6-carboxyfluorescein | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
sulfamic acid | [no description available] | medium | 1 | 0 | sulfamic acids | |
acid phosphatase | [no description available] | medium | 1 | 0 | | |
prolinamide | [no description available] | medium | 1 | 0 | amino acid amide; L-proline derivative; pyrrolidinecarboxamide | |
indole-3-lactic acid | [no description available] | medium | 1 | 0 | hydroxy monocarboxylic acid; indol-3-yl carboxylic acid | human metabolite |
perflexane | [no description available] | medium | 1 | 0 | fluoroalkane; fluorocarbon; volatile organic compound | non-polar solvent; radioopaque medium |
acifluorfen | [no description available] | medium | 1 | 0 | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
ht-2 toxin | [no description available] | medium | 1 | 0 | | |
thuringiensin | [no description available] | medium | 1 | 0 | | |
perphenazine | [no description available] | medium | 1 | 0 | N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines | antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug |
thiouridine | [no description available] | medium | 2 | 0 | nucleoside analogue; thiouridine | affinity label; antimetabolite |
2-thiouridine | [no description available] | medium | 1 | 0 | nucleoside analogue; thiouridine | |
6-hydrazinopyridine-3-carboxylic acid | [no description available] | medium | 1 | 0 | | |
tetraphenylphosphonium | [no description available] | medium | 1 | 0 | heteroorganic entity; phosphorus molecular entity; polyatomic cation | |
tetraphenylborate | [no description available] | medium | 1 | 0 | | |
aminopenicillanic acid | [no description available] | medium | 1 | 0 | amino acid zwitterion; penicillanic acids | allergen |
penicillanic acid | [no description available] | medium | 1 | 0 | penicillanic acids | |
phenoxyacetic acid | [no description available] | medium | 1 | 0 | aromatic ether; monocarboxylic acid | allergen; Aspergillus metabolite; human xenobiotic metabolite; plant growth retardant |
penicillin v | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | |
6-oxopiperidine-2-carboxylate | [no description available] | medium | 1 | 0 | delta-lactam; monocarboxylic acid | bacterial metabolite |
sodium citrate, anhydrous | [no description available] | medium | 1 | 0 | organic sodium salt | anticoagulant; flavouring agent |
amygdalin | [no description available] | medium | 1 | 0 | | |
bisdemethoxycurcumin | [no description available] | medium | 1 | 0 | beta-diketone; diarylheptanoid; enone; polyphenol | EC 3.2.1.1 (alpha-amylase) inhibitor; metabolite |
demethoxycurcumin | [no description available] | medium | 1 | 0 | beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antineoplastic agent; metabolite |
erythromycin estolate | [no description available] | medium | 1 | 0 | aminoglycoside sulfate salt; erythromycin derivative | enzyme inhibitor |
sq-11725 | [no description available] | medium | 1 | 0 | | |
sparfloxacin | [no description available] | medium | 1 | 0 | fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | |
kb 3022 | [no description available] | medium | 1 | 0 | | |
tellurium | [no description available] | medium | 1 | 0 | chalcogen; metalloid atom | |
methyl isocyanate | [no description available] | medium | 1 | 0 | isocyanates | allergen; apoptosis inducer |
dimethylaminopropionitrile | [no description available] | medium | 1 | 0 | | |
2-nitropropane | [no description available] | medium | 1 | 0 | secondary nitroalkane | carcinogenic agent; hepatotoxic agent; polar aprotic solvent; xenobiotic |
propylene oxide | [no description available] | medium | 1 | 0 | epoxide | |
sorbitan monooleate | [no description available] | medium | 1 | 0 | fatty acid ester | |
nipecotic acid | [no description available] | medium | 1 | 0 | beta-amino acid; piperidinemonocarboxylic acid | |
pipecolic acid | [no description available] | medium | 1 | 0 | piperidinemonocarboxylic acid | |
5-aminovaleric acid | [no description available] | medium | 1 | 0 | amino acid zwitterion; delta-amino acid; omega-amino fatty acid | human metabolite |
nifedipine | [no description available] | medium | 1 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
sterigmatocystin | [no description available] | medium | 1 | 0 | sterigmatocystins | metabolite |
sulfosalicylic acid | [no description available] | medium | 1 | 0 | arenesulfonic acid; benzoic acids; phenols | metabolite |
2-cyanoacetamide | [no description available] | medium | 1 | 0 | | |
hyaluronoglucosaminidase | [no description available] | medium | 1 | 0 | | |
2-methoxy ethyl acetate | [no description available] | medium | 2 | 0 | | |
cadmium chloride | [no description available] | medium | 2 | 0 | cadmium coordination entity | |
methylmercuric chloride | [no description available] | medium | 1 | 0 | chlorine molecular entity; mercury coordination entity; one-carbon compound | |
fumaronitrile | [no description available] | medium | 2 | 0 | | |
diethanolamine | [no description available] | medium | 1 | 0 | ethanolamines | human xenobiotic metabolite |
dicarbine | [no description available] | medium | 2 | 0 | | |
pentacaine | [no description available] | medium | 2 | 0 | | |
colchicine | [no description available] | medium | 1 | 0 | alkaloid; colchicine | anti-inflammatory agent; gout suppressant; mutagen |
n-acetylsulfapyridine | [no description available] | medium | 1 | 0 | sulfonamide | |
sulfasalazine | [no description available] | medium | 1 | 0 | | |
piribedil | [no description available] | medium | 1 | 0 | N-arylpiperazine | |
pidotimod | [no description available] | medium | 1 | 0 | peptide | |
pyrrolidonecarboxylic acid | [no description available] | medium | 1 | 0 | 5-oxoproline; L-proline derivative; non-proteinogenic L-alpha-amino acid | algal metabolite |
des-enkephalin-gamma-endorphin | [no description available] | medium | 1 | 0 | | |
desmosterol | [no description available] | medium | 1 | 0 | 3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C27-steroid; cholestanoid | human metabolite; mouse metabolite |
pentamidine | [no description available] | medium | 1 | 0 | aromatic ether; carboxamidine; diether | anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic |
flecainide | [no description available] | medium | 1 | 0 | aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines | anti-arrhythmia drug |
fomepizole | [no description available] | medium | 1 | 0 | pyrazoles | antidote; EC 1.1.1.1 (alcohol dehydrogenase) inhibitor; protective agent |
ethion | [no description available] | medium | 1 | 0 | organic thiophosphate | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide |
parathion | [no description available] | medium | 1 | 0 | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite |
phosalone | [no description available] | medium | 1 | 0 | 1,3-benzoxazoles; carbamate ester; organochlorine insecticide; organothiophosphate insecticide | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
phorate | [no description available] | medium | 1 | 0 | organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
leukotriene b4 | [no description available] | medium | 1 | 0 | dihydroxy monocarboxylic acid; hydroxy polyunsaturated fatty acid; leukotriene; long-chain fatty acid | human metabolite; mouse metabolite; plant metabolite; vasoconstrictor agent |
nitrogenase | [no description available] | medium | 1 | 0 | | |
octyl glucoside | [no description available] | medium | 1 | 0 | beta-D-glucoside | plant metabolite |
diisopropyl ether | [no description available] | medium | 1 | 0 | | |
proadifen | [no description available] | medium | 1 | 0 | diarylmethane | |
metyrapone | [no description available] | medium | 1 | 0 | aromatic ketone | antimetabolite; diagnostic agent; EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor |
atracurium | [no description available] | medium | 1 | 0 | diester; quaternary ammonium ion | muscle relaxant; nicotinic antagonist |
methionine sulfoximine | [no description available] | medium | 1 | 0 | methionine derivative; non-proteinogenic alpha-amino acid; sulfoximide | |
buthionine sulfoximine | [no description available] | medium | 1 | 0 | diastereoisomeric mixture; homocysteines; non-proteinogenic alpha-amino acid; sulfoximide | EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor; ferroptosis inducer |
florox reagent | [no description available] | medium | 1 | 0 | | |
hydroxocobalamin | [no description available] | medium | 1 | 0 | | |
pyrazinoic acid | [no description available] | medium | 1 | 0 | pyrazinecarboxylic acid | antitubercular agent; drug metabolite |
methyl methanesulfonate | [no description available] | medium | 1 | 0 | methanesulfonate ester | alkylating agent; apoptosis inducer; carcinogenic agent; genotoxin; mutagen |
aminopyrine | [no description available] | medium | 1 | 0 | pyrazolone; tertiary amino compound | antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
adiponitrile | [no description available] | medium | 1 | 0 | | |
vanilmandelic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid; aromatic ether; phenols | human metabolite |
glycolonitrile | [no description available] | medium | 1 | 0 | cyanohydrin | |
phenylmethylsulfonyl fluoride | [no description available] | medium | 1 | 0 | acyl fluoride | serine proteinase inhibitor |
diethylhexyl phthalate | [no description available] | medium | 1 | 0 | diester; phthalate ester | androstane receptor agonist; apoptosis inhibitor; plasticiser |
mono-(2-ethylhexyl)phthalate | [no description available] | medium | 1 | 0 | phthalic acid monoester | |
potassium thiocyanate | [no description available] | medium | 1 | 0 | potassium salt | |
scopolamine hydrobromide | [no description available] | medium | 1 | 0 | | |
tin | [no description available] | medium | 1 | 0 | carbon group element atom; elemental tin; metal atom | micronutrient |
tri-o-cresyl phosphate | [no description available] | medium | 1 | 0 | | |
sulfolane | [no description available] | low | 0 | 0 | sulfone; tetrahydrothiophenes | polar aprotic solvent |
boron trifluoride | [no description available] | low | 0 | 0 | boron fluoride | NMR chemical shift reference compound |
trichlorofluoromethane | [no description available] | low | 0 | 0 | chlorofluorocarbon; halomethane | environmental contaminant; NMR chemical shift reference compound; NMR solvent; refrigerant |
tetramethylsilane | [no description available] | low | 0 | 0 | organosilicon compound | NMR chemical shift reference compound |
hexafluorobenzene | [no description available] | low | 0 | 0 | fluorobenzenes; fluorocarbon | NMR chemical shift reference compound |
trimethyl phosphate | [no description available] | low | 0 | 0 | trialkyl phosphate | insect attractant; NMR chemical shift reference compound |
triphenylphosphine | [no description available] | low | 0 | 0 | benzenes; tertiary phosphine | NMR chemical shift reference compound; reducing agent |
hexafluoroacetone | [no description available] | low | 0 | 0 | ketone; perfluorinated compound | NMR chemical shift reference compound |
sulfur hexafluoride | [no description available] | low | 0 | 0 | sulfur coordination entity | greenhouse gas; NMR chemical shift reference compound; ultrasound contrast agent |
3-(trimethylsilyl)propionic acid | [no description available] | low | 0 | 0 | monocarboxylic acid; organosilicon compound | NMR chemical shift reference compound |
3-(trimethylsilyl)propanesulfonic acid | [no description available] | low | 0 | 0 | organosulfonic acid | NMR chemical shift reference compound |
3-cyanoalanine | [no description available] | low | 0 | 0 | alanine derivative; aliphatic nitrile; non-proteinogenic alpha-amino acid | |
pregnenolone carbonitrile | [no description available] | low | 0 | 0 | aliphatic nitrile | |
1,2-dibromo-2,4-dicyanobutane | [no description available] | low | 0 | 0 | aliphatic nitrile; organobromine compound | allergen; sensitiser |
dienogest | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; aliphatic nitrile; steroid hormone | progesterone receptor agonist; progestin; synthetic oral contraceptive |
2-amino-4-(3-cyclohexen-1-yl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydrochromene-3-carbonitrile | [no description available] | low | 0 | 0 | aliphatic nitrile; chromenes; cyclic ketone; enamine; enone | |
rhodiocyanoside a | [no description available] | low | 0 | 0 | aliphatic nitrile; beta-D-glucoside; cyanogenic glycoside; monosaccharide derivative | anti-allergic agent; metabolite |
borrelidin | [no description available] | low | 0 | 0 | aliphatic nitrile; diol; macrolide; monocarboxylic acid; secondary alcohol | antifungal agent; antimalarial; antimicrobial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite |
bromoethane | [no description available] | low | 0 | 0 | bromoalkane; bromohydrocarbon; volatile organic compound | alkylating agent; carcinogenic agent; local anaesthetic; refrigerant; solvent |
3-methylpentane | [no description available] | low | 0 | 0 | alkane; volatile organic compound | allelochemical; human metabolite; non-polar solvent |
methylcyclopentane | [no description available] | low | 0 | 0 | cycloalkane; volatile organic compound | human metabolite; plant metabolite |
benzotrichloride | [no description available] | low | 0 | 0 | benzenes; organochlorine compound; volatile organic compound | carcinogenic agent |
propargyl alcohol | [no description available] | low | 0 | 0 | propynol; terminal acetylenic compound; volatile organic compound | antifungal agent; Saccharomyces cerevisiae metabolite |
3-hexen-1-ol | [no description available] | low | 0 | 0 | alkenyl alcohol; homoallylic alcohol; primary alcohol; volatile organic compound | plant metabolite |
2,3,4-trimethylpentane | [no description available] | low | 0 | 0 | alkane; volatile organic compound | mammalian metabolite; nephrotoxic agent |
ethyl tert-butyl ether | [no description available] | low | 0 | 0 | ether; volatile organic compound | fuel additive |
3-methylfuran | [no description available] | low | 0 | 0 | furans; volatile organic compound | Aspergillus metabolite; environmental contaminant; fungal metabolite; Penicillium metabolite; plant metabolite |
2-ethylfuran | [no description available] | low | 0 | 0 | furans; volatile organic compound | bacterial metabolite; fragrance; Maillard reaction product; plant metabolite |
guaethol | [no description available] | low | 0 | 0 | aromatic ether; phenols; volatile organic compound | flavouring agent |
decane-1,2-diol | [no description available] | low | 0 | 0 | glycol; volatile organic compound | anti-inflammatory agent; antioxidant; human metabolite |
2,4-hexadienal | [no description available] | low | 0 | 0 | hexadienal; polyunsaturated fatty aldehyde; volatile organic compound | flavouring agent; plant metabolite |
3-hydroxy-3-methyl-hexanoic acid | [no description available] | low | 0 | 0 | 3-hydroxy monocarboxylic acid; volatile organic compound | human metabolite |